6-3B3, ANTI-ARS
8/7p10'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
N901L/KOL, ANTI-CD56
e'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
F1_1171'CL, ANTI-FRACTION 1
LG10-1'CL, ANTI-NUCLEOSOME
7G7'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
84-18'CL, ANTI-DNA
H50'CL, ANTI-LAMININ
FF61-2-E4'CL, ANTI-P-AZOPHENYLARSONATE
13'CL, ANTI-DNA AUTOANTIBODY
BO3'CL, ANTI-GM1 GANGLIOSIDE
Anti-Leu3a'CL, ANTI-CD4 (INHIBITING THE BINDING OF HIV GP120 TO CD4)
NQT17/30D'CL, ANTI-2-PHENYLOXAZOLONE
G2'CL, ANTI-ARS
slkv3'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
MRL2-41'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
18/17'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
HY GAL6, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
2E8'CL, ANTI-HUMAN APOLIPOPROTEIN E (SPECIFIC FOR THE LOW DENSITY LIPOPROTEIN RECEPTOR-BINDING SITE)
126HK'CL, ANTI-THYROID PEROXIDASE (TPO)
18.1.16'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
C6-7F12'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
DNA7'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
8G3'CL, ANTI-SM HYBRIDOMA
A4, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
T5-626'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
MMW.2.7.11'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
H3, ANTI-MESOTHELIN
hVH65-217'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=2.1X10EXP6)
Ga_13-H'CL, ANTI-DINITROPHENYL
19B8'CL, ANTI-SM HYBRIDOMA
MH6'CL, ANTI-ACETYLCHOLINE RECEPTOR
mAb 133'CL, ANTI-INSULIN
T8-203'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
Fc_18-H'CL, ANTI-DINITROPHENYL
HIV-B20'CL, ANTI-HIV-1 GP120
G2'CL, ANTI-ARS
UCVH'CL, ANTI-DNA, ANTI-MYELIN
H146-24B1'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
RF-TT9'CL, RHEUMATOID FACTOR
F1_1485'CL, ANTI-FRACTION 1
1E9''CL, ANTI-(NANP)3 DODECAPEPTIDE
B12-3'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
HIV-loop35'CL, ANTI-HIV-1 GP120
T10-5'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
ToP305'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
ITC52'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
Ia_23-H'CL, ANTI-DINITROPHENYL
HF2-1/17, PLATE-BINDING ANTI-DNA AUTOANTIBODY
OVA'CL, ANTI-CHICKEN OVALBUMIN
14-36E1, ANTI-ARS
2INL8'CL, ANTI-HUMAN INSULIN
A.18'CL, ANTI-ARS
174.3F4, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
B72.3'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
MEMORY 17, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
HIV-LC24'CL, ANTI-HIV-1 GP120
Z85VH3'CL, CD20
AC38 205.12, ANTIBODY AC38-POSITIVE HYBRIDOMA
R2C5H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
49-1G5'CL, ANTI-(T,G)-A--L HYBRIDOMA
HV1-31'CL, ANTI-FLUORESCEIN
HB-1'CL, ANTI-HEPATITIS B SURFACE ANTIGEN
37.1E5.2a'CL, ANTI-ALPHA 1,6 DEXTRAN
MRL2-57'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
GLO, ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE; CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
83'CL, ANTI-DSDNA
P65D6-7'CL, ANTI-P-AZOPHENYLARSONATE (KA=2.55 TO 4.9X10EXP5)
HiH10'CL, ANTI-H. INFLUENZAE TYPE B OUTER MEMBRANE PROTEIN P1
SiP057'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
T23-9'CL, ANTI-DNA AUTOANTIBODY
7E10'CL, ANTI-SM HYBRIDOMA
Nb 17-H'CL, ANTI-DNP
I04'CL, ANTI-RH(D)
BA149A-2'CL, ANTI-DOUBLE STRANDED DNA
417.F1.1.35'CL, MONOREACTIVE
39-A11, CATALYTIC ANTIBODY WHICH CATALYSES A DIELS-ALDER REACTION
DB1-310.9'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
Bg359-6'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
HY GAL9, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
S2G7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
aly41-27'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
DF4-12.6'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
DNA12'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
K27-306, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
3B44'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
H56.406.48, ANTI-POLY(GLU60,ALA30,TYR10) DBA/2 HYBRIDOMA
SC5'CL, ANTI-MCPS
126AH'CL, ANTI-THYROID PEROXIDASE (TPO)
ToPA175'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
Na 60-H'CL, ANTI-DNP
Vl FUR2'CL, ANTI-LAMIN B AUTOANTIBODY
9F11'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
248.7B6'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
8C42'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
M2 332'CL, ANTI-MOUSE TYPE II COLLAGEN
ToPA138'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
NQ5 4.3.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
LS5'CL, ANTI-PR2 RBC AUTOANTIBODY
NZW5G3'CL, ANTI-DSDNA
cAbCA04, ANTI-CARBONIC ANHYDRASE
AC18'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
RF9-11A'CL, ANTI-IGG1
5H11'CL, ANTI-PIGEON CYTOCHROME C AND MOUSE CYTOCHROME C
126TP14H'CL, ANTI-THYROID PEROXIDASE (TPO)
MRL2-63'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
3F29-4-15'CL, ANTI-P-AZOPHENYLARSONATE
C94-4B11'CL, ANTI-(TYR,GLU)-ALA-LYS
C05'CL, ANTI-RH(D)
TE32'CL, ANTI-CTP3
BKV1'CL, ANTI-DSDNA
126TO10K'CL, ANTI-THYROID PEROXIDASE (TPO)
Fc_11-H'CL, ANTI-DINITROPHENYL
N901L/KV2F, ANTI-CD56
T8-2'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
2INL4'CL, ANTI-HUMAN INSULIN
131'CL, ANTI-ANGIOTENSION II; ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST MONOCLONAL ANTIBODY 110
Sulf-5'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
FV-ALPHA, ANTI-HCG
HP20'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
H146-24E9'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
mAb426.4.2F20'CL, POLYREACTIVE AUTOANTIBODY
G1-9'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
5.5'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
PERU1'CL, ANTI-P-AZOPHENYLARSONATE
D9D10'CL, ANTI-HUMAN INTERFERON-GAMMA
15-30'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
PR-SJ2'CL, POLYREACTIVE RHEUMATOID FACTOR
BW9-11'CL, ANTI-DNA
MICA 3'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
2A1'CL, ANTI-SM HYBRIDOMA
207.7B10'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
B-33'CL, ANTI-CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR/INSULIN-LIKE GROWTH FACTOR TYPE -2 RECEPTOR
8E3'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
HIV-s5'CL, ANTI-HIV-1 GP120
BMA 031-EUCIV2'CL, ANTI-HUMAN T-CELL RECEPTOR HUMANIZED ANTIBODY
Ia_01-H'CL, ANTI-DINITROPHENYL
ANTI-ARS, ANTI-P-AZOPHENYLARSONATE
133.16'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
RA-4-Pd2'CL, RHEUMATOID FACTOR
4B1'CL, ANTI-DNA
2D9H'CL, ANTI-MURINE SERUM ALBUMIN
RF1-7K'CL, ANTI-IGG1
PL2-6'CL, ANTI-SUBNUCLEOSOMES (H2A-H2B-DNA)
H37-90'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
C7'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
36-65 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=2.5X10EXP5)
ASWA3'CL, ANTI-NUCLEOLAR PARTICLES U3, U8 AND FIBRILLARIN
42.2A.7.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
B-24'CL, ANTI-CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR/INSULIN-LIKE GROWTH FACTOR TYPE -2 RECEPTOR
S35776'CL, ANTI-TESTOSTERONE
261.2F5'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
S8'CL, ANTI-ARS
BrM8'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC, TRIMETHYLAMMONIUM HYBRIDOMA
ALN/17/172'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
40-100, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=7.1X10EXP9)
RF-TS5'CL, MONOREACTIVE RHEUMATOID FACTOR
alpha-poxn2, ANTI-POXN
HG2B10H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
2C8'CL, ANTI-HUMAN INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT (TAC PROTEIN)
L11'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCARIDE
RF3-2CR2A'CL, ANTI-IGG2A
10I'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
FV/IL-2'CL, ANTI-TAG72
3G9'CL, ANTI-DNA
417.F14'CL, MONOREACTIVE TO BETA-GALACTOSIDASE
RF-TT1'CL, RHEUMATOID FACTOR
HuMAb22-13'CL, ANTI-LUNG TUMOR-ASSOCIATED ANTIGEN
563'CL, ANTI-DNA AUTOANTIBODY
mAb 123'CL, ANTI-INSULIN HYBRIDOMA
1F6'CL, ANTI-FECAL BACTERIA
LOI, ANTI-COMPLEMENT FACTOR H (LIGHT CHAIN DIMER)
E63, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
1A11'CL, ANTI-SSDNA HYBRIDOMA
Hb-1, ANTI-FOETAL HAEMOGLOBIN (HBF)
La 34-H'CL, ANTI-DNP
SO2'CL, ANTI9-HLA-DQ3
BWGB9F9'CL, ANTI-DSDNA
bfd39'CL, ANTI-SSDNA HYBRIDOMA
K14'CL, ANTI-HIV-1 GP41.
D2.5'CL, ANTI-NITROBENZYL PHOSPHONATE (TRANSITION STATE ANALOG)
HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME
48SNQP121, ANTI-2-PHENYLOXAZOLONE
mAb105'CL, ANTI-RABIES VIRUS
Ann6'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
BW10C2'CL, ANTI-DSDNA
G7 AB 2.9, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
aPC-63-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP II)
TEPC952, ANTI-EPSILON-DNP-AMINOCAPROATE(BINDING CONSTANT=6.3X10EXP6)
A8C8'CL, ANTI-TETANUS TOXOID
La 04-H'CL, ANTI-DNP
17/9'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HA1 (RESIDUES 75-110) HYBRIDOMA
LN2 189'CL, ANTI-MOUSE TYPE II COLLAGEN
P17.80'CL, ANTI-DNA
slkv12'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
hsiglvk643'CL, ANTI-RABBIT IGG
265.15E8'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
SB5/D6'CL, ANTI HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (RIBOSYLRIBITOLPHOSPHATE)
m32,33, ANTI-IDIOTYPIC
10VA2'CL, AUTOANTIBODY TO THYROGLOBULIN
T6-112'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
BS1z10'CL, ANTI-PHOSPHORYLCHOLINE
L71'CL, ANTI-HUMAN CD4
409'CL, ANTI-P601E
S107.U4'CL, ANTI-DOUBLE-STRANDED DNA
MRL2-186'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
7B6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
d9/14'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
H165-156A2'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
B7'CL, ANTI-HUMAN CARDIAC MYOSIN
HDEX9, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
11IC6'CL, AUTOANTIBODY TO THYROGLOBULIN
s6A3'CL, ANTI-SSDNA/CARDIOLIPIN AUTOANTIBODY
F12.21D2'CL, ANTI-DSDNA
AN02'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=7.5X10EXP6)
ToPG435'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
44.1'CL, ANTI-P-AZOPHENYLARSONATE-KEYHOLE LIMPET HEMOCYANIN
F28C4'CL, ANTI-MYELINE BASIC PROTEIN, ACETYL RESIDUES 1-9
PC3741'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
Z122VH5'CL, CD20
10/8'CL, ANTI-PROGESTERONE HYBRIDOMA
DB1-314.3'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
kappa3'CL, ANTI-HUMAN THYROGLOBULIN
H130'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
CC83'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
UC'CL, ANTI-MYELIN/SSDNA
D2'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST THE THYROTROPIN (TSH) RECEPTOR
MOR44'CL, ANTI-MORPHINE
ToP217'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
T093'CL, ANTI-NITROPHENYL
SW6-3'CL, ANTI-DNA
CLONE 1C4'CL, ANTI-HUMAN RED BLOOD CELL
Dob1'CL, ANTI-STREPTOCOCCUS PNEUMONIAE 6B
6-4'CL, ANTI-IGG2A
G1-1'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
NQ10 15.9'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
103-6'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
mAb49'CL, ANTI-INSULIN
MRA12K'CL, ANTI-HISTONE
103-24'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
HPCM3, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=3.4X10EXP4)
F8, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
ToPA255'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
47SNQP33, ANTI-2-PHENYLOXAZOLONE
DB3'CL, ANTI-PROGESTERONE HYBRIDOMA
402K-B5, ANTI-HIV GP120 V3-LOOP (K OFF = 2.4 X 10EXP-4 SEC-1)
25.12'CL, ANTI-DNA
H280-15'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
CC49'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
4422, ANTI-TYPE II PNEUMOCOCCAL POLYSACCHARIDE
L3G11'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
BKV39'CL, ANTI-DNA
A4'CL, ANTI-GLYCOPHORIN A
NQ2 20.5.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
Day 4 15-164-1'CL, ANTI-2-PHENYL-5-OXAZOLONE
L39'CL, AUTOANTIBODY
F6, ANTI-MESOTHELIN
MRA1H'CL, ANTI-HISTONE
5A3'CL, ANTI-GALACTOSYLGLOBOSIDE
BKD10'CL, ANTI-DSDNA
73-23'CL, ANTI-DNA
NQ11.8.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
No.86'CL, ANTI-HIV GP41
47SNQP23, ANTI-2-PHENYLOXAZOLONE
603'CL, ANTI-MEP-1 17-31 PEPTIDE
NQ17.10.24'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
M56'CL, ANTI-SMITH ANTIGEN HYBRIDOMA
126TP1K'CL, ANTI-THYROID PEROXIDASE (TPO)
D61, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
36.5.7B'CL, ANTI-ALPHA 1,6 DEXTRAN
Bg112-9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
126TO1K'CL, ANTI-THYROID PEROXIDASE (TPO)
165.41'CL, ANTI-DNA
T'CL, ANTI-2-PHENYLOXAZOL-5-ONE
CNJ123'CL, ANTI-P-NITROPHENYL PHOSPHONATE
HY GAL8, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
F11.2.32'CL, ANTI-HIV-1 PROTEASE (KA = 5 NM)
H163-130F2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
P4.6.1'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
BKD10'CL, ANTI-DSDNA
F7.50B1'CL, ANTI-DSDNA
402P4-A9, ANTI-HIV GP120 V3-LOOP (K OFF = 1.4 X 10EXP-4 SEC-1)
234'CL, ANTI-P601E
Da_13-H'CL, ANTI-DINITROPHENYL
HNK20 hu10, ANTI-RESPIRATORY SYNCYTIAL VIRUS
S4P11'CL, RHEUMATOID FACTOR
O18'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCARIDE
G08, ANTI-LYSOZYME HYBRIDOMA
NZB/NZW-11'CL, ANTI-DNA
65.1B3'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
DNA2'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
IM9-2, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN
NQT15/25A'CL, ANTI-2-PHENYLOXAZOLONE
36-15'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
NZB/NZW-5'CL, ANTI-DNA
IAG-1, ANTI-POLYAMINE, CROSS REACTS WITH SPERMIDINE
17s.21'CL, ANTI-DNA
4C11'CL, ANTI-TEPC15 IDIOTYPE ANTIBODY HYBRIDOMA
416.F2.2.34'CL, POLYREACTIVE
C8'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
S107, ANTI-PHOSPHORYLCHOLINE
NQ2/16.2'CL, ANTI-2-PHENYL OXAZOLONE
15e'CL, ANTI-CD4 BINDING SITE OF HIV-1 GP120
NQ6 8.3.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
05'CL, ANTI-DNA AUTOANTIBODY
R16.7 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
AC38 251.5, ANTIBODY AC38-POSITIVE HYBRIDOMA
B6.2'CL, ANTI-HUMAN CARCINOMA CELL HYBRIDOMA WHICH REACTS WITH HUMAN BREAST, LUNG AND COLON CARCINOMA
2C11'CL, ANTI-(NANP) 3 DODECAPEPTIDE
H220-23'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
NZB/NZW-9'CL, ANTI-DNA
Ga_04-H'CL, ANTI-DINITROPHENYL
CBLC235.7'CL, ANTI-BACTERIAL LEVAN
2E7'CL, ANTI-(NANP) 3 DODECAPEPTIDE
HP12'CL, ANTI-PRIVATE IDIOTYPE HYBRIDOMA OF THE GAT SYSTEM
C5-7B12'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
BKD19'CL, ANTI-DSDNA
D23''CL, ANTI-DNA
HIV-b8'CL, ANTI-HIV-1 GP120
Da_14-H'CL, ANTI-DINITROPHENYL
17s.23'CL, ANTI-DNA
AL3-4'CL, ANTI-POLYCATION
NQ10.2.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
Nb 18-H'CL, ANTI-DNP
20.1.43'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
BBLC310.2'CL, ANTI-BACTERIAL LEVAN
NQ7.7.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
717'CL, ANTI-P601E
cDNA4-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
hu2.0, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
BW7E6H1'CL, ANTI-DSDNA
aPC-47-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP II)
Z30VH3'CL, CD20
Ib_17-H'CL, ANTI-DINITROPHENYL
Z17VH3'CL, CD20
BV17-45'CL, ANTI-DSDNA (94%), SSDNA (45%), POLY(DA)
AL3-8'CL, ANTI-POLYCATION
NC13B12'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
26.4.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
scFv192'CL, ANTI-MIR
NQ2 12.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
4-35-7'CL, ANTI-HLA-A1, A23 AND A24
MMW.4.9'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
DP11'CL, ANTI-DNA
Z32VH3'CL, CD20
MC1'CL, ANTI-IDIOTYPIC ANTIBODY RECOGNIZING IDIOTYPE ON ANTI-HIV-1 GP120
Na 89-H'CL, ANTI-DNP
Da_01-H'CL, ANTI-DINITROPHENYL
MRL2-154'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
HuVH'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS (LOW AFFINITY)
L2F10'CL, ANTI-SSDNA AUTOANTIBODY
F1_1471'CL, ANTI-FRACTION 1
NC19-B8G2'CL, ANTI-PHOSPHATIDYL CHOLINE
RF-TT5'CL, RHEUMATOID FACTOR
TR1.6'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
Jb_20-H'CL, ANTI-DINITROPHENYL
CL-J'CL, ANTI-ERYTHROCYTE
NZB/NZW-12'CL, ANTI-DNA
C3H-8'CL, ANTI-DNA
NQT17/40A'CL, ANTI-2-PHENYLOXAZOLONE
ITC39'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
bkv33'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
VH A30, ANTI-CD34
L34'CL, ANTI-HUMAN CD4
Fc_08-H'CL, ANTI-DINITROPHENYL
1C6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 3 (KD = 2.0 X 10EXP-8)
4G12'CL, ANTI-MALIGNANT TUMOR, BROAD SPECIFICITY ESPECIALLY FOR LUNG SQUAMOUS CELL CARCINOMA, HYBRIDOMA
G1'CL, ANTI-ARS
V-88, ANTI-SSDNA
SCH94.03'CL, ANTI-SPECTRIN AUTOANTIBODY
206.4D10'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
HF5.49'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
H210'CL, ANTI-HEPATITIS A VIRUS
H153-70A12'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
GER, MONOCLONAL CRYOIMMUNOGLOBULIN
T5-314'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
AS.1.15'CL, ANTI-HIV-1 GP120 V3 LOOP
12C4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
7B10'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
mAb A''CL, ANTI-CYCLOSPORINE
TR1.9'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
ITC52'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
C52-3G1'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
p4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
s6C9'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
4D11F4'CL, ANTI-TG
UPC10'CL, ANTI-BETA 2,6 FRUCTOSAN
C94-5B11'CL, ANTI-(TYR,GLU)-ALA-LYS
B01'CL, ANTI-RH(D)
48SNQP21, ANTI-2-PHENYLOXAZOLONE
bfd38'CL, ANTI-SSDNA/DSDNA HYBRIDOMA
BA12CD-1'CL, ANTI-DSDNA
N901L/KV4B, ANTI-CD56
HIV-HC1'CL, ANTI-HIV-1 GP120
Day 4 15-164-2'CL, ANTI-2-PHENYL-5-OXAZOLONE
NC6-C12'CL, ANTI-PHOSPHATIDYL CHOLINE
scF11, ANTI-HUMAN FERRITIN
RF-2 PAN'CL, ANTI-IGG-PAN RHEUMATOID FACTOR
11-14F5, ANTI-ARS
1B8'CL, ANTI-HIV GP41 HYBRIDOMA
A6/24'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
6H-3C4'CL, HUMAN SPERM-IMMOBILIZING ANTIBODY
8'CL, ANTI-INSULIN
C1'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
1C4D8.8'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=5.47X10EXP5)
53R-1'CL, ANTI-3M-1
JV9'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
LL2'CL, ANTI-CD22, A SURFACE MOLECULE PRESENT ON B CELL LYMPHOMA
22.218.1'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
5D9'CL, ANTI-PIGEON CYTOCHROME C AND MOUSE CYTOCHROME C
CB20'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
3.B6'CL, ANTI-DNA AUTOANTIBODY.
MN14C11.6, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
MMW.2.7.1'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
SiP005'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
ESC'CL, AUTOANTIBODY
LN2 97'CL, ANTI-MOUSE TYPE II COLLAGEN
56R-9'CL, ANTI-3M-1/ANTI-TUBULAR BASEMENT MEMBRANE
WEI', CRYOGLOBULIN WITH ANTI-LOW-DENSITY LIPOPROTEIN ACTIVITY; B IDIOTYPE
5-14'CL, ANTI-FLUORESCEIN (KA=1.0X10EXP8)
10K26-12A1, ANTI-P-AZOPHENYLARSONATE
26C2'CL, ANTI-P-AZOPHENYLARSONATE
CG-7'CL, ANTI-ERYTHROCYTE
NQT15/18'CL, ANTI-2-PHENYLOXAZOLONE.
mAb113'CL, ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
E49, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
B12-8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
NZW10D8'CL, ANTI-DSDNA
5-27'CL, ANTI-FLUORESCEIN (KA=5.3X10EXP8)
HPCM6, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
HNK20 hu7, ANTI-RESPIRATORY SYNCYTIAL VIRUS
ToP241'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
G1-14'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
OX1''CL, ANTI-2-PHENYLOXAZOLONE.
Amu35-2'CL, ANTI-DNA
VHTF'CL, ANTI-PORCINE TRANSFERRIN
H51.5.2, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C X DBA/2 HYBRIDOMA
B13H4C8'CL, ANTI-MURINE ERYTHROCYTE AUTOANTIBODY
K-25, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
S'CL, ANTI-2-PHENYLOXAZOL-5-ONE
MMW.4.16'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
B4.13.2'CL, ANTI-MOUSE ERYTHROCYTE AUTOANTIBODY
431'CL, ANTI-P601E
YSE'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
lambda1'CL, ANTI-HUMAN THYROGLOBULIN
NC10.11'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
SP26-2'CL, ANTI-DNA
2-4'CL, ANTI-SM HYBRIDOMA
HSCFV198'CL, ANTI-ACHR
HIV-b4'CL, ANTI-HIV-1 GP120
+13-77'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
T13.131.23'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
C488-24F'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
22S25.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
V-lambda-2.DS'CL, ANTI-DNA AUTOANTIBODY
SiP022'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
AF2'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
G1-2'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
9F12Fab'CL, ANTI-TETANUS TOXIN
G10, ANTI-LYSOZYME HYBRIDOMA
T099'CL, ANTI-NITROPHENYL
HPCA97'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
8/23p9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
1E6'CL, ANTI-HUMAN PROCOLLAGENASE
2INH2'CL, ANTI-HUMAN INSULIN
Ga_07-H'CL, ANTI-DINITROPHENYL
BA12CB-1'CL, ANTI-DOUBLE STRANDED DNA
slkv4'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
224.4C9'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
3C3'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
MMW.7.3'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
PE23'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
C72.H'CL, ANTI-DNA,POLY(DC),POLY(DG),POLY(DT)
F1_1254'CL, ANTI-FRACTION 1
4-4-20'CL, ANTI-FLUORESCEIN HYBRIDOMA(BINDING CONSTANT=1.7X10EXP10)
NQT17/29C'CL, ANTI-2-PHENYLOXAZOLONE
SW3-3'CL, ANTI-DNA
CLL'CL, ANTI-IGG (RHEUMATOID FACTOR)
82H'CL, ANTI-R585, A RABBIT ANTI-TAXOL ANTIBODY 
SR1C7'CL, ANTI-DIGOXIN
Nb 58-H'CL, ANTI-DNP
Vh REN'CL, ANTI-CARDIOLIPIN/BETA 2 GLYCOPROTEIN I AUTOANTIBODY
Rh.D1'CL, ANTI-D
ITC39'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
23-10E7'CL, ANTI-(T,G)-A--L HYBRIDOMA
MA 18/7'CL, ANTI-PRE-S1 REGION OF HEPATITIS B VIRUS
H9-A15'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
MuRSV19VH'CL, ANTI-HUMAN RESPIRATORY SYNCYTIAL VIRUS
HuVHNA'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS (MEDIUM AFFINITY)
NQ11.1.18'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
RF-4 PAN'CL, ANTI-IGG-PAN RHEUMATOID FACTOR
5H4'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 9.8X10EXP-8)
La 01-H'CL, ANTI-DNP
NOV, ANTI-POLY-ALPHA(2,8)-LINKED N-ACETYLNEURAMINIC ACID, POLY(A), AND POLY(I)
Agamma21-3'CL, ANTI-DNA
RF7-1'CL, ANTI-IGG2A
2G4'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
I07'CL, ANTI-RH(D)
DP18'CL, ANTI-DNA
1.2D7'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN HYBRIDOMA
AKR-3'CL, ANTI-DNA
D42'CL, ANTI-DNA AUTOANTIBODY, ANTI-POLY(DT) HYBRIDOMA
OKT3 scFv'CL, ANTI-HUMAN CD3 EPSILON
scFV195'CL, ANTI-MIR
21h'CL, ANTI-CD4 BINDING SITE OF HIV-1 GP120
74.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
11E7-1'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
44SNQP25, ANTI-2-PHENYLOXAZOLONE
CG-6'CL, ANTI-ERYTHROCYTE
1-7-3'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
H37-62'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
56R-3'CL, ANTI-3M-1
FOG1-A3'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
Da_10-H'CL, ANTI-DINITROPHENYL
H220-19'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
B'2 (Humkv328-Jk1)'CL, RHEUMATOID FACTOR
P'CL, ANTI-2-PHENYLOXAZOL-5-ONE
12F4'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
91A3 CRI-, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
PE20'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
C108G'CL, ANTI-HIV-1 GP120
131TP7H'CL, ANTI-THYROID PEROXIDASE (TPO)
M77'CL, ANTI-HIV-1 GP120 V3 LOOP (GPGRAF)
C108G clone 2'CL, ANTI-HIV-1 GP120
BA126E-2'CL, ANTI-DSDNA
IC5-4D1'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
Jc_09-H'CL, ANTI-DINITROPHENYL
Mb_49-H'CL, ANTI-DINITROPHENYL
BKD17'CL, ANTI-DSDNA
RSP1'CL, ANTI-SM ANTIGEN
JV6'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
8E6'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
RN901v1.1, ANTI-CD56
C96-6D7'CL, ANTI-(TYR,GLU)-ALA-LYS
HIV-s8'CL, ANTI-HIV-1 GP120
84-9'CL, ANTI-DNA
BrM11'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC HYBRIDOMA
K.Kpb1'CL, ANTI-KP B
PE1'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 187GGFMRG192
BKD23'CL, ANTI-DSDNA
s6H12'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
3D6'CL, ANTI-(NANP) 3 DODECAPEPTIDE
ATM-2, ANTI-TCR VBETA
2INH16'CL, ANTI-HUMAN INSULIN
MMW.4.14'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
44SNQP32, ANTI-2-PHENYLOXAZOLONE
L3'CL, ANTI-HEN EGG WHITE LYSOZYME
MMW.8.15'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
H241'CL, ANTI-DSDNA AND SSDNA AUTOANTIBODY
47SNQP17, ANTI-2-PHENYLOXAZOLONE
36.5.7Bu'CL, ANTI-ALPHA 1,6 DEXTRAN
CNJ2'CL, ANTI-P-NITROPHENYL PHOSPHONATE
CHATE1'CL, ANTI-FLUORESCEIN
ToPG335'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
C041'CL, ANTI-NITROPHENYL
APU-6'CL, ANTI-PSEUDOURIDINE
Day 4 15-164-12'CL, ANTI-2-PHENYL-5-OXAZOLONE
R1C8H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
A7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
H220-22'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
185C'CL, ANTI-FLUORESCEIN
242.2G4'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
126TP13H'CL, ANTI-THYROID PEROXIDASE (TPO)
E29, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
H1-9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
72-2'CL, ANTI-PERIPHERIN AUTOANTIBODY
FF61-2-E3'CL, ANTI-P-AZOPHENYLARSONATE
H33-48'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
MMW.2.7.6'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
48SNQP23, ANTI-2-PHENYLOXAZOLONE
T6-510'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
E4-9'CL, ANTI-CON A
2B6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
14-3E12, ANTI-ARS
P65D6-3'CL, ANTI-P-AZOPHENYLARSONATE (KA=1.7X10EXP5)
REGA-3G12'CL, ANTI-NEUTROPHIL GELATINASE B
4G11'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST THE THYROTROPIN (TSH) RECEPTOR
MRL1-29'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
P5Q'CL, ANTI-HIV GP120
S01'CL, ANTI-RH(D)
p20'CL, ANTI-HIV-1 GP120
A.24.7'CL, ANTI-DNA
BSc05'CL, ANTI-PHOSPHORYLCHOLINE
402J-F7, ANTI-HIV GP120 V3-LOOP (K OFF = 2.1 X 10EXP-4 SEC-1)
CH34'CL, ANTI-DISTEAROYL PHOSPHATIDYL CHOLINE, BROMELAIN-TREATED MOUSE ERYTHROCYTES, SHEEP ERYTHROCYTES, CHICKEN ERYTHROCYTES, E. COLI
1B6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
Fc_14-H'CL, ANTI-DINITROPHENYL
hVH65-211'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1.0X10EXP6)
BO1'CL, ANTI-GM1 GANGLIOSIDE
JAC-1, ANTI-POLYAMINE, CROSS REACTS WITH SPERMINE
119-a1'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
MRL1-70'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
2C3'CL, ANTI-HUMAN PROCOLLAGENASE
NP15-1'CL, ANTI-DNA
AZ-14'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
mAb58'CL, ANTI-RABIES VIRUS
165.45'CL, ANTI-DNA
251.13B2'CL, ANTI-PHOSPHORYLCHOLINE (P.MORGANII) HYBRIDOMA
rsv6L'CL, ANTI-RESPIRATORY SYNCYTIAL VIRUS F GLYCOPROTEIN
ED6.1'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
Fc_05-H'CL, ANTI-DINITROPHENYL
RF8-2'CL, ANTI-IGG2A
F6H3'CL, ANTI-DEXTRAN B512
NZB/NZW-3'CL, ANTI-DNA
U.2.1'CL, ANTI-HIV-1 GP120 V3 LOOP
F1_1354'CL, ANTI-FRACTION 1
C595, ANTI-(MUC1 MUCIN)
bkv22'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
SiP004'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
MOR8'CL, ANTI-MORPHINE
RF1-6'CL, ANTI-IGG2A
BW10D9'CL, ANTI-DSDNA
224.2B8'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
208,D-5, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
MMW.2.7.5'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
8C29'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
NC12H5'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
VM201'CL, ANTI-PR8 (HIN1) VIRUS VARIANT (VM113-V1)
B/SB5-39'CL, ANTI-H2A/H2B
SiP024'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
BB344'CL, ANTI HIV-1 P24 CORE PROTEIN
B12-7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
MP1'CL, ANTI-HLA CLASS II (DQB1*0201)
F10.17-8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
52-1'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
La 68-H'CL, ANTI-DNP
VLREN'CL, CD5+
HIV-b21'CL, ANTI-HIV-1 GP120
447, ANTI-HIV GP120 V3-LOOP (K OFF = 4.0 X 10EXP-4 SEC-1)
28.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
BKV39'CL, ANTI-DSDNA
2F7'CL, REACTS WITH RECOMBINANT HIV-1 GP160.
245F.6g'CL, ANTI-PGOSPHORYLCHOLINE, DSDNA
MEMORY 10, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
Lb 92-H'CL, ANTI-DNP
RF10-2'CL, ANTI-IGG2A
NQT15/23'CL, ANTI-2-PHENYLOXAZOLONE
mAb A41 kappa-1'CL, ANTI-HUMAN INTERLEUKIN-2 RECEPTOR BETA SUBUNIT (P75)
21/7'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
35-20, ANTI-DIGOXIN
DP7'CL, ANTI-DNA
23-9D10'CL, ANTI-(T,G)-A--L HYBRIDOMA
T5-334'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
HNK20, ANTI-RESPIRATORY SYNCYTIAL VIRUS
E20'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
F10.12-7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
8/7p11'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
564'CL, ANTI-DNA AUTOANTIBODY
F2-4'CL, ANTI-DNA
+26-108'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
RA-2-L21'CL, RHEUMATOID FACTOR
Py69, ANTI-PHOSPHOTYROSYLPROTEIN
202.135'CL, ANTI-DNA
MP6'CL, ANTI-HLA CLASS I (A*3002)
NC10.12'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
TB-1-P7'CL, RHEUMATOID FACTOR
180.2G6'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
MH6'CL, ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY
RF-2'CL, ANTI-IGG3 RHEUMATOID FACTOR
Fa_09-H'CL, ANTI-DINITROPHENYL
BW9-13'CL, ANTI-DNA
17F12'CL, ANTI-HUMAN IGG
28B4.2'CL, CATALYTIC ANTIBODY
AC11'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
72-11D3'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
2G8, ANTI-AZOBENZYLPHOSPHONATE
H1-45'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
17s.16'CL, ANTI-DNA
RN90v1.1, ANTI-CD56
PQXB1/2'CL, ANTI-PARAQUAT
O'CL, ANTI-2-PHENYLOXAZOL-5-ONE
WSc61'CL, ANTI-PHOSPHORYLCHOLINE
MRL2-75'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
MR-1'CL, ANTI-MURINE GP39
5C3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
CLONE 1C9'CL, ANTI-HUMAN RED BLOOD CELL
FS12, ANTI-VH4-34
XP-1, ANTI-P-AZOBENZOATE
N4-1'CL, ANTI-DS DNA HYBRIDOMA
126TP6K'CL, ANTI-THYROID PEROXIDASE (TPO)
mAb198'CL, ANTI-MAIN IMMUNOGENIC REGION OF HUMAN ACETYLCHOLINE RECEPTOR
MMW.2.7.17'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
Z97VH3'CL, CD20
1-20'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
RF-4'CL, ANTI-IGG1 RHEUMATOID FACTOR
NC10.14'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
NGD9'CL, ANTI-DSDNA AUTOANTIBODY
RF-DI2'CL, RHEUMATOID FACTOR
46E7'CL, ANTI-RH(D)
ToP202'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
126TP15K'CL, ANTI-THYROID PEROXIDASE (TPO)
12S28-16'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
E14, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
VH FUR1'CL, ANTI-LAMIN B AUTOANTIBODY
47SNQP19, ANTI-2-PHENYLOXAZOLONE
FF61-2-E5'CL, ANTI-P-AZOPHENYLARSONATE
C6, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
6A4'CL, ANTI-PSEUDOMONAS AERUGINOSA OUTER MEMBRANE PROTEIN I
F5-1336'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
CH27'CL, ANTI-DISTEAROYL PHOSPHATIDYL CHOLINE, BROMELAIN-TREATED MOUSE ERYTHROCYTES, SHEEP ERYTHROCYTES, CHICKEN ERYTHROCYTES
3B6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
MRL1-56'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
BI1279'CL, ANTI HIV-1 P24 CORE PROTEIN
ToPA184'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
D11'CL, ANTI-SEROTYPE 8 STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE
GP-3'CL, ANTI-ERYTHROCYTE
Lb 17-H'CL, ANTI-DNP
PC49'CL, ANTI-PS1CT3
NP4-1'CL, ANTI-DNA
AB3'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
7-13'CL, ANTI-SM
HIV-HC14'CL, ANTI-HIV-1 GP120
Da_11-H'CL, ANTI-DINITROPHENYL
3381, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
RF6-6A'CL, ANTI-IGG1
H241'CL, ANTI-NATIVE DNA AUTOANTIBODY
F240'CL, ANTI-HIV-1 GP41 AND GP160
SE20.2'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
KIM46L'CL, ANTI-DNA HYBRIDOMA
HuHMFG1'CL, ANTI-HUMAN MUCIN
NQ19.8.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
ZM1-1'CL, ANTI-HEPATITUS B VIRUS SURFACE ANTIGEN ('A' DETERMINANT)
H12'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
242.4G3'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
A02, ANTI-LYSOZYME HYBRIDOMA
H1-51'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
8/7p7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
F19ML1'CL, ANTI-SSDNA, POLY-DT
126TO1H'CL, ANTI-THYROID PEROXIDASE (TPO)
scFv 1F9'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
419.1'CL, ANTI-P-AZOPHENYLARSONATE-KEYHOLE LIMPET HEMOCYANIN
MD3-4'CL, ANTI-HEPATITUS B VIRUS SURFACE ANTIGEN ('A' DETERMINANT)
COF'CL, RHEUMATOID FACTOR
MMW.2.6.10'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
98-1F5'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN HYBRIDOMA
TB-3-D91'CL, RHEUMATOID FACTOR
S2OA2, ANTI-VH4-34
HIV-s6'CL, ANTI-HIV-1 GP120
68.3D3'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
bkv17'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
1F6'CL, ANTI-PIGEON CYTOCHROME C AND MOUSE CYTOCHROME C
D10'CL, ANTI-RH(D)
0.5-BETA'CL, ANTI-PRINCIPLE NEUTRALIZING DOMAIN (PND) OF HIV-1 GP120
AD10/13'CL, ANTI-ERYTHROCYTE RH(D) 
F3, ANTI-MESOTHELIN
A31.90'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
NQ11.8.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
Fc_10-H'CL, ANTI-DINITROPHENYL
CLONE 1G7'CL, ANTI-HUMAN RED BLOOD CELL
H144-17B7'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
HA-3'CL, ANTI-ERYTHROCYTE
93G7, ANTI-ARSONATE
FS-4'CL, COLD AGGLUTININ
CAL-19'CL, ANTI-CARDIOLIPIN
Na 24-H'CL, ANTI-DNP
Amu1D11-3'CL, ANTI-DNA
C80-3E12'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
8C24'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
slkv13'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
19/3'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
A1.2'CL, ANTI-HEPATITIS B SURFACE ANTIGEN
L2B8'CL, ANTI-SSDNA AUTOANTIBODY
mAb B'CL, ANTI-CYCLOSPORINE
aPC-23-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
81D2'CL, AUTOANTIBODY TO THYROGLOBULIN
C25'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 2 (KD = 1.1 X 10EXP-9)
P65D6-5'CL, ANTI-P-AZOPHENYLARSONATE (KA=3.6X10EXP5)
3F29-4-4'CL, ANTI-P-AZOPHENYLARSONATE
RF4-4'CL, ANTI-IGG2A
BKD34'CL, ANTI-DNA
8/23p1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
FF29-36-10'CL, ANTI-P-AZOPHENYLARSONATE
2B12B3'CL, ANTI-DER P 2  (HOUSE DUST MITE ALLERGEN)
111.68'CL, ANTI-DNA
NQT15/5'CL, ANTI-2-PHENYLOXAZOLONE.
88C6/12'CL, ANTI-4-HYDROXY-3NITROPHENYL ACETIC ACID
FF57-9-7'CL, ANTI-P-AZOPHENYLARSONATE
WS2z13'CL, ANTI-PHOSPHORYLCHOLINE
2B9H'CL, ANTI-MURINE SERUM ALBUMIN
14.7.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
105-2H'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
T33-17'CL, ANTI-DNA AUTOANTIBODY
605'CL, ANTI-MEP-1 17-31 PEPTIDE
AP.1.7'CL, ANTI-HIV-1 GP120 V3 LOOP
SW3-1'CL, ANTI-DNA
EL-14'CL, ANTI-FACTOR VIII
4.3.6F8'CL, ANTI-ALPHA 1,6 DEXTRAN
pVCM(VD93)'CL, ANTI-PSEUDOMONAS AERUGINOSA HYBRIDOMA
HIV-HC9'CL, ANTI-HIV-1 GP120
HBW4-1'CL, ANTI-HIV GP120
AB1/2'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
RF-5'CL, ANTI-IGG1 RHEUMATOID FACTOR
1H12.3'CL, ANTI-DSDNA
SM2K'CL, ANTI-SM
L34'CL, AUTOANTIBODY
MRL-RF24'CL, ANTI-IGG1,2A,3 HYBRIDOMA
281.10'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
3H9'CL, ANTI-SSDNA, DSDNA, CARDIOLIPIN HYBRIDOMA
Jb_08-H'CL, ANTI-DINITROPHENYL
d9/7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
H73'CL, ANTI-DNA
HIV-LC13'CL, ANTI-HIV-1 GP120
SiP054'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
1G7'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
HUMANIZED YFC51.1'CL, ANTI-HUMAN CD18
48SNQP28, ANTI-2-PHENYLOXAZOLONE
Na 55-H'CL, ANTI-DNP
24A5'CL, ANTI-PH(D)
48SNQP128, ANTI-2-PHENYLOXAZOLONE
4D12'CL, ANTI-SM HYBRIDOMA
MRA3H'CL, ANTI-HISTONE
HUL-mRF'CL, ANTI-IGG (RHEUMATOID FACTOR)
Jb_24-H'CL, ANTI-DINITROPHENYL
44SNQP26, ANTI-2-PHENYLOXAZOLONE
G1'CL, ANTI-ARS
VD2H9'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
1-12'CL, ANTI-SM HYBRIDOMA
MAb 4C1'CL, ANTI-MAB 1/1
3F2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
BA12CB01'CL, ANTI-DSDNA
BMA 031 VH'CL, ANTI-HUMAN TCR-ALPHA/BETA
47SNQP10, ANTI-2-PHENYLOXAZOLONE
LS6'CL, ANTI-PR2 RBC AUTOANTIBODY
RF-ET9'CL, RHEUMATOID FACTOR
L37'CL, AUTOANTIBODY
H1, ANTI-MESOTHELIN
ToPG437'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
L11-1A1'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
bfd05'CL, ANTI-SSDNA HYBRIDOMA
40SNQP24, ANTI-2-PHENYLOXAZOLONE
My10, ANTI-HUMAN CD34 (KD = 2.4 X 10EXP-7 M)
126TO6H'CL, ANTI-THYROID PEROXIDASE (TPO)
MMW.8.7'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
Lb 82-H'CL, ANTI-DNP
B122'CL, ANTI-DENATURED DNA, ANTI-PLATELET
O-81'CL, ANTI-SSDNA
BSc51'CL, ANTI-PHOSPHORYLCHOLINE
BKV22'CL, ANTI-DNA
3G3'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
NPYII-269.3'CL, ANTI-NEUROPEPTIDE Y
I05'CL, ANTI-RH(D)
205.12'CL, ANTI-IDIOTOPE HYBRIDOMA
MRL2-98'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
S63, ANTI-PHOSPHORYLCHOLINE
NQT17/29'CL, ANTI-2-PHENYLOXAZOLONE.
S3 12D'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
VH G61'CL, ANTI-GLUTATHIONE S-TRANSFERASE
mAb A''CL, ANTI-HALOPERIDOL.
CB 268'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
ToP016'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
M02/10/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
B4'CL, ANTI-F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
PM81'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
IC5-4F4'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
CAL-17'CL, ANTI-CARDIOLIPIN
163.43'CL, ANTI-DNA
K1, ANTI-MESOTHELIN
Ib_10-H'CL, ANTI-DINITROPHENYL
+10-151'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
BSb12'CL, ANTI-PHOSPHORYLCHOLINE
scFv(digoxin)'CL, ANTI-DIGOXIN
S21'CL, ANTI-ARS
cDNA1-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
262.9'CL, ANTI-B1335 DEX
10.82'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
SiP014'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
S2-14.2'CL, ANTI-TC,ANTI-RBC
LB4'CL, ANTI-DIGOXIN
84-26'CL, ANTI-DNA
anti-Est'CL, ANTI-17 BETA-ESTRADIOL (BINDING CONSTANT = 1.01 X 10EXP8)
3C8H'CL, ANTI-MURINE SERUM ALBUMIN
8C3.2'CL, ANTI-DSDNA
HPCG14, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=4.4X10EXP5)
L77'CL, ANTI-HUMAN CD4
7D7-3'CL, ANTI-PARAQUAT
Z55VH3'CL, CD20
B3(Fv)'CL, ANTI-CARBOHYDRATE ANTIGEN IN THE LEY FAMILY
HuKLVH'CL, ANTI-HUMAN HIGH BINDING AFFINITY RECEPTOR FOR FC OF IGG (FCGRI)
3-24'CL, ANTI-FLUORESCEIN (KA=2.8X10EXP6)
7A4-1/212 SCA'CL, ANTIBODY CATALYSES HYDROLYSES OF P-CHLOROPHENYL ESTER 3
H220-7'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
HuVHNIKNA'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS (HIGH AFFINITY)
T4-57'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
103-48'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
Ab3 CE5'CL, ANTI-HUMAN TUMOR-ASSOCIATED ANTIGEN GA733
6F8'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
L3G5'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
F1_1352'CL, ANTI-FRACTION 1
Z86VH4'CL, CD20
MMW.8.2'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
BKD19'CL, ANTI-DSDNA
MabA34'CL, ANTI-HUMAN PLASMA APOLIPOPROTEIN A-1
Pab 101'CL, ANTI-CARBOXYL TERMINUS OF SV40 T ANTIGEN
GF4/1.1'CL, ANTI-TETANUS TOXOID
heavy5'CL, ANTI-HUMAN THYROGLOBULIN
18F7'CL, ANTI-SM HYBRIDOMA
scFv03, POLYSPECIFIC
16.3'CL, ANTI-B1335 DEX
8A7'CL, ANTI-GALACTOSYLGLOBOSIDE
T6-626'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
FF29-15-4'CL, ANTI-P-AZOPHENYLARSONATE
TR1.5'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
MRL2-169'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
d'CL, ANTI-2-PHENYLOXAZOL-5-ONE
Gu0-2'CL, ANTI-QUANOSINE
BW5F2'CL, ANTI-DOUBLE STRANDED DNA
RSP4'CL, ANTI-CARDIOLIPIN
d9/1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
F'CL, ANTI-2-PHENYLOXAZOL-5-ONE
D6'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
LES, RHEUMATOID FACTOR
3F29-5-43'CL, ANTI-P-AZOPHENYLARSONATE
RF3-2CR2K'CL, ANTI-IGG2A
MOPC104E, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN
N901H/G36005, ANTI-CD56
F10.17-2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
HIV-b13'CL, ANTI-HIV-1 GP120
Day 2 15-167-8'CL, ANTI-2-PHENYL-5-OXAZOLONE
NQ22.9.11'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
C3H-6'CL, ANTI-DNA
SiP010'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
417.F33.3'CL, MONOREACTIVE
RT2B, ANTI-VH4-34
MMW.4.13'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
165.49'CL, ANTI-DNA
103-31'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
VTNP'CL, ANTI-2,4,6-TRINITROPHENYL HYBRIDOMA
V-K10 ARS-A'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
E225, ANTI-D1.3 HYBRIDOMA
131TP6H'CL, ANTI-THYROID PEROXIDASE (TPO)
d9/13'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
PMN29'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBDIROMA
163.2, ANTI-P53
6F6'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
EL-25'CL, ANTI-FACTOR VIII
Sulf-7'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
HuNMVH'CL, ANTI-HUMAN HIGH BINDING AFFINITY RECEPTOR FOR FC OF IGG (FCGRI)
AG11'CL, ANTI-C-TERMINUS OF NEF OF HIV-1 STRAIN LAI (VARELHPEYFKNC) BUT NOT SF2 (MARELHPEYYKDC)
NQ11 8.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
Vl REN'CL, ANTI-CARDIOLIPIN/BETA 2 GLYCOPROTEIN I AUTOANTIBODY
NQT17/30B'CL, ANTI-2-PHENYLOXAZOLONE
48SNQP110, ANTI-2-PHENYLOXAZOLONE
LES-A'CL, RHEUMATOID FACTOR
MMW.4.7'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
119-a31'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
B17-1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
BBLC508.17'CL, ANTI-BACTERIAL LEVAN
VH iii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
PME77'CL, ANTI-DNA HYBRIDOMA
WSc77'CL, ANTI-PHOSPHORYLCHOLINE
HSCFV198, ANTI-ACHR
2-12'CL, ANTI-SM HYBRIDOMA
2D9L'CL, ANTI-MURINE SERUM ALBUMIN
18.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
HP25'CL, ANTI-PUBLIC IDIOTYPE HYBRIDOMA OF THE GAT SYSTEM
C08'CL, ANTI-RH(D)
123E6 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
PL2-4'CL, ANTI-SUBNUCLEOSOMES (H2A-H2B-DNA)
T33-5'CL, ANTI-DNA AUTOANTIBODY
P3.6.5'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
MMW.7.11'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
AH7'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
Bg110-2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL (KA=2.9X10EXP6)
S204'CL, ANTI-DNA
AAD4-3/3'CL, ANTI-DSDNA
40-40, ANTI-DIGOXIN
174.2E10'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
N61'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
PB17IV'CL, ANTI-STREPTOCOCCUS GROUP A CARBOHYDRATE WITH SPECIFICITY FOR N-ACETYL GLUCOSAMINE
1E-81'CL, ANTI-DNA
70.3.1'CL, ANTI-DNA, ACTIN, MYOSIN
9702'CL, ANTI-DENATURED DNA, ANTI-PLATELET
PV11'CL, ANTI-DSDNA AUTOANTIBODY
A12', ANTI-LYSOZYME HYBRIDOMA
SiP065'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
43SNQP27, ANTI-2-PHENYLOXAZOLONE
S/SB5-72'CL, ANTI-H4
MMW.4.17'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
B/SB5-41'CL, ANTI-H4
SC8'CL, ANTI-MCPS
BLY3'CL, ANTI-CD19
AN06'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=1.2X10EXP7)
MMW.2.7.15'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
NQT17/45D'CL, ANTI-2-PHENYLOXAZOLONE
D9D10'CL, ANTI-HUMAN INTERFERON-GAMMA
MN12H2'CL, ANTI-OUTER MEMBRANE PROTEIN PORA OF NEISSERIA MENINGITIDIS
Na 88-H'CL, ANTI-DNP
LN2 423'CL, ANTI-MOUSE TYPE II COLLAGEN
18.1'CL, ANTI-BACTERIAL LEVAN
CBPC-49'CL, ANTI-EPSILON-DNP-AMINOCAPROATE(BINDING CONSTANT=1.3X10EXP6)
NZB/NZW-10'CL, ANTI-DNA
BW6F11'CL, ANTI-DSDNA
RF-IP9'CL, RHEUMATOID FACTOR
ToP014'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
NQT17/53B'CL, ANTI-2-PHENYLOXAZOLONE
ARMVH'CL, ANTI-MYELIN ASSOCIATED PROTEIN
ToPG438'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
48SNQP9, ANTI-2-PHENYLOXAZOLONE
Ia_26-H'CL, ANTI-DINITROPHENYL
FF29-39-3'CL, ANTI-P-AZOPHENYLARSONATE
ToP018'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
LS8'CL, ANTI-PR2 RBC AUTOANTIBODY
BS.1.21'CL, ANTI-HIV-1 GP120 V3 LOOP
81C6'CL, ANTI-TENASCIN
B11'CL, ANTI-IDIOTYPE OF THE MURINE MAB RSV19
W3082, ANTI-BETA 2,1 FRUCTOSAN
G01'CL, ANTI-RH(D)
NQ6 24.2.2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
163.67'CL, ANTI-DNA
BSb15'CL, ANTI-PHOSPHORYLCHOLINE
98-6'CL, ANTI-HIV TYPE 1 SPECIFIC FOR AMINO ACIDS 644-663 OF GP41
MRA5K'CL, ANTI-HISTONE
L2 8C'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
402K-G1, ANTI-HIV GP120 V3-LOOP (K OFF = 2.3 X 10EXP-4 SEC-1)
Ia_32-H'CL, ANTI-DINITROPHENYL
5E2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-CONJUGATED CHICKEN GAMMA GLOBULIN
HIV-HC3'CL, ANTI-HIV-1 GP120
42.5D4.2'CL, ANTI-ALPHA 1,6 DEXTRAN
alphaGPIIIa leu 33'CL, ANTI-LEUCINE-33 FORM OF PLATELET GLYCOPROTEIN IIIA
ITC52'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
56R-7'CL, ANTI-3M-1
111.61'CL, ANTI-DNA
Ab44'CL, POLYREACTIVE AUTOANTIBODY
NPYII-1.2'CL, ANTI-NEUROPEPTIDE Y
MP12'CL, ANTI-HLA CLASS II (DRB1*11)
MICA 7'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
SC6'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE
40-20, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=5.9X10EXP9)
12S18-1'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
CBA/J 6F9, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=6.1X10EXP5)
1G3.E3'CL, ANTI-COW 44 CYTOCHROME C
DN4'CL, ANTI-MCPS
126GH'CL, ANTI-THYROID PEROXIDASE (TPO)
mAb57'CL, ANTI-RABIES VIRUS
MRL1-50'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
48SNQP138, ANTI-2-PHENYLOXAZOLONE
K01'CL, ANTI-RH(D)
AD4-37'CL, ANTI-DSDNA
5E9''CL, ANTI-SM HYBRIDOMA
84-11'CL, ANTI-DNA
'CL, ANTI-MELANOMA
JD21'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
DZ33'CL, ANTI-HIV-1
M37GO37'CL, ANTI-E2 COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX
24-5E1, ANTI-ARS
43F10'CL, ANTI-RH(D)
1G5'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
F172-D8'CL, ANTI-HIV-1
19.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
SiP053'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
SiP042'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
W230'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
2G9'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN HYBRIDOMA
mAb G'CL, ANTI-CYCLOSPORINE
111.34'CL, ANTI-DNA
44SNQP29, ANTI-2-PHENYLOXAZOLONE
Day 2 15-164-3'CL, ANTI-2-PHENYL-5-OXAZOLONE
LB8'CL, ANTI-PASTEURELLA PNEUMOTROPICA HYBRIDOMA
CP5 B5-3'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
14.6b.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
H37-40'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
HIV-HC13'CL, ANTI-HIV-1 GP120
J04'CL, ANTI-RH(D)
ToPA113'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
202.61'CL, ANTI-DNA
13E10'CL, ANTI-PH(D)
HDEX4, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
126TP5K'CL, ANTI-THYROID PEROXIDASE (TPO)
1F3'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 4 (KD = 1.2 X 10EXP-8)
3B10'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
126TO10H'CL, ANTI-THYROID PEROXIDASE (TPO)
NQT15/2B'CL, ANTI-2-PHENYLOXAZOLONE
A9'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
9-12'CL, ANTI-IGG2A
19E11'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
BSb45'CL, ANTI-PHOSPHORYLCHOLINE
1/1'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=7X10EXP7)
AKR2'CL, ANTI-P-AZOPHENYLARSONATE
42.7B3.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX31, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
RFT2'CL, ANTI-CD7
HIV-HC11'CL, ANTI-HIV-1 GP120
ToPA135'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
H1-29'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
cAbAM07, ANTI-ALPHA-AMYLASE
Nb 09-H'CL, ANTI-DNP
MMW.8.8'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
104-A6'CL, ANTI-HEPATITIS B SURFACE ANTIGEN
26-1'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
BBLC259.11'CL, ANTI-BACTERIAL LEVAN
E3-19'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-CONJUGATED CHICKEN GAMMA GLOBULIN
L69'CL, ANTI-HIV-1 GP120
45-49'CL, ANTI-P-AZOPHENYLARSONATE
73-7'CL, ANTI-DNA
RF-IP24'CL, RHEUMATOID FACTOR
NZW12F7'CL, ANTI-DOUBLE STRANDED DNA
SM2R2A'CL, ANTI-SM
21.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
Y13-238 scFv'CL, ANTI-P21 RAS
BWR4.H'CL, ANTI-RNA,POLY(G,C)
402P5-B8, ANTI-HIV GP120 V3-LOOP (K OFF = 1.4 X 10EXP-4 SEC-1)
B9'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
587'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
RF-ET5'CL, RHEUMATOID FACTOR
Id3'CL, ANTI-TRINITROPHENYL
NQ19.22.21'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
VL A30, ANTI-CD34
NZB/NZW-14'CL, ANTI-DNA
PAY, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
Lb 15-H'CL, ANTI-DNP
T13.131.24'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
A1'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
NZW6B11'CL, ANTI-DSDNA
BW16E5'CL, ANTI-DSDNA
G10-1'CL, ANTI-HUMAN CD8
Vk FUR1'CL, ANTI-LAMIN B AUTOANTIBODY
AZ-4'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
SC17'CL, CATIONIC ANTI-DNA AUTOANTIBODY
E50, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
NZB/NZW-15'CL, ANTI-DNA
CP4 12-18'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
74.122'CL, ANTI-DNA
scFv27, ANTI-LOW DENSITY LIPROPROTAIN RECEPTOR THUS INHIBITING RHINOVIRUS INFECTION
CLONE 1E8'CL, ANTI-HUMAN RED BLOOD CELL
G71'CL, ANTI-MELANOMA
BB223'CL, ANTI HIV-1 P24 CORE PROTEIN
2-115-19'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
VL G69'CL, ANTI-GLUTATHIONE S-TRANSFERASE
VS3, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
103-25'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
ToP027'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
AB4'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
VL iii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
HIV-b29'CL, ANTI-HIV-1 GP120
SiP061'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
ToP310'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
BP.1.3'CL, ANTI-HIV-1 GP120 V3 LOOP
K02'CL, ANTI-RH(D)
5E1'CL, ANTI-HUMAN PROCOLLAGENASE
A2, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
S12M1'CL, ANTI-BROMELAIN-TREATED MOUSE RBC, SHEEP RBC, TRIMETHYLAMMONIUM HYBRIDOMA
E47, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
F19L16'CL, ANTI-SSDNA, CARDIOLIPIN, POLY-DT
MS1-1E10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
RF9-3'CL, ANTI-IGG2A
H220-11'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
12G10'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
SiP007'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
10K44-7A1, ANTI-P-AZOPHENYLARSONATE
T215'CL, ANTI-NITROPHENYL
DP15'CL, ANTI-DNA
1-2'CL, ANTI-IGG2A
B/SB5-72'CL, ANTI-H4
SW2-1'CL, ANTI-DNA
I10'CL, ANTI-RH(D)
T15-42'CL, ANTI-DNA AUTOANTIBODY
T34-1'CL, ANTI-DNA
GB4v2.0, ANTI-CD19
L11'CL, ANTI-GP41
B12'CL, ANTI-IDIOTYPE OF THE MURINE MAB RSV19
2.7.1G.10'CL, ANTI-CARCINOEMBRYONIC ANTIGEN HYBRIDOMA
clone 28'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
RF-DI1'CL, RHEUMATOID FACTOR
A5.B12.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
H20-A15'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
111.33'CL, ANTI-DNA
Fc_16-H'CL, ANTI-DINITROPHENYL
Jb_13-H'CL, ANTI-DINITROPHENYL
DBF1-235.4'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
p9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2E9E9'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
167.2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
mAb3.B6'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
165.52'CL, ANTI-DNA
F1C1'CL, ANTI-DEXTRAN B512
37-77'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
J7-11H3'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
G2b-3'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
3B5'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
RF-ET6'CL, RHEUMATOID FACTOR
OST577'CL, ANTI-HEPATITUS B VIRUS SURFACE ANTIGEN ('A' DETERMINANT)
IgG+ CL'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
L03'CL, ANTI-RH(D)
NQ11 7.12'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
D35'CL, ANTI-DINITROPHENYL HYBRIDOMA
126TP2K'CL, ANTI-THYROID PEROXIDASE (TPO)
A17'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
73-17'CL, ANTI-DNA
4F5'CL, ANTI-HUMAN PROCOLLAGENASE
MH5'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
M03/01/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
MRL1-20'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
13F1'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
NQT17/10B'CL, ANTI-2-PHENYLOXAZOLONE
93-6'CL, ANTI-BETA-SUBUNIT OF ESCHERICHIA COLI TRYPTOPHAN SYNTHETASE (BINDING CONSTANT=6.7XEXP9)
1-185-37'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
RF-FO2'CL, RHEUMATOID FACTOR
9.14.7'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
84-40'CL, ANTI-DNA
mAb C''CL, ANTI-HALOPERIDOL.
198.3D3'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
CDP571, ANTI-RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR-ALPHA
HIV-loop2'CL, ANTI-HIV-1 GP120
O01'CL, ANTI-RH(D)
Jc_51-H'CL, ANTI-DINITROPHENYL
T5-224'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
mAb368-21'CL, ANTI-MORPHINE-6-HEMISUCCINATE-BSA
FOG1-H6'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
Id-F2'CL, ANTI-ID FH-6, WHICH IS AN ANTIBODY AGAINST SIALYL SSEA-1
VL ii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
MRA5H'CL, ANTI-HISTONE
12-3'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
4C2'CL, ANTI-HEPATITIS B
AZ-12'CL, CATALYTIC ANTIBODY
MMW.2.7.13'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
14-29A1, ANTI-ARS
C55-7E3'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
BW9-8'CL, ANTI-DNA
14-32A3, ANTI-ARS
scFv7, ANTI-LOW DENSITY LIPROPROTAIN RECEPTOR THUS INHIBITING RHINOVIRUS INFECTION
I12'CL, ANTI-RH(D)
p4H9.1'CL, ANTI-HERPESVIRUS 1
La 20-H'CL, ANTI-DNP
HUL-GL'CL, ANTI-IGG (RHEUMATOID FACTOR)
57'CL, ANTI-DSDNA
P5.40.1'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
Hb-6, ANTI-FOETAL HAEMOGLOBIN (HBF)
NQ19.1.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
HV1L1'CL, RHEUMATOID FACTOR
42.5D4.2a'CL, ANTI-ALPHA 1,6 DEXTRAN
ToP103'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
H220-17'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
MBr1'CL, ANTI-HUMAN MAMMARY CARCINOMA LINE MCF-7 HYBRIDOMA
30'CL, ANTI-DNA AUTOANTIBODY
HUMHA4114'CL, KIM11.4
M-T310'CL, ANTI-HUMAN CD4
1B3'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
402L-H11, ANTI-HIV GP120 V3-LOOP (K OFF = 4.0 X 10EXP-4 SEC-1)
B19.7, ANTI-DNA
G1-10'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
S7'CL, ANTI-DNA
M74 (VH3-JH4)'CL, RHEUMATOID FACTOR
UN42.5'CL, ANTI-TC,ANTI-RBC
U22B5 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA (BALB/C)
40-50'CL, ANTI-DIGOXIN
DO1'CL, ANTI-GM1 GANGLIOSIDE
TR1.21'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
202.80'CL, ANTI-DNA
HA-7'CL, ANTI-ERYTHROCYTE
CBLC213.7'CL, ANTI-BACTERIAL LEVAN
SP6'CL, ANTI-2,4,6-TRINITROPHENYL
FF29-12-4'CL, ANTI-P-AZOPHENYLARSONATE
DM1'CL, KIM11.4
Jc_68-H'CL, ANTI-DINITROPHENYL
H35-D1'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
Ab1 CO17-1A'CL, ANTI-HUMAN TUMOR-ASSOCIATED ANTIGEN GA733
NQ7 34.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
302'CL, ANTI-INSULIN
2F6F2'CL, ANTI-TG
RF-KES1'CL, RHEUMATOID FACTOR AUTOANTIBODY
F3A11'CL, ANTI-DEXTRAN B512
C9'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
TR1.22'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
AZ-6'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
36-4'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
ITC33'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
H1-8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
37A11'CL, ANTI-ALPRENOLOL HYBRIDOMA
III-3R'CL, ANTI-DNA
F5-444'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
HA-RI'CL, ANTI-ERYTHROCYTE
Nb 15-H'CL, ANTI-DNP
h'CL, ANTI-2-PHENYLOXAZOL-5-ONE
P9.37.1'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
58.2C.10.3'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
87.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
SCFV198, ANTI-ACHR
165.3m'CL, ANTI-DNA
MH6'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
H17-L19'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
611'CL, ANTI-MEP-1 17-31 PEPTIDE
SCFV198, ANTI-ACHR
MOPC-467, ANTI-FLAGELLIN
mAb65'CL, POLYREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
103-7E'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
2-4'CL, ANTI-IGG2A
H72'CL, ANTI-DNA
WSc02'CL, ANTI-PHOSPHORYLCHOLINE
CNJ19'CL, ANTI-P-NITROPHENYL PHOSPHONATE
SW2-17'CL, ANTI-DNA
BW9B5F7'CL, ANTI-DSDNA
13D10'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 2.8X10EXP-8)
126BH'CL, ANTI-THYROID PEROXIDASE (TPO)
K'CL, ANTI-2-PHENYLOXAZOL-5-ONE
D2'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
mAb216'CL, ANTI-LIPID A OF BACTERIAL LPS POLYREACTIVE
NC10.8'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
8/7p8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
gammaR99'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
CR1'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
Day 2 15-167-3'CL, ANTI-2-PHENYL-5-OXAZOLONE
Bg53-5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL (KA=2.6X10EXP7)
AH80-5, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
Ga_15-H'CL, ANTI-DINITROPHENYL
37-63'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
j'CL, ANTI-2-PHENYLOXAZOL-5-ONE
mAb410.30F305'CL, POLYREACTIVE AUTOANTIBODY
D15'CL, ANTI-RH(D)
6H2.B4'CL, ANTI-RAT 62 CYTOCHROME C
D18'CL, ANTI-RH(D)
SiP046'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
E03, ANTI-LYSOZYME HYBRIDOMA
ToPA142'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
10G10'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
PCG1-1'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
S2D8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
E10'CL, ANTI-MOUSE TYPE II COLLAGEN
NC12-H8'CL, ANTI-PHOSPHATIDYL CHOLINE
TT117'CL, ANTI-TETANUS TOXIN, TOXOID AND A FRAGMENT (LIGHT CHAIN) OF TETANUS TOXIN
163.69'CL, ANTI-DNA
RR.VH1.1'CL, ANTI-CARDIOLIPIN/SSDNA AUTOANTIBODY
H37-84'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
MRA10K'CL, ANTI-HISTONE
M2 87'CL, ANTI-MOUSE TYPE II COLLAGEN
5G2'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
C23B-10C10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
C108G clone 4'CL, ANTI-HIV-1 GP120
III-2R'CL, ANTI-DNA
SP1.2'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
MabB23'CL, ANTI-HUMAN PLASMA APOLIPOPROTEIN B-100
bkv35'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
BW9-9'CL, ANTI-DNA
WRI-170'CL, ANTI-HISTONE H1 (RESIDUES 1-16 AND 204-218)
H163-130H9'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
L24'CL, AUTOANTIBODY
La 64-H'CL, ANTI-DNP
NQT15/4C'CL, ANTI-2-PHENYLOXAZOLONE
NC6C8'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
448.9G.F1'CL, ANTI-SSDNA,DSDNA,TETANUS TOXOID
RC6 (VH4.22-JH4)'CL, RHEUMATOID FACTOR
HIV-b18'CL, ANTI-HIV-1 GP120
Z18VH4'CL, CD20
MEMORY 15, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
2INH10'CL, ANTI-HUMAN INSULIN
NP6-1'CL, ANTI-DNA
124E1 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
mAb B''CL, ANTI-HALOPERIDOL.
32'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
hsiglvl150'CL, ANTI-RABBIT IGG
244D.3g'CL, ANTI-PHOSPHORYLCHOLINE, DSDNA
T957, ANTI-BETA 2,1 FRUCTOSAN
d9/4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
285.2E2'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
WG2'CL, ANTI-PROTEINASE 3
82B6a'CL, AUTOANTIBODY TO THYROGLOBULIN
HIV-b22'CL, ANTI-HIV-1 GP120
1H12'CL, ANTI-LAMININ RECEPTOR OF STAPHYLOCOCCUS AUREUS
KJ16'CL, ANTI-TCR VB8.1 & VB8.2
ToPA136'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
NL-112-9'CL, ANTI-AMINOPHENYL-BETA-N-ACETYLGLUCOSAMINIDE, BETA(1-6)POLY-D-COUPLED TO BSA
129'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
546'CL, ANTI-P601E
1C9'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
MA-15C5'CL, ANTI-HUMAN FIBRIN FRAGMENT D-DIMER
HDEX25, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
MAB61'CL, KIM11.4
LS7'CL, ANTI-PR2 RBC AUTOANTIBODY
DS1F8'CL, NATURAL AUTO-ANTIBODY REACTIVE WITH OLIGODENDROCYTE
M2 139'CL, ANTI-MOUSE TYPE II COLLAGEN
9604'CL, ANTI-DENATURED DNA, ANTI-PLATELET
A12'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
121'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
AZ-42'CL, CATALYTIC ANTIBODY
18G8'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
ToPA213'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
ToP204'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
402O-C7, ANTI-HIV GP120 V3-LOOP (K OFF = 1.3 X 10EXP-4 SEC-1)
A4.6.1, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
L01'CL, ANTI-RH(D)
D11'CL, ANTI-RH(D)
27.7.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
3F29-8-5'CL, ANTI-P-AZOPHENYLARSONATE
Hb-5, ANTI-FOETAL HAEMOGLOBIN (HBF)
9.4.5'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
d9/9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
VhOx1'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
B03, ANTI-LYSOZYME HYBRIDOMA
MRA11K'CL, ANTI-HISTONE
H250-6'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
8.46.2'CL, ANTI-DNA
REI-based resh. CAMPATH-9, ANTI-HUMAN CD4
L11-2E2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
HIV-b14'CL, ANTI-HIV-1 GP120
S1F2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
180.5G4'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
VH6-19'CL, ANTI-IGG2A RHEUMATOID FACTOR
NQ11.7.22'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
SO4'CL, ANTI9-HLA-DQ3
6B5, ANTI-PCHAP (5-[N-(1'PHENYLCYCLOHEXYL)AMINO]PENTANOIC ACID)
MMW.2.6.14'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
K20'CL, ANTI-BETA 1 CHAIN OF HUMAN INTEGRIN
bkv7'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
A07, ANTI-LYSOZYME HYBRIDOMA
N901H, ANTI-CD56
MRL3-21'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
H37-80'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
41-4F5'CL, ANTI-(T,G)-A--L HYBRIDOMA
GSD2B5B10'CL, ANTI-HIV-1
MRL2-17'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
CLONE 1C8'CL, ANTI-HUMAN RED BLOOD CELL
202.9'CL, ANTI-DNA
MICA 6'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
JD31'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
44SNQP8, ANTI-2-PHENYLOXAZOLONE
6-2'CL, ANTI-IGG2A
SP1.5'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
26-10VH'CL, ANTI-DIGOXIN
C1'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
A.18.13'CL, ANTI-DNA
J02'CL, ANTI-RH(D)
B8807'CL, ANTI-DENATURED DNA
JV5'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
MRL2-111'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
WR1.112'CL, ANTI-THYROID PEROXIDASE
TR1.10'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
2D10'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
14-41A10, ANTI-ARS
F12.24E4'CL, ANTI-DSDNA
22.202.16'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
MMW.2.6.17'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
Fb_05-H'CL, ANTI-DINITROPHENYL
ANTI-TGAL 17'CL, ANTI-BRANCHED POLY-L-(TYR,GLU)-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
Na 01-H'CL, ANTI-DNP
34-2B'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
NQT15/3B'CL, ANTI-2-PHENYLOXAZOLONE
mAb56'CL, ANTI-RABIES VIRUS
DP17'CL, ANTI-DNA
VHD42.INF127'CL, ANTI-INFLUENZA
HPCM4, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
E38, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
LS1'CL, ANTI-PR2 RBC AUTOANTIBODY
C488-23C'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
FF29-12-2'CL, ANTI-P-AZOPHENYLARSONATE
SCH94.03'CL, AUTOANTIBODY REACTIVE WITH SPECTRIN, (4-HYRDOXY-3-NITROPHENYL)ACETYL, AND FLUORESCEIN, WHICH  PROMOTES CENTRAL NERVOUS SYSTEM REMYELINATION
BSb25'CL, ANTI-PHOSPHORYLCHOLINE
NQT15/24B'CL, ANTI-2-PHENYLOXAZOLONE
p35'CL, ANTI-HIV-1 GP120
119-22'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
C2'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
MRK16'CL, ANTI-MULTIDRUG TRANSPORTER P-GLYCOPROTEIN
S8'CL, ANTI-ARS
clone 14'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
RA-1-DT7'CL, RHEUMATOID FACTOR
F12.15G2'CL, ANTI-DSDNA
NQT17/29A'CL, ANTI-2-PHENYLOXAZOLONE
D7'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
19'CL, ANTI-INSULIN
84-39'CL, ANTI-DNA
ABD4-lam2'CL, ANTI-DSDNA
Y12'CL, ANTI-SM HYBRIDOMA
2INL3'CL, ANTI-HUMAN INSULIN
Sulf-1'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
3C52'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
A-10D3'CL, ANTI-DOUBLE STRANDED DNA
KO3-256'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
BBLC1.1'CL, ANTI-BACTERIAL LEVAN
17G5'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
CH4A10'CL, ANTI-FLUORESCEIN
RA-2-L5'CL, RHEUMATOID FACTOR
CP5 A21-1'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
163.100'CL, ANTI-DNA
hVH65-217'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=2.1X10EXP6)
JV8'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
F4'CL, ANTI-MOUSE TYPE II COLLAGEN
24-2G3, ANTI-ARS
NQ10.12.4.7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
9G6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
H36-2'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
MRL1-49'CL, ANTI-DNA
D09'CL, ANTI-RH(D)
AD6'CL, ANTI-ERYTHROCYTE RH(D) 
85.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
RF-MR41'CL, RHEUMATOID FACTOR
MUSE11'CL, ANTI-TANDEM REPEAT DOMAIN OF MUCIN CORE PROTEIN MUC1
22.11'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
F.12'CL, ANTI-ARS
CBA/N 1B8E5, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
H107, ANTI-HUMAN H FERRITIN
AF14, ANTI-ANTI-IDIOTYPIC, I.E. ANTI-E5.2 (AN ANTI-D1.3 WHICH IS ANTI-HEN EGG LYSOZYME), WITH KA (FAB E5.2) = 1.0 X 10EXP9 M AND KA (HEN EGG LYSOZYME) = 1.8 X 10EXP6 M
6N'CL, ANTI-DNA
5D3'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
NQT15/18A'CL, ANTI-2-PHENYLOXAZOLONE
CLONE 42PF'CL, ANTI-LEUCINE ZIPPER
SiP034'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
EH1'CL, ANTI-C-TERMINUS OF NEF OF HIV-1 STRAIN LAI (VARELHPEYFKNC) AND SF2 (MARELHPEYYKDC)
ToPA121'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
7C28'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
ARM'CL, ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN
126'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 AFTER TREATMENT WITH 7D11.
NQ7 24.6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
HDEX2, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
221.2D10''CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
mAb10.2.5'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
ToPA208'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
H230-5'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
25G09, ANTI-LYSOZYME HYBRIDOMA
HUMLV117'CL, ANTI-DNA
MMW.7.12'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
NZB/NZW-4'CL, ANTI-DNA
17s.2'CL, ANTI-DNA
BPPII-5.1'CL, ANTI-BOVINE PANCREATIC POLYPEPTIDE
H1-91'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
SA-4A'CL, ANTI-TITIN AUTOANTIBODY
93C1'CL, ANTI-FLUORESCEIN
222.1D1'CL, ANTI-PHOSPHORYLCHOLINE (P.MORGANII) HYBRIDOMA
E5'CL, ANTI-MOUSE TYPE II COLLAGEN
16M3C8'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
N1G9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
NQ10.11.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
NQ22.18.7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
AC33'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
McPC603-H11, ANTI-PHOSPHORYLCHOLINE
A1'CL, AB3 (SEE NOTES)
Pab 419'CL, ANTI-CARBOXYL TERMINUS OF SV40 T ANTIGEN
RF2-7'CL, ANTI-IGG2A
280.21'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
T15-H11, ANTI-PHOSPHORYLCHOLINE
TB-1-P5'CL, RHEUMATOID FACTOR
AC38 15.3, ANTIBODY AC38-POSITIVE HYBRIDOMA
C32'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
AN04'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=6.8X10EXP6)
hVH65-211'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1.0X10EXP6)
8/7p9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
104-8'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
RF-1, ANTI-RSV
F5-1419'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
JV4'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
RC6 (Vg-Jk5)'CL, RHEUMATOID FACTOR
4F8'CL, ANTI-P-AZOPHENYLARSONATE
MICA 5'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
GP138-10'CL, ANTI-POLY(GLU50,TYR50)(KA=3.68X10EXP7),DNA(KA=2.42X10EXP6),SMITH ANTIGEN(KA=2.56X10EXP6),IGG2A(KA=3.84X10EXP6)
D31'CL, ANTI-RH(D)
23-54H8, ANTI-ARS
LOC'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
slkv7'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
311, ANTI-TYPE II PNEUMOCOCCAL POLYSACCHARIDE
MMW.2.6.11'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
VS3'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
1-38'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
mH-M, ANTI-IDIOTYPIC
126TP8K'CL, ANTI-THYROID PEROXIDASE (TPO)
N'CL, ANTI-2-PHENYLOXAZOL-5-ONE
BBLC434.22'CL, ANTI-BACTERIAL LEVAN
3A183'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
17p.80'CL, ANTI-DNA
Z26'CL, ANTI-SMITH ANTIGEN HYBRIDOMA
WEA, ANTI-3,4-PYRUVYLATED GALACTOSE MONOCLONAL
MICA 4'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
B22'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 6.0 X 10EXP-5)
TNF-E7'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
RA-4-Pd18'CL, RHEUMATOID FACTOR
RF-IP13'CL, RHEUMATOID FACTOR
I06'CL, ANTI-RH(D)
T33-16'CL, ANTI-DNA
4.14'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
MMW.2.7.14'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
40-150 A2.4 P.10'CL, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=4.4X10EXP8)
Di62'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
BSb51'CL, ANTI-PHOSPHORYLCHOLINE
BA149A-2'CL, ANTI-DSDNA
T13.203.37'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2H1'CL, ANTI-HEPATITIS B SURFACE ANTIGEN
NZB/NZW-8'CL, ANTI-DNA
402P4-F5, ANTI-HIV GP120 V3-LOOP (K OFF = 1.2 X 10EXP-4 SEC-1)
C31'CL, ANTI-HIV-1
M'CL, ANTI-2-PHENYLOXAZOL-5-ONE
C10'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
RF3-4'CL, ANTI-IGG2A
W3207, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=2.5X10EXP5)
F01'CL, ANTI-RH(D)
Q01'CL, ANTI-RH(D)
14-30E4, ANTI-ARS
T10-352'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
40-150 A2.4'CL, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=9X10EXP6)
NZW12F7'CL, ANTI-DSDNA
D2.3'CL, ANTI-NITROBENZYL PHOSPHONATE (TRANSITION STATE ANALOG)
2-11'CL, ANTI-SM HYBRIDOMA
163.14, ANTI-P53
4H10'CL, ANTI-TRINITROPHENYL HYBRIDOMA
402P4-H1, ANTI-HIV GP120 V3-LOOP (K OFF = 1.4 X 10EXP-4 SEC-1)
mAb61'CL, MONOREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
SER'CL, AUTOANTIBODY
H37-43'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
126FH'CL, ANTI-THYROID PEROXIDASE (TPO)
mAb3G-10'CL, ANTI-HUMAN IL2 RECEPTOR TAC PROTEIN
126'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
NQN1/A14.4.3'CL, ANTI-2-PHENYL OXAZOLONE
3-7'CL, ANTI-SM HYBRIDOMA
8-2'CL, ANTI-IGG2A
B1-48'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
265.9G4'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
C52-6D9'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
anti-Test'CL, ANTI-TESTOSTERONE (BINDING CONSTANT = 5.41 X 10EXP7)
Day 4 15-164-14'CL, ANTI-2-PHENYL-5-OXAZOLONE
VH G69'CL, ANTI-GLUTATHIONE S-TRANSFERASE
F124'CL, ANTI-HEPATITIS B VIRUS (HBV)
5E4'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
HuFd79'CL, ANTI-HERPES SIMPLEX VIRUS-1 GLYCOPROTEIN B AND GLYCOPROTEIN D
133'CL, ANTI-KEY HOLE LIMPET HEMOCYANIN-COUPLED ANGIOTENSIN II
3-7'CL, ANTI-SM HYBRIDOMA
G2b-4'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
BA141AX2'CL, ANTI-DOUBLE STRANDED DNA
H1-60'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
ASWU1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
TNF-A1'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
Lb 84-H'CL, ANTI-DNP
10/14'CL, ANTI-MONOCLONAL ANTIIDIOTYPIC ANTIBODY IDA10 HYBRIDOMA
2H12'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
SiP037'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
OX26'CL, ANTI-RAT TRANSFERRIN RECEPTOR
73.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
Day 4 15-164-15'CL, ANTI-2-PHENYL-5-OXAZOLONE
TR1.3'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
ToP027'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
HP29'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
L33'CL, AUTOANTIBODY
T33-4'CL, ANTI-DNA AUTOANTIBODY
10F1.4'CL, ANTI-HISTONE 2A-HISTONE 2B-DNA SUBNUCLEOSOME
F10.17-7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
AS.1.29'CL, ANTI-HIV-1 GP120 V3 LOOP
L612'CL, ANTI-GANGLIOSIDE GM3, II3NEUAC-LACCER
PE13'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
Z45VH1'CL, CD20
scFv21, ANTI-LOW DENSITY LIPROPROTAIN RECEPTOR THUS INHIBITING RHINOVIRUS INFECTION
RF-KL1'CL, RHEUMATOID FACTOR AUTOANTIBODY
B17-4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
18R.136.1'CL, CATALYTIC ANTIBODY
94F5'CL, ANTI-FLUORESCEIN
PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
48SNQP102, ANTI-2-PHENYLOXAZOLONE
1E12'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN HYBRIDOMA
D20''CL, ANTI-DNA
K1B12L'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
H01'CL, ANTI-RH(D)
VH HER2'CL, ANTI-LAMIN B AUTOANTIBODY
BMA 0310EUCIV2'CL, ANTI-HUMAN T-CELL RECEPTOR HUMANIZED ANTIBODY
RH-14'CL, ANTI-DNA
B7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
E07, ANTI-LYSOZYME HYBRIDOMA
ToP104'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
Day 4 15-164-8'CL, ANTI-2-PHENYL-5-OXAZOLONE
3F29-8-3'CL, ANTI-P-AZOPHENYLARSONATE
PERU2'CL, ANTI-P-AZOPHENYLARSONATE
HD37'CL, ANTI-CD19
82B6b'CL, AUTOANTIBODY TO THYROGLOBULIN
RF-FO3'CL, RHEUMATOID FACTOR
2A9'CL, ANTI-GALACTOSYLGLOBOSIDE
VL A121, ANTI-CD34
Jel42'CL, ANTI-ESCHERICHIA COLI HISTIDINE-CONTAINING PROTEIN (HPR)
DN3'CL, ANTI-MCPS
243.14B6'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
Fd79'CL, ANTI-HERPES SIMPLEX VIRUS-1 GLYCOPROTEIN B AND GLYCOPROTEIN D
43SNQP5, ANTI-2-PHENYLOXAZOLONE
HV3P8'CL, ANTI-FLUORESCEIN
126JH'CL, ANTI-THYROID PEROXIDASE (TPO)
H35-C6'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
D3'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
PC287'CL, ANTI-PSICT3
ToPA132'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
HIG1, ANTI-ACHR
L2H7'CL, ANTI-CARDIOLIPIN AUTOANTIBODY
A9A7'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
1E9'CL, ANTI-(NANP) 3 DODECAPEPTIDE
scFv8, ANTI-LOW DENSITY LIPROPROTAIN RECEPTOR THUS INHIBITING RHINOVIRUS INFECTION
BA3'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE
M2 136'CL, ANTI-MOUSE TYPE II COLLAGEN
14-16H2, ANTI-ARS
5A4'CL, ANTI-CORTISOL
36-65'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
NQ10.15.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
F6-3'CL, ANTI-TEPC15 IDIOTYPE ANTIBODY HYBRIDOMA
MRL2-117'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
47SNQP18, ANTI-2-PHENYLOXAZOLONE
I02'CL, ANTI-RH(D)
c'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
HDEX12, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
253.12D3, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
64.9D'CL, ANTI-DNA
MRL1-17'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
CNJ157'CL, ANTI-P-NITROPHENYL PHOSPHONATE
E4-17'CL, ANTI-CON A
NQ2 48.2.2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
+9-22'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
c'CL, ANTI-2-PHENYLOXAZOL-5-ONE
BBLC44.1'CL, ANTI-BACTERIAL LEVAN
SD6'CL, ANTI-DSDNA AUTOANTIBODY
7-1'CL, ANTI-IGG2A
R1-38'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
412.67.F1.3'CL, ANTI-SSDNA,DSDNA
NQT17/30E'CL, ANTI-2-PHENYLOXAZOLONE
B1-4'CL, ANTI-HEN BOVINE SERUM ALBUMIN
1B1'CL, NEUTRALIZING ANTI-HIV-1
F1A5'CL, ANTI-DEXTRAN B512
BV17-31'CL, ANTI-DSDNA (86%), SSDNA (32%)
SW2-11'CL, ANTI-DNA
NQ10.2.22'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
DILp1'CL, ANTI-DNA
11G3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
2INL9'CL, ANTI-HUMAN INSULIN
126TP6K'CL, ANTI-THYROID PEROXIDASE (TPO)
CBA/J 6G6, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
2C5-3'CL, ANTI-88 KDA SPLICING FACTOR 53/4
BW14C7B1'CL, ANTI-DSDNA
Mb_35-H'CL, ANTI-DINITROPHENYL
S1F12'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
82B6'CL, AUTOANTIBODY TO THYROGLOBULIN
BXW-16'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
I16'CL, ANTI-RH(D)
PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
B1-8.V4'CL, ANTI-DINITROPHENYLATED BOVINE SERUM ALBUMIN HYBRIDOMA
3F29-4-19'CL, ANTI-P-AZOPHENYLARSONATE
MMW.2.6.9'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
BSA3'CL, ANTI-BOVINE SERUM ALBUMIN
T10-421'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
36-17'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
1.6'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
MOPC511, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=1.6X10EXP4)
MAR'CL, POLYREACTIVE
Mb_58-H'CL, ANTI-DINITROPHENYL
F1_1357'CL, ANTI-FRACTION 1
Mab13-1, ANTI-MESO-TETRAKIS(4-CARBOXYPHENYL)PORPHYRIN, TCPP
185B'CL, ANTI-FLUORESCEIN
PIE, AUTOANTIBODY WHICH BINDS SPECIFICALLY TO INTERMEDIATE FILAMENTS
4-3C2'CL, ANTI-DOUBLE STRANDED DNA
2INH3'CL, ANTI-HUMAN INSULIN
8H9D4'CL, ANTI-PLASMINOGEN ACTIVATOR INHIBITOR-1 (BY SWITCHING THE INHIBITORY CONFORMATION TO A SUBSTRATE CONFORMATION)
Lb 34-H'CL, ANTI-DNP
Ib_02-H'CL, ANTI-DINITROPHENYL
B/SB5-37'CL, ANTI-H4
119-30'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
8H3'CL, ANTI-CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE (SEROPTYPE A)
E6'CL, ANTI-HUMAN TRANSFERRIN RECEPTOR
B17-8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
1H4'CL, ANTI-CD20
Na 13-H'CL, ANTI-DNP
265.10B6'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
K27-489, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
GAN4B.5'CL, ANTI-ERYTHROCYTE SURFACE ANTIGEN, RHESUS D
165.5'CL, ANTI-DNA
106-10E'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
2F7'CL, ANTI-SSDNA
6.29'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
3F29-4-14'CL, ANTI-P-AZOPHENYLARSONATE
FS5, ANTI-VH4-34
F2-2'CL, ANTI-DNA
HIV-s3'CL, ANTI-HIV-1 GP120
89'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
167'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
AP1'CL, ANTI-GLYCOPHORIN A
BSb44'CL, ANTI-PHOSPHORYLCHOLINE
A6, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
SiP062'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
Mb_55-H'CL, ANTI-DINITROPHENYL
C3H-7'CL, ANTI-DNA
scFv19, ANTI-LOW DENSITY LIPROPROTAIN RECEPTOR THUS INHIBITING RHINOVIRUS INFECTION
AMPC1, ANTI-BETA 2,1 FRUCTOSAN
S18'CL, ANTI-ARS
119.12'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
ABL364'CL, ANTI-LEWIS Y CARBOHYDRATE ANTIGEN (LE Y)
Fc_20-H'CL, ANTI-DINITROPHENYL
NQ22.91.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
scFv(DIGOXIN)'CL, ANTI-DIGOXIN
316'CL, ANTI-P601E
F12.40G2'CL, ANTI-DSDNA
103-A14'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
mAb A'CL, ANTI-HALOPERIDOL.
R5A3K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
4-8D10'CL, ANTI-DOUBLE STRANDED DNA
12D4'CL, ANTI-MORPHINE
DF8-611.1'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
NC1-A7'CL, ANTI-PHOSPHATIDYL CHOLINE
S/SB5-37'CL, ANTI-H4
17-9'CL, ANTI-DEXTRAN B512
2B1-78'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
ToPA280'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
7C38'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
LN2 173'CL, ANTI-MOUSE TYPE II COLLAGEN
F30-4'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
STRAb SA-1A'CL, ANTI-ACTIN/ALPHA-ACTININ AUTOANTIBODY
SiP047'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
HY18'CL, ANTI-B CELL AUTOANTIBODY
115'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 AFTER TREATMENT WITH 7D11.
HuRSV19VK, ANTI-HUMAN RESPIRATORY SYNCYTIAL VIRUS
2E8'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
A1'CL, ANTI-GLYCOPHORIN A
DP12'CL, ANTI-DNA
253.15E2, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
40-150'CL, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=5.4X10EXP9)
L2 12B'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
402L-B5, ANTI-HIV GP120 V3-LOOP (K OFF = 2.2 X 10EXP-4 SEC-1)
MOPC460, ANTI-DINITROPHENYL
K4820, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
224.2G3'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
AB1/2'CL, ANTI-ACETYLCHOLINE RECEPTOR
Sulf-3'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
47SNQP14, ANTI-2-PHENYLOXAZOLONE
J06'CL, ANTI-RH(D)
UN34.11'CL, ANTI-TC,ANTI-RBC
MEMORY 11, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
C52-4H3'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
17s.128'CL, ANTI-DNA
19-19B1'CL, ANIT-DOUBLE STRANDED DNA
NQT17/40'CL, ANTI-2-PHENYLOXAZOLONE.
JB32'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
Ca_13-H'CL, ANTI-DINITROPHENYL
248.7G11'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
MMW.2.7.4'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
RF-MR5'CL, RHEUMATOID FACTOR
47SNQP28, ANTI-2-PHENYLOXAZOLONE
126GK'CL, ANTI-THYROID PEROXIDASE (TPO)
2G12'CL, NEUTRALIZING ANTI-HIV-1
BKV39'CL, ANTI-DSDNA
H152-43B2'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
DP9'CL, ANTI-DNA
ANTI-ID mAb 114'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-CYCLOSPORINE MAB R45-45-11
lambda4'CL, ANTI-HUMAN THYROGLOBULIN
Tg10'CL, ANTI-HUMAN THYROGLOBULIN
10-25'CL, ANTI-FLUORESCEIN (KA=5.4X10EXP7)
71.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
PC289'CL, ANTI-PSICT3
mAb60'CL, MONOREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
AD21'CL, ANTI-ERYTHROCYTE RH(D) 
5.54.4.24.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
ASWS1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
163.47'CL, ANTI-DNA
F10.17-1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
6F'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
3D1'CL, ANTI-CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE (SEROPTYPE A)
M02/04/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
aly44-73'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
9H12.2'CL, ANTI-HISTONE
2INL10'CL, ANTI-HUMAN INSULIN
126TP5H'CL, ANTI-THYROID PEROXIDASE (TPO)
252.5E11'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
L26'CL, AUTOANTIBODY
ITH5-2'CL, ANTI-HIV-1 V3 LOOP
ARMVl'CL, ANTI-MYELIN ASSOCIATED PROTEIN
GEE, ANTI-VH4-34
CLONE 13AD'CL, ANTI-LEUCINE ZIPPER
LUNm01'CL, ANTI-CLASS 5C OUTER MEMBRANE PROTEIN OF NEISSERIA MENINGITIDIS
84-14'CL, ANTI-DNA
73-5'CL, ANTI-DNA
Ham-B'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
B62.L'CL, ANTI-DNA,POLY(DG)
40SNQP28, ANTI-2-PHENYLOXAZOLONE
PE22'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
3910'CL, ANTI-OESTRONE-3-GLUCURONIDE
CEA 66-E3'CL, ANTI-CARCINOEMBRYONIC ANTIGEN
GN901v1.0, ANTI-CD56
417.F28'CL, MONOREACTIVE
HY GAL4, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
H37-311'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
S1P15'CL, RHEUMATOID FACTOR
NC19-F5'CL, ANTI-PHOSPHATIDYL CHOLINE
14C10'CL, ANTI-SM HYBRIDOMA
L36'CL, AUTOANTIBODY
4A9.D6'CL, ANTI-HORSE 47 CYTOCHROME C
1-1B5'CL, ANTI-DOUBLE STRANDED DNA
MMW.2.7.8'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
SS269, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
MuRSV19'CL, ANTI-HUMAN RESPIRATORY SYNCYTIAL VIRUS
1E8'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
40SNQP12, ANTI-2-PHENYLOXAZOLONE
40.3'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
5-7, ANTI-EPSILON-DNP-AMINOCAPROATE(BINDING CONSTANT=0.05 TO 0.1X10EXP6)
3.4.1'CL, ANTI-DNA, ACTIN, MYOSIN, THYROGLOBULIN
BIII.136'CL, ANTI-HUMAN BAND 3 PROTEIN CYTOPLASMIC DOMAIN
GAT50'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
HDEX10, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
McPC603, ANTI-PHOSPHORYLCHOLINE
RF2-4'CL, ANTI-IGG2A
s6G4'CL, ANTI-SSDNA/CARDIOLIPIN AUTOANTIBODY
HIV-LC1'CL, ANTI-HIV-1 GP120
6G6''CL, ANTI-DNA
MOR33'CL, ANTI-MORPHINE
T24-9'CL, ANTI-DNA AUTOANTIBODY
Ma_33-H'CL, ANTI-DINITROPHENYL
HY GAL2, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
K03'CL, ANTI-RH(D)
FV-BETA, ANTI-HCG
2-11'CL, ANTI-SM HYBRIDOMA
H1-31'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
1-10'CL, ANTI-SM
417.7.3.1'CL, POLYREACTIVE
RF-KL5'CL, ANTI-HUMAN/RABBIT IGG RHEUMATOID FACTOR
3B62'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
CH12''CL, ANTI-DISTEAROYL PHOSPHATIDYL CHOLINE, BROMELAIN-TREATED MOUSE ERYTHROCYTES, SHEEP ERYTHROCYTES, CHICKEN ERYTHROCYTES
L4'CL, ANTI-HEN EGG WHITE LYSOZYME
PA1'CL, ANTI-CHROMATIN
BKV1'CL, ANTI-DNA
B12-9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
NQT15/4A'CL, ANTI-2-PHENYLOXAZOLONE
6Q'CL, ANTI-DNA
NQT17/30A'CL, ANTI-2-PHENYLOXAZOLONE
147'CL, ANTI-P601E
112'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 AFTER TREATMENT WITH 7D11.
H20C3K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
6-6-4'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
3F29-8-2'CL, ANTI-P-AZOPHENYLARSONATE
163.1, ANTI-P53
Ib_01-H'CL, ANTI-DINITROPHENYL
HDEX3, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
tat107'CL, ANTI-HIV-1 TAT
DPK24, ANTI-P53
HY GAL11, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
88.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
RF-1''CL, ANTI-IGG3 RHEUMATOID FACTOR
35.8.2H'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
7-4'CL, ANTI-PSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDE INNER CORE
RF51'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
AL1-2'CL, ANTI-POLYCATION
33.H11'CL, ANTI-DSDNA
1-187-29'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
3F4'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
BrM1'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC, TRIMETHYLAMMONIUM HYBRIDOMA
MF8 (VH4.22-JH4)'CL, RHEUMATOID FACTOR
24'CL, ANTI-LE X, SIALYL LE X
pMDABG2-4'CL, ANTI-HEMAGGLUTININ
NQT17/30C'CL, ANTI-2-PHENYLOXAZOLONE
RF-MR27'CL, RHEUMATOID FACTOR
192VH15'CL, ANTI-MIR
4G9'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
G21'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
S1-1F4'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
PopVH'CL, ANTI-DNA, ANTI-MYELIN
7B6'CL, ANTI-SM
Z36VH4'CL, CD20
PAC1'CL, ANTI-PLATELET FIBRINOGEN RECEPTOR.
18C10'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
E26, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
H158-89H4'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
MMW.8.14'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
42.4B.12.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
Oak-3'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
GAR', CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
C05, ANTI-LYSOZYME HYBRIDOMA
2INH1'CL, ANTI-HUMAN INSULIN
C471'CL, ANTI-DENATURED DNA, ANTI-PLATELET
MOPC511, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=1.6X10EXP4)
17s.161'CL, ANTI-DNA
3322-B, ANTI-TYPE VIII PNEUMOCOCCAL POLYSACCHARIDE
SOL10'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (HIB PS)
1A2'CL, ANTI-DNA
6B5 Fab, ANTI-5-[N-(1'PHENYLCYCLOHEXYL)AMINO]PENTANOIC ACID (PCHAP)
AF52, ANTI-ANTI-IDIOTYPIC, I.E. ANTI-E5.2 (AN ANTI-D1.3 WHICH IS ANTI-HEN EGG LYSOZYME), WITH KA (FAB E5.2) = 2.4 X 10EXP7 M AND KA (HEN EGG LYSOZYME) = 3.8 X 10EXP6 M
Jb_16-H'CL, ANTI-DINITROPHENYL
WRD8'CL, RHEUMATOID FACTOR
AKR-4'CL, ANTI-DNA
14D2.D6'CL, ANTI-RAT 62 CYTOCHROME C
mAb B'CL, ANTI-HALOPERIDOL.
4/F'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
402P4-E7, ANTI-HIV GP120 V3-LOOP (K OFF = 1.3 X 10EXP-4 SEC-1)
A3, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
EV1-15'CL, ANTI-CYTOMEGALOVIRUS HYBRIDOMA
NQ10 12.4.7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
4B4'CL, ANTI-HUMAN PROCOLLAGENASE
LAY, ANTI-HUMAN GAMMA G1 AND G3 GLOBULINS; PO IDIOTYPE
C6-8-2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-CONJUGATED CHICKEN GAMMA GLOBULIN
I13'CL, ANTI-RH(D)
3F9H4'CL, ANTI-FLUORESCEIN
FOG1-G8'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
MRL3-34'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
124'CL, ANTI-P601E
K9-335, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
3-69'CL, ANTI-SM HYBRIDOMA
17s.130'CL, ANTI-DNA
NG3B7'CL, ANTI-HIV-1
mAb 124'CL, ANTI-INSULIN
D98, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
LN2 7'CL, ANTI-MOUSE TYPE II COLLAGEN
4C8'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
NQ5 89.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
1-8'CL, ANTI-SM, ANTI-SSDNA
IE12'CL, ANTI-F(AB')2
3707 E9'CL, ANTI-SHIGELLA DYSENTERIAE TYPE I
44SNQP27, ANTI-2-PHENYLOXAZOLONE
B/SB5-35'CL, ANTI-H4
mAb 126'CL, ANTI-INSULIN HYBRIDOMA
3D7.2'CL, ANTI-CHROMATIN
AB4'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
24.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
L3 11D'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
7C30'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
304'CL, ANTI-INSULIN
ToP309'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
AN01'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=5.1X10EXP4)
47SNQP3, ANTI-2-PHENYLOXAZOLONE
CLONE pMEK1LC'CL, ANTI-HLA-DR ANTIGENS
A20/44'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
mAb E''CL, ANTI-CYCLOSPORINE
RF-MR24'CL, RHEUMATOID FACTOR
MCG, ANTI-EPSILON-DNP-LYS, EPSILON-DNP-AMINOCAPROATE, DNP-LEU, TRIACETIN, SODIUM MERTHIOLATE, METHADONE, 1,10-PHENANTHROLINE, CAFFEINE, THEOPHYLLINE, DI-DNP-LYS, DNP-TRP, DNP-PHE, DI-DNP-TYR, COLCHICINE, P-NITROANILINE, P-NITROPHENYLPHOSPHORYL CHOLINE, 5-ACETYLURACIL, MENADIONE, MEPERIDINE, TRIBUTYRIN, OMEGA-BROMOHEPTANOAT
TB-2-H71'CL, RHEUMATOID FACTOR
heavy4'CL, ANTI-HUMAN THYROGLOBULIN
93G7 CRI+'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
192VH9'CL, ANTI-MIR
2.31.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
m'CL, ANTI-2-PHENYLOXAZOL-5-ONE
22.176'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
1F12'CL, ANTI-HUMAN PROCOLLAGENASE
KS3'CL, ANTI-DSDNA AUTOANTIBODY
3.14.9'CL, ANTI-LEVAN
ToPA101'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
1G1B6'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
25G12'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
2INH15'CL, ANTI-HUMAN INSULIN
Resurfaced Anti-B4, ANTI-CD19
scFv(225.28S)'CL, ANTI-HUMAN HIGH-MOLECULAR WEIGHT MELANOMA-ASSOCIATED ANTIGEN
46'CL, ANTI-DSDNA
U'CL, ANTI-2-PHENYLOXAZOL-5-ONE
A3.1'CL, ANTI-HEPATITIS B SURFACE ANTIGEN
NQ19.16.37'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
HY GAL10, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
rsv6H'CL, ANTI-RESPIRATORY SYNCYTIAL VIRUS F GLYCOPROTEIN
447.8H'CL, ANTI-SSDNA
RF-SB1'CL, RHEUMATOID FACTOR
MRL2-162'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
SiP017'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
RF1-2'CL, ANTI-IGG2A
ToP247'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
F10.12-5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
m95-99, ANTI-IDIOTYPIC
K30-267, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
D44'CL, ANTI-RNA AUTOANTIBODY, ANTI-POLY(G,C) HYBRIDOMA
H17'CL, ANTI-ARS
53R-4'CL, ANTI-3M-1
IC5-2A6'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
H09, ANTI-LYSOZYME HYBRIDOMA
Lb 35-H'CL, ANTI-DNP
7-10A'CL, ANTI-CORONAVIRUS
HuVK'CL, ANTI-HUMAN HIGH BINDING AFFINITY RECEPTOR FOR FC OF IGG (FCGRI)
48SNQP10, ANTI-2-PHENYLOXAZOLONE
NQT17/40C'CL, ANTI-2-PHENYLOXAZOLONE
CP8 B3-D3'CL, ANTI-BROMELINIZED MOUSE RED BLOOD CELL (BRMRBC) HYBRIDOMA
L1'CL, ANTI-GP41
alphaGPIIIa leu 33'CL, ANTI-LEUCINE-33 FORM OF PLATELET GLYCOPROTEIN IIIA
MMW.8.6'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
MRL-DNA10'CL, ANTI-SINGLE STRAND DNA HYBRIDOMA
C57BL 293, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=6.3X10EXP5)
CB 334'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
AZ-14'CL, CATALYTIC ANTIBODY
WSd16'CL, ANTI-PHOSPHORYLCHOLINE
GOT, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
12-3-4'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
D03'CL, ANTI-RH(D)
H05'CL, ANTI-DNA
2INL7'CL, ANTI-HUMAN INSULIN
B14'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 7.0 X 10EXP-5)
Ab18'CL, POLYREACTIVE AUTOANTIBODY
HDEX24, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
1A6'CL, ANTI-SSDNA
F12B2'CL, ANTI-DEXTRAN B512
KAS, ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE
FF29-15-1'CL, ANTI-P-AZOPHENYLARSONATE
C57BL 1613, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=1.8X10EXP5)
CB-mab-p24/13-5'CL, ANTI-P24 CORE PROTEIN OF HIV-1
S3'CL, ANTI-ARS
C119'CL, ANTI-DENATURED DNA, ANTI-PLATELET
28/12'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
ABO.HI1'CL, ANTI-HI
281.4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
DBF1-608.1'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
ToP306'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
AN12'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=2.1X10EXP6)
M5'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
aPC-59-D4'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
13G12'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
ToP028'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
RF-SJ4'CL, MONOREACTIVE RHEUMATOID FACTOR
ToPG405'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
2717, ANTI-P-AZOBENZOATE
RF4-3FA'CL, ANTI-IGG1
La 70-H'CL, ANTI-DNP
13.5A2'CL, ANTI-FLUORESCEIN
GG8.3'CL, ANTI-2-PHENYLOXAZOLONE
H152-42B11'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
HPCG8, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=1.3X10EXP5)
MMW.8.12'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
NQ2 16.2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
2.64'CL, ANTI-PNEUMOCOCCAL
H1-5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
60.3'CL, ANTI-CD18
GG48'CL, RHEUMATOID FACTOR
Ma_28-H'CL, ANTI-DINITROPHENYL
CEA4-8A'CL, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN
40SNQP26, ANTI-2-PHENYLOXAZOLONE
MMW.4.5'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
F12E6'CL, ANTI-DEXTRAN B512
1-42'CL, ANTI-SM HYBRIDOMA
RF34'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
SiP059'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
AS17'CL, ANTI-DSDNA AUTOANTIBODY
25G05, ANTI-LYSOZYME HYBRIDOMA
NC9-B4'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
10.82'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
B5G10H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
PC283'CL, ANTI-PSICT3
4.16.1'CL, ANTI-MOUSE ERYTHROCYTE AUTOANTIBODY
40SNQP3, ANTI-2-PHENYLOXAZOLONE
H81'CL, ANTI-LAMININ
C3H-9'CL, ANTI-DNA
mAb55'CL, ANTI-RABIES VIRUS
DP13'CL, ANTI-DNA
N901H/PLO123, ANTI-CD56
NQT15/5A'CL, ANTI-2-PHENYLOXAZOLONE
Nb 72-H'CL, ANTI-DNP
4A6 Fab'CL, ANTI-RECOMBINANT BIRCH PROFILIN
AP.2.8'CL, ANTI-HIV-1 GP120 V3 LOOP
165.54'CL, ANTI-DNA
126IK'CL, ANTI-THYROID PEROXIDASE (TPO)
C95-4F10'CL, ANTI-(TYR,GLU)-ALA-LYS
ToPA244'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
F2-15'CL, ANTI-DNA
MA8-13, ANTI-2,4,6-TRINITROPHENYL-HEMOCYANIN HYBRIDOMA,EPSILON-DNP-AMINOCAPROATE(BINDING CONSTANT=1.1X10EXP7)
2INL1'CL, ANTI-HUMAN INSULIN
HIV-HC2'CL, ANTI-HIV-1 GP120
207,B-4, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
417.F21.5'CL, POLYREACTIVE
mAbA6H4C5'CL, ANTI-LIPID A OF BACTERIAL LPS POLYREACTIVE
SP19-1'CL, ANTI-DNA
aPC-122-10'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
H9-D3'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
CLONE 1E3'CL, ANTI-HUMAN RED BLOOD CELL
PE17'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
H11'CL, CATALYTIC ANTIBODY WHICH CATALYSES A DIELS-ALDER CYCLOADDITION REACTION
AC32'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
177'CL, ANTI-PSEUDOMONAS AERUGINOSA LIPID A LIPOPOLYSACCHARIDE
414.2'CL, ANTI-B1335 DEX
402P4-E2, ANTI-HIV GP120 V3-LOOP (K OFF = 1.4 X 10EXP-4 SEC-1)
202.17'CL, ANTI-DNA
NQ16.38.18'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
B/SB5-33'CL, ANTI-H2A/H2B
g'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
BA126-E2'CL, ANTI-DOUBLE STRANDED DNA
KA3D1'CL, RHEUMATOID FACTOR
M2 88'CL, ANTI-MOUSE TYPE II COLLAGEN
NQT17/10'CL, ANTI-2-PHENYLOXAZOLONE.
cAbCA10, ANTI-CARBONIC ANHYDRASE
H210-56'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
MRA10H'CL, ANTI-HISTONE
RF-ET13'CL, RHEUMATOID FACTOR
122'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
HIV-B35'CL, ANTI-HIV-1 GP120
R19.9'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
42.8E.9.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
bfd03'CL, ANTI-SSDNA/DSDNA HYBRIDOMA
119.13'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
2E7'CL, ANTI-PLATELET INTEGRIN GPIIB-IIIA IIB HEAVY CHAIN (RES. 231-238)
N4-10'CL, ANTI-DS DNA HYBRIDOMA
B'2 (VH3-JH4)'CL, RHEUMATOID FACTOR
723569, ANTI-TYPE VIII PNEUMOCOCCAL POLYSACCHARIDE
LES-B'CL, RHEUMATOID FACTOR
KOL, ANTI-CD56
M25-9'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
VH i.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
C11'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
mAb D'CL, ANTI-CYCLOSPORINE
NZB/NZW-7'CL, ANTI-DNA
2C4-C2'CL, ANTI-CARDIOLIPIN/DNA
scFv-KJ16 wild-type'CL, ANTI-T-CELL RECEPTOR (V-BETA8 REGION)
10.2.8'CL, ANTI-ALPHA 1,6 DEXTRAN
8/7p1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
126TP7H'CL, ANTI-THYROID PEROXIDASE (TPO)
2E10'CL, ANTI-SM HYBRIDOMA
Jb_42-H'CL, ANTI-DINITROPHENYL
BWR4.L1'CL, ANTI-RNA,POLY(G,C)
VL G61'CL, ANTI-GLUTATHIONE S-TRANSFERASE
TB-3-D13'CL, RHEUMATOID FACTOR
F2-12'CL, ANTI-DNA
A.18'CL, ANTI-ARS
BSa37'CL, ANTI-PHOSPHORYLCHOLINE
4-33'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
B9'CL, ANTI-DESIPRAMINE
95G5'CL, ANTI-FLUORESCEIN
119-a33'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
MEMORY 5, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
Mb_22-H'CL, ANTI-DINITROPHENYL
J'CL, ANTI-2-PHENYLOXAZOL-5-ONE
ABPC4, ANTI-BETA 2,1 FRUCTOSAN
S2H5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
FF61-2-E1'CL, ANTI-P-AZOPHENYLARSONATE
HIV-b3'CL, ANTI-HIV-1 GP120
C16-11D11'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
R6B8K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
SCFV198'CL, ANTI-ACHR
16.4.12E'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
3G2'CL, ANTI-SM HYBRIDOMA
48SNQP5, ANTI-2-PHENYLOXAZOLONE
ToP015'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
S17.161'CL, ANTI-DNA
F10.12-9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
rev9.33'CL, ANTI-HIV-1 REV
2BBLC803.1'CL, ANTI-BACTERIAL LEVAN
CL-G'CL, ANTI-ERYTHROCYTE
NQ7 3.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
MMW.2.7.16'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
84-7'CL, ANTI-DNA
WRD2'CL, RHEUMATOID FACTOR
HA-6'CL, ANTI-ERYTHROCYTE
43SNQP8, ANTI-2-PHENYLOXAZOLONE
567'CL, ANTI-DNA AUTOANTIBODY
SP2'CL, ANTI-HUMAN THYROID PEROXIDASE
DSC'CL, ANTI-DSDNA AUTOANTIBODY
C1'CL, ANTI-MOUSE TYPE II COLLAGEN
64-16G1, ANTI-ARS
MH6'CL, ANTI-ACETYLCHOLINE RECEPTOR
SC11'CL, ANTI-MCPS
NEO C49-3G10'CL, ANTI-(T,G)-A--L
10C3'CL, ANTI-MORPHINE
MOPC315, ANTI-DINITROPHENYL,TRINITROPHENYL,MENADIONE(VITAMIN K3)(BINDING CONSTANT=5.4X10EXP5),EPSILON-DNP-L-LYS(BINDING CONSTANT=1.0X10EXP7), 2,4-DINITRONAPHTHOL(BINDING CONSTANT=2.5X10EXP6),EPSILON-DNP-AMINOCAPROATE(BINDING CONSTANT=6.7X10EXP6)
S2P10'CL, RHEUMATOID FACTOR
ToPA243'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
7C5'CL, ANTI-SM
mAb C'CL, ANTI-HALOPERIDOL.
G3-3'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
MSL5, ANTI-LEWIS Y
402O-A12, ANTI-HIV GP120 V3-LOOP (K OFF = 1.5 X 10EXP-4 SEC-1)
P10.15.1' 'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
80.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
DN6'CL, ANTI-MCPS
C2'CL, ANTI-MOUSE TYPE II COLLAGEN
C3H-3'CL, ANTI-DNA
V86'CL, ANTI-MELANOMA
JV10'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
Ga_22-H'CL, ANTI-DINITROPHENYL
18/9'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
7B6''CL, ANTI-SM HYBRIDOMA
POP'CL, ANTI-MYELIN/SSDNA
R16.7 CRI+'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
E'CL, ANTI-2-PHENYLOXAZOL-5-ONE
PHOX15'CL, ANTI-2-PHENYLOXAZOL-5-ONE
ABA2'-4'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1.0X10EXP7)
CB 313'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
48SNQP107, ANTI-2-PHENYLOXAZOLONE
ITC48'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
1C10'CL, ANTI-DIGOXIN
I01'CL, ANTI-RH(D)
MRL1-166'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
MCPC603, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=1.6X10EXP5)
253.15D10, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
DBF1-386.5'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
hsighvm148'CL, ANTI-BETA-AMYLOID
DN9'CL, ANTI-MCPS
TUR, COLD AGGLUTININ WITH ANTI-PR ACTIVITY
4.2.6D12'CL, ANTI-ALPHA 1,6 DEXTRAN
S1.2'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
mAb410.7.F91'CL, POLYREACTIVE AUTOANTIBODY
TR1.32'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
NQ22.10.17'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
PL2-3'CL, ANTI-SUBNUCLEOSOMES (H2A-H2B-DNA)
B5'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
mAb E'CL, ANTI-CYCLOSPORINE
ABD4-lam3'CL, ANTI-DSDNA
RF1-7M'CL, ANTI-IGG1
FF29-36-13'CL, ANTI-P-AZOPHENYLARSONATE
Nb 74-H'CL, ANTI-DNP
83.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
VH HER1'CL, ANTI-LAMIN B AUTOANTIBODY
3B12-2'CL, ANTI-88 KDA SPLICING FACTOR 53/4
HPCG12, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
7S34.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE, ANTI-BETA-1,3-N-ACETYL-D-GLUCOSAMINE
VK-25-47'CL, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
FF29-36-6'CL, ANTI-P-AZOPHENYLARSONATE
C09, ANTI-LYSOZYME HYBRIDOMA
Lb 29-H'CL, ANTI-DNP
Ib_20-H'CL, ANTI-DINITROPHENYL
87.92.6'CL, ANTI-9B.G5 ANTIBODY HYBRIDOMA
500A2'CL, ANTI-MURINE CD3
G3'CL, ANTI-ARS
550'CL, ANTI-DNA AUTOANTIBODY
4D4''CL, ANTI-CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE (SEROPTYPE A)
101F11, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
260.1C10'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
F2-3'CL, ANTI-DNA
7C5'CL, ANTI-SM HYBRIDOMA
MOR180'CL, ANTI-MORPHINE
C72.L'CL, ANTI-DNA,POLY(DC),POLY(DG),POLY(DT)
T077'CL, ANTI-NITROPHENYL
L2'CL, ANTI-GP41
D20'CL, ANTI-DNA
VH G64'CL, ANTI-GLUTATHIONE S-TRANSFERASE
SV5-P-k'CL, ANTI-SIMIAN VIRUS 5 PHOSPHO (P) PROTEIN PEPTIDE 98-IPNPLLGLD-106
u'CL, ANTI-2-PHENYLOXAZOL-5-ONE
3315, ANTI-TYPE VIII PNEUMOCOCCAL POLYSACCHARIDE
CNJ174'CL, ANTI-P-NITROPHENYL PHOSPHONATE
slkv14'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
3-4'CL, ANTI-IGG2A
La 58-H'CL, ANTI-DNP
N4-19'CL, ANTI-DS DNA HYBRIDOMA
S17'CL, ANTI-ARS
17s.13'CL, ANTI-DNA
47SNQP40, ANTI-2-PHENYLOXAZOLONE
126TO6K'CL, ANTI-THYROID PEROXIDASE (TPO)
N92'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
MP10'CL, ANTI-HLA CLASS II (DRB1*01,*09,*1001,*15,*16)
18G9'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
Fa_08-H'CL, ANTI-DINITROPHENYL
HIV-B26'CL, ANTI-HIV-1 GP120
E26'CL, ANTI-MELANOMA
202.105'CL, ANTI-DNA
131'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
RA-3-A3.2'CL, RHEUMATOID FACTOR
BLI'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
ToP023'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
B10, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
DF4-29.4'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
JAC-1, ANTI-POLYAMINE, CROSS REACTS WITH SPERMINE
Fd138-80'CL, ANTI-HERPES SIMPLEX VIRUS-1 GLYCOPROTEIN B AND GLYCOPROTEIN D
H36-12'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
5E9'CL, ANTI-CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE (SEROPTYPE A)
NQT15/10'CL, ANTI-2-PHENYLOXAZOLONE
A2.1'CL, ANTI-HEPATITIS B SURFACE ANTIGEN
28'CL, ANTI-DSDNA
126TO15K'CL, ANTI-THYROID PEROXIDASE (TPO)
S5P3'CL, RHEUMATOID FACTOR
2E11'CL, ANTI-DNA
FS-3'CL, COLD AGGLUTININ
d9/3'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
12.5H'CL, ANTI-MURINE IGG ANTI-DNA ANTIBODIES
Ery.X1'CL, PANAGGLUTININ
pB7S2'CL, ANTI-HERPESVIRUS 1
hsigkvm148'CL, ANTI-BETA-AMYLOID
163.20, ANTI-P53
NEWM, ANTI-3-(3'-HYDROXY-3',7',11',15',TETRAMETHYL HEXADECYL) 2-METHYL 1,4 NAPHTHOQUINONE(VIT.K1OH)
126TO9H'CL, ANTI-THYROID PEROXIDASE (TPO)
18-26C7'CL, ANIT-DOUBLE STRANDED DNA
THY-32'CL, ANTI-HUMAN THYROGLOBULIN
2D12'CL, ANTI-LA PROTEIN (SS-B)
36-60 CRI-, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1.4X10EXP6)
Nb 62-H'CL, ANTI-DNP
A1, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
57-2, ANTI-ESTRADIOL
ToP312'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
LN2 15'CL, ANTI-MOUSE TYPE II COLLAGEN
2F2'CL, ANTI-SSDNA HYBRIDOMA
MMW.2.7.9'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
H130-6'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
AZ-42'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
84-21'CL, ANTI-DNA
Lb 83-H'CL, ANTI-DNP
BBLC107.5'CL, ANTI-BACTERIAL LEVAN
ITC39'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
F17.170.2, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
CB 105'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
268-D'CL, ANTI-HIV TYPE 1 SPECIFIC FOR THE PRINCIPLE NEUTRALIZING DOMAIN OF GP120 OF MN AND MAPS TO RESIDUES HIGPGR
CAL-27'CL, ANTI-CARDIOLIPIN
HDEX6, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
BW24-37'CL, ANTI-DNA
M02/11/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
402B-D3, ANTI-HIV GP120 V3-LOOP (K OFF = 4.0 X 10EXP-4 SEC-1)
d9/15'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
R6'CL, ANTI-SINDBIS VIRUS E2 ENVELOPE GLYCOPROTEIN
La 21-H'CL, ANTI-DNP
d9/12'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
B/SB5-3'CL, ANTI-H4
123'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
NC19-F2'CL, ANTI-PHOSPHATIDYL CHOLINE
ASWA2'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
TE-33'CL, ANTI-CHOLERA TOXIN PEPTIDE 3
TR1.37'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
HIV-HC7'CL, ANTI-HIV-1 GP120
239.10D7'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
AN03'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=6.2X10EXP4)
E11, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
FF29-12-5'CL, ANTI-P-AZOPHENYLARSONATE
B72.3-1-3'CL, ANTI-TAG72
Bg112-10'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
44SNQP24, ANTI-2-PHENYLOXAZOLONE
CB6'CL, ANTI-TRINITROPHENYL HYBRIDOMA
F5-963'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
DN8'CL, ANTI-MCPS
131TP5H'CL, ANTI-THYROID PEROXIDASE (TPO)
198.5C8'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
MRB4'CL, ANTI-NUCLEOSOME
CD4-74'CL, ANTI-HUMAN RECOMBINANT CD4
RC3'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
163.6, ANTI-P53
623'CL, ANTI-MEP-1 17-31 PEPTIDE
aly17-9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2G5'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
59.1G2.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
o'CL, ANTI-2-PHENYLOXAZOL-5-ONE
Ma_63-H'CL, ANTI-DINITROPHENYL
5.5'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
RC1H, LOW AFFINITY POLYREACTIVE (ANTI-FC,ANTI-TETANUS TOXOID,ANTI-RABBIT IGG, ANTI-SSDNA) RHEUMATOID FACTOR (RF)
F10.12-10'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2A1-17'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
BKD12'CL, ANTI-DNA
44-10 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=4.2X10EXP5)
ALN/11/53'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
BEN-27'CL, ANTI-HISTONE H1 (RESIDUES 204-218)
T21-9'CL, ANTI-DNA AUTOANTIBODY
NQ10.2.12.8'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
F4-3'CL, ANTI-CON A
AN07'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=2.5X10EXP7)
3H4'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
JV3'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
HiH2'CL, ANTI-H. INFLUENZAE TYPE B LIPOPOLYSACCHARIDE
K16-167, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
NQ22.16.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
MMW.8.11'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
47SNQP1, ANTI-2-PHENYLOXAZOLONE
219.7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
10-2'CL, ANTI-IGG2A
AB5'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
BKD12'CL, ANTI-DSDNA
Na 09-H'CL, ANTI-DNP
2677.1'CL, ANTI-BACTERIAL LEVAN
5G12-4'CL, ANTI-DNA
PY102''CL, ANTI-HEMAGGLUTININ OF PR8 (H1N1) VIRUS
Z112VH3'CL, CD20
H564'CL, ANTI-DNA
DN10'CL, ANTI-MCPS
S4 10H'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
MRL1-46'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
44SNQP33, ANTI-2-PHENYLOXAZOLONE
8/23p3'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
127'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
N4-18'CL, ANTI-DS DNA HYBRIDOMA
9E10'CL, ANTI-C-MYC
RF10-4K'CL, ANTI-IGG2A
2INH12'CL, ANTI-HUMAN INSULIN
CAL-15'CL, ANTI-CARDIOLIPIN
MRL2-120'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
B3, ANTI-DNA
F10.12-4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
NZW14E10'CL, ANTI-DSDNA
RF-TMC'CL, MONOREACTIVE RHEUMATOID FACTOR
16/6'CL, ANTI-DNA
aPC-41-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
AB3'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
PC700'CL, ANTI-PHOSPHORYLCHOLINE
ITC33'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
ToPG440'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
224.1C7'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
HP27'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
NC1/34HL'CL, ANTI-SUBSTANCE P
C6'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
14C3'CL, ANTI-ALPRENOLOL HYBRIDOMA
NC13C1'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
B13'CL, ANTI-F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
1H6'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
anti-Leu3a'CL, ANTI-HUMAN CD4
MMW.7.5'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
126DH'CL, ANTI-THYROID PEROXIDASE (TPO)
Humkv305'CL, CROSS-REACTIVE IDIOTYPES ON VK-IGM AUTO-ANTI-IGG
17E12'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
B8815'CL, ANTI-DENATURED DNA
A73, ANTI-SMRNP
U9A5 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA (BALB/C)
C57BL 2857, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
1P1C'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=3.8X10EXP5)
MMW.7.7'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
M03'CL, ANTI-RH(D)
2INL12'CL, ANTI-HUMAN INSULIN
A09, ANTI-LYSOZYME HYBRIDOMA
MAL'CL, POLYREACTIVE
FS3, ANTI-VH4-34
G9'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC (ALPHA-GALACTOSYL) EPITOPE
HIV-b12'CL, ANTI-HIV-1 GP120
E13'CL, ANTI-MELANOMA
62H3'CL, ANTI-HLA-DR RHEUMATOID FACTOR AUTOANTIBODY
4D4'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
J01'CL, ANTI-RH(D)
Jb_21-H'CL, ANTI-DINITROPHENYL
LSF2'CL, ANTI HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (RIBOSYLRIBITOLPHOSPHATE)
G15'CL, ANTI-GP41
202.38m'CL, ANTI-DNA
2INH13'CL, ANTI-HUMAN INSULIN
SM3, ANTI-CARCINOMA-ASSOCIATE MUCIN, RECOGNIZING THE PEPTIDE PDTRP
H3, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
PC43'CL, ANTI-PS1CT3
8/7p13'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
RF-SJ2'CL, RHEUMATOID FACTOR AUTOANTIBODY
126TP14K'CL, ANTI-THYROID PEROXIDASE (TPO)
clone10-Vh'CL, ANTI-ASIALO GA1 GANGLIOSIDE
CBGA1'CL, POLY-REACTIVE INCLUDING PSEUDOMONAS AERUGINOSA PA C7-67, ESCHERICHIA COLI O1Z, ERYTHROCYTES FROM DONOR, ETC.
11G11'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
I-2a'CL, ANTI-DNA
36-65'CL, ANTI-ARS
ToP243'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
402K-B9, ANTI-HIV GP120 V3-LOOP (K OFF = 2.0 X 10EXP-4 SEC-1)
NQ10 2.2.5'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
T13.204.70'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
KC4G3'CL, ANTI-HUMAN BREAST MUCIN (AFFINITY CONSTANT=1.1X10EXP9)
6A7.E5'CL, ANTI-RAT 62 CYTOCHROME C
mAb D''CL, ANTI-HALOPERIDOL.
Lb 81-H'CL, ANTI-DNP
F12.17D3'CL, ANTI-DSDNA
FIF, ANTI-I
2B1-76'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
11C7'CL, ANTI-MORPHINE
165'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
l'CL, ANTI-2-PHENYLOXAZOL-5-ONE
N19-8 scFv'CL, ANTI-HUMAN COMPLEMENT C5 CONVERTASE
La 32-H'CL, ANTI-DNP
163.72'CL, ANTI-DNA
Nb 01-H'CL, ANTI-DNP
D30'CL, ANTI-RH(D)
Amu1F6-3'CL, ANTI-DNA
Fb_12-H'CL, ANTI-DINITROPHENYL
Mb_12-H'CL, ANTI-DINITROPHENYL
Ib_04-H'CL, ANTI-DINITROPHENYL
BW18F8'CL, ANTI-DSDNA
AZ-28'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
aPC-111-6'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP II)
TE2'CL, ANTI-TRICHOSANTHIN (AN ACTIVE COMPONENT OF A TRADITIONAL CHINESE MEDICINE USED FOR INDUCING ABORTION)
47SNQP20, ANTI-2-PHENYLOXAZOLONE
C1'CL, ANTI-GLYCOPHORIN A
D3'CL, ANTI-MOUSE TYPE II COLLAGEN
CLONE 1D8'CL, ANTI-HUMAN RED BLOOD CELL
d9/2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
ToP003'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
MRL-4'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
MRA12H'CL, ANTI-HISTONE
TR1.23'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
P13'CL, ANTI-PROTHROMBIN (KD = 1.4 X 10EXP-6)
248.4D5'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
4F7'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 4X10EXP-8)
F10.12-3'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
1X7RG1'CL, ANTI-DNA
13D4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
Og-31'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
DPD'CL, ANTI-GLUTAMIC ACID DECARBOXYLASE 65
THY-23'CL, ANTI-HUMAN THYROGLOBULIN
BW24-G11'CL, ANTI-DNA
MIMA-8'CL, ANTI-JS(B+)
3368, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
18/9'CL, ANTI-DNA
MRA11H'CL, ANTI-HISTONE
mAb C'CL, ANTI-CYCLOSPORINE
Nb 37-H'CL, ANTI-DNP
3A5-1'CL, ANTI-METATOPE OF 4-4-20
MMW.8.4'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
NC6.7'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
37.1.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
M16'CL, ANTI-HUMAN INSULIN
HIV-b27'CL, ANTI-HIV-1 GP120
1E8'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
E4-12'CL, ANTI-CON A
MEMORY 3, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
MOPC167, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=1.2 TO 1.9X10EXP5)
B5G10K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA, 3-FL-BSA)
3B10'CL, ANTI-CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE (SEROPTYPE A)
hVH65-110'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1X10EXP4)
CP3 23-24'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
ALN/9/94'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
DNA6'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
Bg53-17'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
R5A3H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
ToPA126'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
HA-5'CL, ANTI-IGG (NO ANTI-ERYTHROCYTE ACTIVITY)
NQT17/40B'CL, ANTI-2-PHENYLOXAZOLONE
19.22.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
A30c'CL, ANTI-DSDNA AUTOANTIBODY
2B9L'CL, ANTI-MURINE SERUM ALBUMIN
DN11'CL, ANTI-MCPS
ToPG426'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
LG8-1'CL, ANTI-NUCLEOSOME
Sulf-4'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
LL2'CL, ANTI-DIGOXIN
d9/11'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
L7'CL, AUTOANTIBODY
SiP031'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
VM202'CL, ANTI-PR8 (HIN1) VIRUS VARIANT (VM113-V1)
126CH'CL, ANTI-THYROID PEROXIDASE (TPO)
103-11'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
RP93'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
4153-I, ANTI-STREPTOCOCCAL GROUP C CARBOHYDRATE
ATM-1, ANTI-TCR VBETA
NQ10.12.5'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
ToP019'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
B13I2'CL, ANTI-PEPTIDE 69-87 OF MYOHEMERYTHRIN.
1E49'CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
F7.48B7'CL, ANTI-DSDNA
SM1'CL, ANTI-GM1 GANGLIOSIDE
cDNA5-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
ToP002'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
F29'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
MMW.4.4'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
Ab1 GA733'CL, ANTI-HUMAN TUMOR-ASSOCIATED ANTIGEN GA733
A10'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
2B8E3'CL, ANTI-FLUORESCEIN
QB1'CL, ANTI-CHROMATIN
J558, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN
CB-201'CL, ANTI-LIPID A
Ma_60-H'CL, ANTI-DINITROPHENYL
VH FUR2'CL, ANTI-LAMIN B AUTOANTIBODY
b'CL, ANTI-2-PHENYLOXAZOL-5-ONE
2C7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
Fom-A'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
HIV-LC25'CL, ANTI-HIV-1 GP120
MAb C3'CL, ANTI-HEAT-INACTIVATED POLIOVIRION, MAHONEY STRAIN OF TYPE 1 POLIOVIRUS
RF-SJ3'CL, RHEUMATOID FACTOR AUTOANTIBODY
NQT15/17A'CL, ANTI-2-PHENYLOXAZOLONE
T10-440'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
14-37A1, ANTI-ARS
Meso 3, ANTI-RECOMBINANT MESOTHELIN, MESOTHELIN-POSITIVE CELLS
Nb 84-H'CL, ANTI-DNP
HA-5'CL, ANTI-IGG (NO ANTI-ERYTHROCYTE ACTIVITY)
G6, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
ASWA1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8 AND FIBRILLARIN
L202'CL, ANTI-HUMAN CD4
HuFd138-80'CL, ANTI-HERPES SIMPLEX VIRUS-1 GLYCOPROTEIN B AND GLYCOPROTEIN D
WR1.107'CL, ANTI-THYROID PEROXIDASE
mAb D'CL, ANTI-HALOPERIDOL.
G3D10K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GM1, GA1, GALGALNAC-BSA, NLC4, 3-FL-BSA)
280.15'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
IN-1'CL, ANTI-MYELIN-ASSOCIATED INHIBITORS OF NEURITE GROWTH
Lb 80-H'CL, ANTI-DNP
G'CL, ANTI-2-PHENYLOXAZOL-5-ONE
AKR-11'CL, ANTI-DNA
43SNQP19, ANTI-2-PHENYLOXAZOLONE
IM9, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN
RF-KES'CL, MONOREACTIVE RHEUMATOID FACTOR
S43'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
H45-5'CL, ANTI-POLY(GLU50,TYR50)(KA=1.27X10EXP7),DNA(KA=4.67X10EXP6),SMITH ANTIGEN(KA=1.33X10EXP6),IGG2A(KA=1.68X10EXP6)
BA1224-2'CL, ANTI-DOUBLE STRANDED DNA
L2-10C1'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
RF-ET12'CL, RHEUMATOID FACTOR
RF-IP18'CL, RHEUMATOID FACTOR
SiP063'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
CAL-6'CL, ANTI-CARDIOLIPIN
305'CL, ANTI-INSULIN
Nb 16-H'CL, ANTI-DNP
MF8 (Humkv328-Jk1)'CL, RHEUMATOID FACTOR
MMW.8.10'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
PopVK'CL, ANTI-DNA, ANTI-MYELIN
clone 5'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
PE16'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
GP44'CL, ANTI-CD4-BINDING SITE OF HIV-1 GP120.
ToP218'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
DR12910-2F8'CL, ANTI-DR 1,2,9,10 HYBRIDOMA
mAb53'CL, ANTI-RABIES VIRUS
1G2'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
ToPG344'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
CB 340'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
40-160, ANTI-DIGOXIN
RF4-3FK'CL, ANTI-IGG1
1-10'CL, ANTI-SM HYBRIDOMA
TE-34'CL, ANTI-CHOLERA TOXIN PEPTIDE 3
HIV-B2'CL, ANTI-HIV-1 GP120
NQ10.3.8'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
17p.3'CL, ANTI-DNA
H8'CL, ANTI-PRE-S2 ANTIGEN OF HEPATITUS B VIRUS (ADR SUBTYPE)
333'CL, HETEROHYBRIDOMA ANTIBODY TO LYMPHOMA CELLS POSSESSING IDIOTOPE REACTING WITH ANTI-IDIOTYPE 7D11 BEFORE TREATMENT WITH 7D11.
120-16'CL, ANTI-HIV TYPE 1 SPECIFIC FOR AMINO ACIDS 644-663 OF GP41
6-32B2'CL, ANTI-DOUBLE STRANDED DNA
P11'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 1.6 X 10EXP-6), ANTI-PROTHROMBIN (KD = 3.2 X 10EXP-6)
MMW.7.9'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
12'CL, ANTI-DNA AUTOANTIBODY
P65I4-2'CL, ANTI-P-AZOPHENYLARSONATE (KA=3.7 TO 7.1X10EXP4)
CAL-18'CL, ANTI-CARDIOLIPIN
SiP066'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
M7-625'CL, ANTI-IDIOTYPIC ANTIBODY SPECIFIC FOR ANTI-CEA MAB MA208
D13'CL, ANTI-RH(D)
D08'CL, ANTI-RH(D)
ToP250'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
40SNQP5, ANTI-2-PHENYLOXAZOLONE
FS-2'CL, ANTI-IDIOTYPIC 9G4
F4-23'CL, ANTI-CON A
42.8G.4.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
1-8'CL, ANTI-SM HYBRIDOMA
NQ22.56.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
H 113'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
H1-7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
SC3'CL, ANTI-MCPS
MF15-4'CL, ANTI-PSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDE O5 O-ANTIGEN
D23K'CL, ANTI-SM AND ANTI-DNA
246B.4g'CL, ANTI-PGOSPHORYLCHOLINE, DSDNA
B/SB5-28'CL, ANTI-H2A/H2B
44SNQP20, ANTI-2-PHENYLOXAZOLONE
RF-3'CL, ANTI-IGG1 RHEUMATOID FACTOR
163.9, ANTI-P53
3D61'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
H220-10'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
cDNA3-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
8/7p14'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2-115-58'CL, ANTI-IDIOTYPIC ANTIBODY SPECIFIC FOR MURINE MONOCLONAL ANTI-ACHR ANTIBODY 63
ToPG343'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
CBL166.10.28'CL, ANTI-BACTERIAL LEVAN
B13'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
F2-20'CL, ANTI-DNA
7F11'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
251.9C6'CL, ANTI-PHOSPHORYLCHOLINE (P.MORGANII) HYBRIDOMA
3B8G9'CL, ANTI-TG
e'CL, ANTI-2-PHENYLOXAZOL-5-ONE
D2.4'CL, ANTI-NITROBENZYL PHOSPHONATE (TRANSITION STATE ANALOG)
4-10F7'CL, ANTI-DOUBLE STRANDED DNA
1F7'CL, NEUTRALIZING ANTI-HIV-1
C20-7D6'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
PC2812'CL, ANTI-PSICT3
GP1'CL, ANTI-ARSONATE HYBRIDOMA
48SNQP6, ANTI-2-PHENYLOXAZOLONE
40SNQP8, ANTI-2-PHENYLOXAZOLONE
cAbCA05, ANTI-CARBONIC ANHYDRASE
40SNQP29, ANTI-2-PHENYLOXAZOLONE
7C6'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
WG4'CL, ANTI-PROTEINASE 3
slkv15'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
hsiglvl295'CL, ANTI-RABBIT IGG
3T74, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
GN901v1.1, ANTI-CD56
H35-C7'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
609'CL, ANTI-MEP-1 17-31 PEPTIDE
73-15'CL, ANTI-DNA
22B5'CL, ANTI-ARSONATE HYBRIDOMA
F-423'CL, ANTI-DNA
HIV-loop13'CL, ANTI-HIV-1 GP120
HYHEL-8, ANTI-HEN EGG WHITE LYSOZYME
Ma_31-H'CL, ANTI-DINITROPHENYL
p'CL, ANTI-2-PHENYLOXAZOL-5-ONE
bfd37'CL, ANTI-SSDNA/DSDNA HYBRIDOMA
AE6'CL, ANTI-C-TERMINUS OF NEF OF HIV-1 STRAIN LAI (VARELHPEYFKNC) BUT NOT SF2 (MARELHPEYYKDC)
NQ7 6.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
MRA7K'CL, ANTI-HISTONE
47SNQP9, ANTI-2-PHENYLOXAZOLONE
P65J4-1'CL, ANTI-P-AZOPHENYLARSONATE (KA=3.3 TO 6.3X10EXP4)
50S10.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
T17'CL, ANTI-(T,G)-A--L
Bg53-32'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
SiP006'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
ToP301'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
ABE48'CL, ANTI-BETA 2,6 FRUCTOSAN
9-5'CL, ANTI-IGG2A
S/SB5-84'CL, ANTI-H4
AN11'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=5.0X10EXP5)
JB21'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
34-3C'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
HA-VG'CL, ANTI-ERYTHROCYTE
Lb 12-H'CL, ANTI-DNP
2A81G5'CL, ANTI-CD(II)-BSA-THIOUREIDO-L-BENZYL-EDTA (BINDING CONSTANT=1.4X10EXP10)
C219'CL, ANTI-P-GLYCOPROTEIN
1A6'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
33.F12'CL, ANTI-DSDNA
VS1'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
MMW.7.4'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
2BBLC403.4'CL, ANTI-BACTERIAL LEVAN
T13.204.83'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
G6, ANTI-MESOTHELIN
L30'CL, AUTOANTIBODY
hVH65-107'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1X10EXP3)
69.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
111.185'CL, ANTI-DNA
ToPA118'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
2F5'CL, NEUTRALIZING ANTI-HIV-1
H7'CL, ANTI-DNA
CM4'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
AC31'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
42.7C.11.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
T5-58'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
cAb-Lys3, ANTI-LYSOZYME
BSa10'CL, ANTI-PHOSPHORYLCHOLINE
21/28'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
3T72, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
POR'CL, ANTI-FC IGG
Ma_41-H'CL, ANTI-DINITROPHENYL
Bg359-4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL (KA=2.9X10EXP7)
Ia_12-H'CL, ANTI-DINITROPHENYL
NQT15/23C'CL, ANTI-2-PHENYLOXAZOLONE
1-6'CL, ANTI-IGG2A
SCA, CRYOGLOBULIN WITH ANTI-LOW-DENSITY LIPOPROTEIN ACTIVITY; B IDIOTYPE
RF-ET7'CL, RHEUMATOID FACTOR
A09'CL, ANTI-HUMAN M BLOOD GROUP ANTIGEN
Mb_09-H'CL, ANTI-DINITROPHENYL
5.M13'CL, AUTOANTIBODY TO THE ACETYLCHOLINE RECEPTOR.
402K-F3, ANTI-HIV GP120 V3-LOOP (K OFF = 2.0 X 10EXP-4 SEC-1)
Fog-B'CL, ANTI-D ANTIGEN OF THE RH-BLOOD-GROUP SYSTEM
B1-8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
HPCM27'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
68.2D8'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
AB1/2'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
L32'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
AD5/16'CL, ANTI-ERYTHROCYTE RH(D) 
FS4, ANTI-VH4-34
T142'CL, ANTI-NITROPHENYL
ANTI-TGAL 6'CL, ANTI-BRANCHED POLY-L-(TYR,GLU)-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
NC10.1'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
WR1.102'CL, ANTI-THYROID PEROXIDASE
C488-30B'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
3F6'CL, ANTI-NUCLEOSOME, TOTAL HISTONE, H2A-H2B DIMER
28.4.10A'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
126CK'CL, ANTI-THYROID PEROXIDASE (TPO)
7'CL, ANTI-INSULIN
8/23p7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
16.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
NC2.3'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
ToP239'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
VL A47, ANTI-CD34
Py20, ANTI-PHOSPHOTYROSYLPROTEIN
HIC5-4D1'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
265.13D10'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
ITC88'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
R1C8K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
6B10'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
D1.3, ANTI-LYSOZYME HYBRIDOMA
MRL-Histone7'CL, ANTI-HISTONE 2A,4 HYBRIDOMA
47SNQP21, ANTI-2-PHENYLOXAZOLONE
16C3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
NQ11.5.2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
412.66.F1'CL, ANTI-SSDNA,CARDIOLIPIN,PHOSPHORYLCHOLINE,ACTIN,INSULIN,TEATANUS TOXOID
1411E.3b'CL, ANTI-PHOSPHORYLCHOLINE, DSDNA
BPPI-6.4'CL, ANTI-BOVINE PANCREATIC POLYPEPTIDE
Mb_62-H'CL, ANTI-DINITROPHENYL
91.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
IdB5.7'CL, ANTIIDIOTYPE TO ANTI-ALPHA 1,6 DEXTRAN 45.21.1
S107.U1, ANTI-PHOSPHORYLCHOLINE
AC-1001'CL, ANTI-BLOOD GROUP A SUBSTANCE HYBRIDOMA
S10P19'CL, RHEUMATOID FACTOR
Ab25'CL, ANTI-THYROGLOBULIN AUTOANTIBODY
126TO8K'CL, ANTI-THYROID PEROXIDASE (TPO)
MMW.2.6.12'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
2C10'CL, ANTI-NATIVE DNA AUTOANTIBODY
B5Fv'CL, ANTI-LEWIS(GAMMA)-RELATED CARBOHYDRATE ANTIGEN ABUNDANT ON VARIOUS CARCINOMAS
SC4'CL, ANTI-MCPS
CAL-23'CL, ANTI-CARDIOLIPIN
Lb 31-H'CL, ANTI-DNP
RF6-2'CL, ANTI-IGG2A
1G8G10'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
C7, ANTI-MESOTHELIN
HIV-s4'CL, ANTI-HIV-1 GP120
WAG'CL, RHEUMATOID FACTOR
G2a-1'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
C3H-4'CL, ANTI-DNA
HY GAL3, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
BKD17'CL, ANTI-DSDNA
5-3'CL, ANTI-IGG2A
cAbAMB10, ANTI-ALPHA-AMYLASE
198.5C2'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
MMW.4.6'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
BrE-3'CL, ANTI-HUMAN BREAST EPITHELIAL MUCIN
P4.16.25'CL, ANTI-4-(HYDROXY-3-NITROPHENYL)ACETYL IDIOTYPIC ANTIBODIES
48SNQP18, ANTI-2-PHENYLOXAZOLONE
NQT15/18B'CL, ANTI-2-PHENYLOXAZOLONE
73-1'CL, ANTI-DNA
Ma_20-H'CL, ANTI-DINITROPHENYL
slkv16'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
mAb52'CL, ANTI-RABIES VIRUS
ToPA114'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
8G6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
D.3'CL, ANTI-ARS
BV04-01'CL, ANTI-SSDNA AUTOANTIBODY HYBRIDOMA
638'CL, ANTI-P601E
Ma_62-H'CL, ANTI-DINITROPHENYL
17C1'CL, ANTI-ALPRENOLOL HYBRIDOMA
KO3-34'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
126TO9K'CL, ANTI-THYROID PEROXIDASE (TPO)
27.10.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
F10.12-6'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
SiP019'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
H8' 'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
HuVHLYS'CL, ANTI-LYSOZYME HYBRIDOMA
MOR76'CL, ANTI-MORPHINE
111-1'CL, ANTI-PHOSPHORYLCHOLINE-KEYHOLE LIMPET HEMOCYANIN
F4B6'CL, ANTI-DEXTRAN B512
WIL'CL, RHEUMATOID FACTOR
ToPA110'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
MRL3-55'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
Z44'CL, ANTI-Z-DNA
BAT123'CL, ANTI-GLYCOPROTEIN GP120 OF HTLV-IIIB STRAIN OF HIV TYPE 1. 
MMW.2.7.3'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
M-T151'CL, ANTI-HUMAN CD4
NQT15/3'CL, ANTI-2-PHENYLOXAZOLONE
18/2'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
22'CL, ANTI-INSULIN
4B4'CL, ANTI-SM AUTOANTIBODY HYBRIDOMA
FF57-9-9'CL, ANTI-P-AZOPHENYLARSONATE
ANTI-TGAL 14'CL, ANTI-BRANCHED POLY-L-(TYR,GLU)-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
UPC61, ANTI-BETA 2,1 FRUCTOSAN
2INH5'CL, ANTI-HUMAN INSULIN
BOR', ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE
NQT15/23B'CL, ANTI-2-PHENYLOXAZOLONE
B12'CL, ANTI-TG
A39.40.5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
RF49'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
72.3, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
ToPG331'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
C488-20C'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
CB6'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
Se 155-4'CL, ANTI-OLIGOSACCHARIDE REPEATING UNIT OF A SALMONELLA SEROTYPE B O-ANTIGEN
NQ7.47.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
E225'CL, ANTI-D1.3 MAB
18/2'CL, ANTI-DNA
Day 4 15-167-11'CL, ANTI-2-PHENYL-5-OXAZOLONE
P61B27'CL, REHEUMATOID FACTOR
SW3-6'CL, ANTI-DNA
CC92'CL, ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72)
47SNQP27, ANTI-2-PHENYLOXAZOLONE
48G7'CL, ANTI-NITROPHENYL PHOSPHONATE TRANSITION STATE ANALOGUE 3 CATALYTIC ANTIBODY
p5H4.1'CL, ANTI-HERPESVIRUS 1
E8'CL, ANTI-HORSE CYTOCHROME C
MMW.2.7.12'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
Jb_32-H'CL, ANTI-DINITROPHENYL
d'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
X3'CL, ANTI-HUMAN INTERLEUKIN-1 ALPHA
m62N/D, ANTI-IDIOTYPIC
N3'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
HIV-loop8'CL, ANTI-HIV-1 GP120
mAb10.2.3'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
ABA2'-4'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=1.0X10EXP7)
F1_1259'CL, ANTI-FRACTION 1
MMW.2.7.2'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
PL2-7'CL, ANTI-SUBNUCLEOSOMES (H2A-H2B-DNA)
Nb 08-H'CL, ANTI-DNP
tat104'CL, ANTI-HIV-1 TAT
M3'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBDIROMA
LC4'CL, ANTI-CD19
ToP303'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
10C11'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
KSa1F5'CL, ANTI-FLUORESCEIN
M02/09/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
H35-C10'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
L69'CL, ANTI-HUMAN CD4
40SNQP27, ANTI-2-PHENYLOXAZOLONE
3C10'CL, ANTI-FLUORESCEIN
BW5F2'CL, ANTI-DSDNA
B/SB5-62'CL, ANTI-H2A/H2B
A2, ANTI-MESOTHELIN
I11'CL, ANTI-RH(D)
LG2-1'CL, ANTI-BOVINE THYMUS HISTONES (H3 RES. 30-45)
S25'CL, ANTI-ARS
A.1.11'CL, ANTI-DNA
mAb50'CL, ANTI-RABIES VIRUS
LA1L1'CL, RHEUMATOID FACTOR
17p.79'CL, ANTI-DNA
G28'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
1C4C9'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
36-18'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
DA4.4/212'CL, ANTI-HUMAN IGM (KA = 3.03 X 10^9 M^-1)
402P4-G4, ANTI-HIV GP120 V3-LOOP (K OFF = 1.4 X 10EXP-4 SEC-1)
WW, ANTI-VH4-34
HIV-b6'CL, ANTI-HIV-1 GP120
H2'CL, ANTI-HUMAN LIVER CELLS
HDEX5, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
44SNQP14, ANTI-2-PHENYLOXAZOLONE
PR1-3'CL, ANTI-NUCLEOSOME
MMW.4.11'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
C04'CL, ANTI-RH(D)
111.67'CL, ANTI-DNA
D10, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
628'CL, ANTI-MEP-1 17-31 PEPTIDE
ToP307'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
4-6-2'CL, ANTI-ESE (EXTRA SHEEP E ANTIGEN)
ED8.4'CL, ANTI HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (RIBOSYLRIBITOLPHOSPHATE)
VH ii.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
Lb 13-H'CL, ANTI-DNP
F4H2'CL, ANTI-DEXTRAN B512
Nb 39-H'CL, ANTI-DNP
S5P14'CL, RHEUMATOID FACTOR
Lb 04-H'CL, ANTI-DNP
5/8'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=6X10EXP6)
22.8'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
F17.170.2'CL, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C X DBA/2 HYBRIDOMA
48SNQP123, ANTI-2-PHENYLOXAZOLONE
AD9'CL, ANTI-ERYTHROCYTE RH(D) 
NC13-B12'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
RF5-7'CL, ANTI-IGG2A
Anti-B4, ANTI-CD19
Amu10-2b'CL, ANTI-DNA
HPCG13, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA(BINDING CONSTANT=1.8X10EXP5)
RF-ET11'CL, RHEUMATOID FACTOR
SiP060'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
Hu PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
DAUDI, ANTI-ACHR
Na 40-H'CL, ANTI-DNP
2H7'CL, ANTI-CD20 CELL SURFACE PHOSPHOPROTEIN HYBRIDOMA
mAb10'CL, POLYREACTIVE AUTOANTIBODY
F10.17-5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
POM, ANTI-HUMAN GAMMA G1 GLOBULIN; PO IDIOTYPE
L'CL, ANTI-2-PHENYLOXAZOL-5-ONE
mAb F'CL, ANTI-CYCLOSPORINE
BXW-7'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
WS2z27'CL, ANTI-PHOSPHORYLCHOLINE
AC7'CL, ANTI-RGD (ARG-GLY-ASP) BINDING SITE ON THE GPIIIA SUBUNIT OF THE PLATELET FIBRINOGEN RECEPTOR, THE GPIIB-GPIIIA COMPLEX
7C80'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
M02/05/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
Day 2 15-167-6'CL, ANTI-2-PHENYL-5-OXAZOLONE
126TP13K'CL, ANTI-THYROID PEROXIDASE (TPO)
D7'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
Ma_49-H'CL, ANTI-DINITROPHENYL
AKR1'CL, ANTI-P-AZOPHENYLARSONATE
A.21'CL, ANTI-ARS
402J-E9, ANTI-HIV GP120 V3-LOOP (K OFF = 2.0 X 10EXP-4 SEC-1)
D16'CL, ANTI-RH(D)
Brad-3'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
424.F6.24'CL, ANTI-SSDNA
E67, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
SiP035'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
MOPC 315'CL, ANTI-DINITROPHENYL HYBRIDOMA
Z48VH3'CL, CD20
C16-15F6'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
36-71 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=4.5X10EXP7)
4.3.6.F8a'CL, ANTI-ALPHA 1,6 DEXTRAN
66.4A10'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
p7'CL, ANTI-HIV-1 GP120
89.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
G05, ANTI-LYSOZYME HYBRIDOMA
WRD4'CL, RHEUMATOID FACTOR
RF-ET10'CL, RHEUMATOID FACTOR
AN10'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=2.5X10EXP7)
91A3'CL, ANTI-P-AZOPHENYLARSONATE
Jb_49-H'CL, ANTI-DINITROPHENYL
48SNQP19, ANTI-2-PHENYLOXAZOLONE
WS2z06'CL, ANTI-PHOSPHORYLCHOLINE
8D5'CL, ANTI-PHENYLOXAZOLONE HYBRIDOMA
47SNQP7, ANTI-2-PHENYLOXAZOLONE
E3G6'CL, ANTI-GLYCOPROTEIN (GP) IA/IIA
H02, ANTI-LYSOZYME HYBRIDOMA
7-13'CL, ANTI-SM HYBRIDOMA
H147-25H1'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
1-54'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
HIV-b2'CL, ANTI-HIV-1 GP120
103-51'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
S2E9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
MEMORY 13, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
B17-9'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2G7'CL, ANTI-SM HYBRIDOMA
S8P10'CL, RHEUMATOID FACTOR
MMW.7.8'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
HPCG11, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
K9-338, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
mAb48'CL, ANTI-INSULIN
cDNA6-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
kappa5'CL, ANTI-HUMAN THYROGLOBULIN
37-85'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
WSd14'CL, ANTI-PHOSPHORYLCHOLINE
Fc_24-H'CL, ANTI-DINITROPHENYL
cAbAMD9, ANTI-ALPHA-AMYLASE
O8'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCARIDE
10.2.3'CL, ANTI-GROUP A STREPTOCOCCAL M PROTEIN, SKELETAL MYOSIN, CARDIAC MYOSIN, LIGHT MEROMYOSIN
Jc_39-H'CL, ANTI-DINITROPHENYL
Day 4 15-167-12'CL, ANTI-2-PHENYL-5-OXAZOLONE
ToP254'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
S1P1'CL, RHEUMATOID FACTOR
ToPG433'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
402P5-H7, ANTI-HIV GP120 V3-LOOP (K OFF = 0.79 X 10EXP-4 SEC-1)
GB4v2.3, ANTI-CD19
27.3EIa'CL, ANTI-DNA, ACTIN, MYOSIN, THYROGLOBULIN, IGG
T2-150'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
scFv13, ANTI-BETA-GALACTOSIDASE
NQ7 41.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
A10'CL, ANTI-SSDNA, DSDNA, CARDIOLIPIN, POLY-DT, HEN EGG LYSOZYME
31-9D'CL, ANTI-MOUSE RED BLOOD CELL AUTOANTIBODIES
12.3B7'CL, ANTI-FLUORESCEIN
93G7 CRI+, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
LAR'CL, RHEUMATOID FACTOR
B9601 (VH3-JH3)'CL, RHEUMATOID FACTOR
GG3'CL, RHEUMATOID FACTOR
Mb_31-H'CL, ANTI-DINITROPHENYL
402L-B6, ANTI-HIV GP120 V3-LOOP (K OFF = 2.0 X 10EXP-4 SEC-1)
TNF-E1'CL, ANTI-HUMAN TUMOR NECROSIS FACTOR ALPHA
6B10D2'CL, ANTI-PHTHALATE COUPLED KEYHOLE LIMPET HEMOCYANIN
H151-31D10'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
9A6'CL, ANTI-TRINITROPHENYL HYBRIDOMA
136/9'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
3F9L'CL, ANTI-MURINE SERUM ALBUMIN
CLONE 1D2'CL, ANTI-HUMAN RED BLOOD CELL
1.8'CL, ANTI-DSDNA
G8 CA 1.7, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
ITC48'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
242.F6.24'CL, ANTI-SSDNA
D.3'CL, ANTI-ARS
6B8'CL, ANTI-DNA
50'CL, ANTI-DSDNA
S21'CL, ANTI-ARS
3A10'CL, ANTI-P601E
HDEX14, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
HPC4, ANTI-HUMAN PROTEIN C
DP-50'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
A431'CL, ANTI-SSDNA, DSDNA, CARDIOLIPIN, POLY-DT, PIGEON CYTOCHROME C 
HN.14'CL, ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN HYBRIDOMA
ANTI-TMA, ANTI-P-AZOBENZENETRIMETHYLAMMONIUM
MOPC104E, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN
C11'CL, ANTI-HUMAN PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1 TO 34 (KA=5.8X10EXP8)
HCV-63'CL, ANTI-PP65 VIRAL MATRIX PHOSPHOPROTEIN OF HUMAN CYTOMEGALOVIRUS
126FK'CL, ANTI-THYROID PEROXIDASE (TPO)
L19'CL, ANTI-HIV-1 GP120
A1, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
ITC63B'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
1D5'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
2-9'CL, ANTI-IGG2A
AZ-12'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
2INL2'CL, ANTI-HUMAN INSULIN
17s.74'CL, ANTI-DNA
F2-21'CL, ANTI-DNA
HA-1'CL, ANTI-ERYTHROCYTE
5D1'CL, ANTI-HUMAN PROCOLLAGENASE
M7-049'CL, ANTI-IDIOTYPIC ANTIBODY SPECIFIC FOR ANTI-CEA MAB MA208
Ab17'CL, POLYREACTIVE AUTOANTIBODY
C55-8D10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
HUNVK'CL, ANTI-MYELIN ASSOCIATED PROTEIN
SC12'CL, ANTI-MCPS
B1Fv'CL, ANTI-LEWIS(GAMMA)-RELATED CARBOHYDRATE ANTIGEN ABUNDANT ON VARIOUS CARCINOMAS
4F10'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
T24-3'CL, ANTI-DNA AUTOANTIBODY
ABO.B1'CL, ANTI-B
CL-O'CL, ANTI-ERYTHROCYTE
AS.1.28'CL, ANTI-HIV-1 GP120 V3 LOOP
C039'CL, ANTI-NITROPHENYL
1-5'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
No.13'CL, ANTI-HIV GP120
FF29-36-9'CL, ANTI-P-AZOPHENYLARSONATE
BWR5.L'CL, ANTI-RNA,POLY(A)-POLY(U),POLY(I)-POLY(C)
CL-P'CL, ANTI-ERYTHROCYTE
103-54'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
D7.4'CL, AUTOANTI-IDIOTYPIC MAB TO ANTI-DNA MAB A52(IGG2B-KAPPA)
aPC-28-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
BA129B-1'CL, ANTI-DSDNA
BW12F3'CL, ANTI-DSDNA
AB5'CL, ANTI-ACETYLCHOLINE RECEPTOR
S106'CL, ANTI-DNA
253.12G5'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
11/32'CL, ANTI-PROGESTERONE HYBRIDOMA
NC10.10'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
4.14'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
PC47'CL, ANTI-PS1CT3
402O-C11, ANTI-HIV GP120 V3-LOOP (K OFF = 2.1 X 10EXP-4 SEC-1)
A28K'CL, ANTI-IGG2A
2INL13'CL, ANTI-HUMAN INSULIN
F(ab)-12, ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
Agamma6-3b'CL, ANTI-DNA
202s.38'CL, ANTI-DNA
C01'CL, ANTI-RH(D)
scFv-KJ16 mut4'CL, ANTI-T-CELL RECEPTOR (V-BETA8 REGION)
D3'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
33.C9'CL, ANTI-DSDNA
38C13'CL, ANTI-IDIOTYPIC ANTIBODY HYBRIDOMA
SiP013'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
12ICI'CL, AUTOANTIBODY TO THYROGLOBULIN
SiP041'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
165.14'CL, ANTI-DNA
E01'CL, ANTI-RH(D)
2A1'CL, ANTI-TRICHOSANTHIN (AN ACTIVE COMPONENT OF A TRADITIONAL CHINESE MEDICINE USED FOR INDUCING ABORTION)
R01'CL, ANTI-RH(D)
AD14'CL, ANTI-ERYTHROCYTE RH(D) 
RF2-11'CL, ANTI-IGG2A
HCV-2'CL, ANTI-PP65 VIRAL MATRIX PHOSPHOPROTEIN OF HUMAN CYTOMEGALOVIRUS
kappa6'CL, ANTI-HUMAN THYROGLOBULIN
HEW''CL, AUTOANTIBODY
F12, ANTI-MESOTHELIN
F04, ANTI-LYSOZYME HYBRIDOMA
AZ-34'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
126TO8H'CL, ANTI-THYROID PEROXIDASE (TPO)
CH10'CL, ANTI-E. COLI
AJ1'CL, ANTI-P-AZOPHENYLARSONATE
F12.34D8'CL, ANTI-DSDNA
MP14'CL, ANTI-HLA CLASS II (DRB1*08,*12)
SO1'CL, ANTI9-HLA-DQ3
HY GAL7, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
D9D10'CL, ANTI-HUMAN INTERFERON-GAMMA
206.8D3'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
3C8L'CL, ANTI-MURINE SERUM ALBUMIN
m32Y/S, ANTI-IDIOTYPIC
165.3'CL, ANTI-DNA
48SNQP113, ANTI-2-PHENYLOXAZOLONE
17s.93g'CL, ANTI-DNA
28E4'CL, ANTI-RH(D)
Jb_46-H'CL, ANTI-DINITROPHENYL
84-37'CL, ANTI-DNA
BW21D11'CL, ANTI-DSDNA
B'20 (VH3-JH4)'CL, RHEUMATOID FACTOR
HIV-b20'CL, ANTI-HIV-1 GP120
2INH14'CL, ANTI-HUMAN INSULIN
RF9-5'CL, ANTI-IGG2A
CAL-16'CL, ANTI-CARDIOLIPIN
F3D2'CL, ANTI-DEXTRAN B512
NQT15/9'CL, ANTI-2-PHENYLOXAZOLONE.
306'CL, ANTI-INSULIN
DNA13'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
BKD12'CL, ANTI-DSDNA
W5.1B4.4'CL, ANTI-IDIOTYPIC ANTIBODY
126TO3H'CL, ANTI-THYROID PEROXIDASE (TPO)
TA2'CL, ANTI-TG
mAb402-10'CL, ANTI-MORPHINE-6-HEMISUCCINATE-BSA
6D6'CL, ANTI-CORTISOL
MRA3K'CL, ANTI-HISTONE
WG3'CL, ANTI-PROTEINASE 3
ToP304'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
HYHEL-5, ANTI-HEN EGG WHITE LYSOZYME
29-1G5'CL, ANTI-(T,G)-A--L HYBRIDOMA
48.2.1'CL, ANTI-IDIOTYPIC ANTIBODY
QC1'CL, ANTI-CHROMATIN
48SNQP118, ANTI-2-PHENYLOXAZOLONE
111.19'CL, ANTI-DNA
Fog-3'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
B/SB5-7'CL, ANTI-H2A/H2B
Pag-1'CL, ANTI-D ANTIGEN OF THE RH-BLOOD GROUP SYSTEM
44-2F5'CL, ANTI-(T,G)-A--L HYBRIDOMA
SiP040'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
m33N/D, ANTI-IDIOTYPIC
P17.79'CL, ANTI-DNA
MMW.2.6.13'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
NQ22.17.18'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
n'CL, ANTI-2-PHENYLOXAZOL-5-ONE
Bip 1'CL, ANTI-BET V 1 (MAJOR BIRCH POLLEN ALLERGEN)
MD2F4'CL, ANTI-HIV-1
402I-A10, ANTI-HIV GP120 V3-LOOP (K OFF = 2.4 X 10EXP-4 SEC-1)
44SNQP2, ANTI-2-PHENYLOXAZOLONE
E3-MPO'CL, ANTI-MYELOPEROXIDASE
L2,5'CL, ANTI-HEN EGG WHITE LYSOZYME
H220-5'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
84-6'CL, ANTI-DNA
AS.1.30'CL, ANTI-HIV-1 GP120 V3 LOOP
7C83'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
Fb_06-H'CL, ANTI-DINITROPHENYL
Ga_16-H'CL, ANTI-DINITROPHENYL
67.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
ToP214'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
T33-20'CL, ANTI-DNA
ToPG341'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
r'CL, ANTI-2-PHENYLOXAZOL-5-ONE
Vl HER1'CL, ANTI-LAMIN B AUTOANTIBODY
S1P9'CL, RHEUMATOID FACTOR
MMW.8.18'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
AB5'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
clone 31'CL, ANTI-TIMOTHY GRASS POLLEN MAJOR ALLERGEN PHI P 5
126DK'CL, ANTI-THYROID PEROXIDASE (TPO)
Mb_25-H'CL, ANTI-DINITROPHENYL
RF9-12'CL, ANTI-IGG2A
AD4-18'CL, ANTI-DSDNA
18'CL, ANTI-P601E
HDEX8, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
ASWB1'CL, ANTI-NUCLEOLAR PARTICLES U3, U8
417.F22'CL, POLYREACTIVE
Bg359-8'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
126TO2K'CL, ANTI-THYROID PEROXIDASE (TPO)
T10-505'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
5G11'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
M02/01/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
HVP2H4'CL, ANTI-FLUORESCEIN
La 49-H'CL, ANTI-DNP
BV16-19'CL, ANTI-DSDNA (12%), SSDNA (90%), POLY(DT), POLY(DU)
417.32.F24.7'CL, MONOREACTIVE
64.22.2'CL, ANTI-DNA, ACTIN, MYOSIN, THYROGLOBULIN, IGG
Ca_18-H'CL, ANTI-DINITROPHENYL
SS629, ANTI-P1.7 PORA PROTEIN LOOP OF NEISSERIA MENINGITIDIS
1.8'CL, ANTI-DSDNA
CAL-3'CL, ANTI-CARDIOLIPIN
4A6'CL, ANTI-METATOPE OF 4-4-20
C3H-11'CL, ANTI-DNA
S54'CL, ANTI-DNA
MICA 1'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
MOR39'CL, ANTI-MORPHINE
DB2-101.1'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
R'CL, ANTI-2-PHENYLOXAZOL-5-ONE
3D6'CL, ANTI-HIV GP41
C488-25E'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
A003=40/5G7'CL, ANTI-BLOOD GROUP A SUBSTANCE HYBRIDOMA
CHIMPANZEE CH4-14'CL, ANTI-DIGOXIN HYBRIDOMA
NPYII-287.3'CL, ANTI-NEUROPEPTIDE Y
174.2E7'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
VS4'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
K1 like, ANTI-MESOTHELIN-POSITIVE CELLS
Mad-2'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
N10'CL, ANTI-STAPHYLOCOCCAL NUCLEASE
DN12'CL, ANTI-MCPS
P19'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC (ALPHA-GALACTOSYL) EPITOPE
402C-D6, ANTI-HIV GP120 V3-LOOP (K OFF = 4.0 X 10EXP-4 SEC-1)
F2-22'CL, ANTI-DNA
BKD19'CL, ANTI-DNA
417.32.E4.8.5'CL, MONOREACTIVE
ToP212'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
GP-4'CL, ANTI-ERYTHROCYTE
A.21'CL, ANTI-ARS
JSJ-1, ANTI-POLYAMINE, CROSS REACTS WITH PUTRESCINE AND SPERMINE
CAL4G, ANTI-VH4-34
S27'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
4135, ANTI-STREPTOCOCCAL GROUP C CARBOHYDRATE
HDEX11, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
73-13'CL, ANTI-DNA
NQT17/45E'CL, ANTI-2-PHENYLOXAZOLONE
8/7p6'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
FS9, ANTI-VH4-34
4A11'CL, ANTI-P601E
GP-1'CL, ANTI-ERYTHROCYTE
GOL', HUMAN MONOCLONAL ANTIBODY WITH WA IDIOTYPE
F5-830'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
MMW.7.10'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
BA141AX2'CL, ANTI-DSDNA
B003=46/2D7'CL, ANTI-BLOOD GROUP B SUBSTANCE HYBRIDOMA
bkv6'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
163.17, ANTI-P53
bkv16'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
132.16'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
AB3'CL, ANTI-ACETYLCHOLINE RECEPTOR
3A112'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
HA-10'CL, ANTI-ERYTHROCYTE
B6204'CL, ANTI-DENATURED DNA, ANTI-PLATELET
RF-IP16'CL, RHEUMATOID FACTOR
+16-23'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
L2 11C'CL, ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR
BKV29'CL, ANTI-DNA
11/160'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
Py54, ANTI-PHOSPHOTYROSYLPROTEIN
CUR, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
126TO15H'CL, ANTI-THYROID PEROXIDASE (TPO)
RF-TS7'CL, ANTI-HUMAN/RABBIT IGG RHEUMATOID FACTOR
18/17'CL, ANTI-DNA
F1_1355'CL, ANTI-FRACTION 1
NC17-D8'CL, ANTI-PHOSPHATIDYL CHOLINE
HuVNP'CL, ANTI-4-HYDROXY-3-NITROPHENACETYL CAPROIC ACID  (BINDING CONSTANT = 1.9X10EXP6)
RF-SJ5'CL, ANTI-HUMAN/RABBIT IGG RHEUMATOID FACTOR
126TP9K'CL, ANTI-THYROID PEROXIDASE (TPO)
clone 1,3-12'CL, ANTI-F(AB')2 AUTOANTIBODY (BINDING CONSTANT=2.8X10EXP7)
AAD4-HC2'CL, ANTI-DSDNA
8.55'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
H9'CL, ANTI-DNA
2F2.7'CL, ANTI-DSDNA
2.64'CL, ANTI-PNEUMOCOCCAL
RF2-9'CL, ANTI-IGG2A
HIV-s7'CL, ANTI-HIV-1 GP120
Jb_48-H'CL, ANTI-DINITROPHENYL
12D11'CL, ANTI-SM HYBRIDOMA
Ab2022'CL, ANTI-INSULIN AUTOANTIBODY
MAL'CL, ANTI-MYELIN ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONIC PARAGLOBOSIDE
HP21'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
FF29-15-5'CL, ANTI-P-AZOPHENYLARSONATE
aCD3'CL, ANTI-CD3
C04, ANTI-LYSOZYME HYBRIDOMA
ToP102'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
hsiglvp1213'CL, ANTI-RABBIT IGG
L41'CL, AUTOANTIBODY
3D6'CL, ANTI-HIV GP41
K29-213, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
1F6'CL, ANTI-O POLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA SEROGROUP O6 LIPOPOLYSACCHARIDE
47SNQP8, ANTI-2-PHENYLOXAZOLONE
A6'CL, ANTI-HUMAN INTERFERON GAMMA RECEPTOR
163.15, ANTI-P53
48SNQP117, ANTI-2-PHENYLOXAZOLONE
RF-SJ1'CL, RHEUMATOID FACTOR AUTOANTIBODY
126HH'CL, ANTI-THYROID PEROXIDASE (TPO)
FF29-39-1'CL, ANTI-P-AZOPHENYLARSONATE
5G12-6'CL, ANTI-DNA
Fa_01-H'CL, ANTI-DINITROPHENYL
40-60, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=6.7X10EXP9)
d9/5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2C3A'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT<2X10EXP4)
131TP14H'CL, ANTI-THYROID PEROXIDASE (TPO)
HIV-b1'CL, ANTI-HIV-1 GP120
402D-F12, ANTI-HIV GP120 V3-LOOP (K OFF = 4.1 X 10EXP-4 SEC-1)
Mc3'CL, ANTI-BA46 (A 46-KDA GLYCOPROTEIN OF THE HUMAN MILK FAT GLOBULE MEMBRANE EXPRESSED IN BREAST CARCINOMA CELLS)
4.3F1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
216, ANTI-VH4-34
G03, ANTI-LYSOZYME HYBRIDOMA
HuVHCAMP'CL, ANTI-HUMAN LYMPHOCYTE HYBRIDOMA
CB 300'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
B/SB5-65'CL, ANTI-H2A/H2B
Ia_35-H'CL, ANTI-DINITROPHENYL
d9/18'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
SW3-13'CL, ANTI-DNA
48SNQP136, ANTI-2-PHENYLOXAZOLONE
AL1-3'CL, ANTI-POLYCATION
38'CL, ANTI-DSDNA
WAT'CL, RHEUMATOID FACTOR
84-15'CL, ANTI-DNA
W3129'CL, ANTI-ALPHA 1,6 DEXTRAN
3G8'CL, ANTI-FECAL BACTERIA
ToPA139'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
2C9A7'CL, ANTI-FLUORESCEIN
FS2, ANTI-VH4-34
hu PR1A3, ANTI-CELL-BOUND CARCINOEMBRYONIC ANTIGEN
SC7'CL, ANTI-MCPS
cDNA2-Hul'CL, ANTI-IGG (RHEUMATOID FACTOR)
AN08'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=7.3X10EXP7)
NQT17/45A'CL, ANTI-2-PHENYLOXAZOLONE
T1-107'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
S1-1H5'CL, ANTI-POLY-L-(TYR,GLU)-POLY-D,L-ALA--POLYL-LYS HYBRIDOMA
a'CL, ANTI-2-PHENYLOXAZOL-5-ONE
111.100'CL, ANTI-DNA
BJ3.33'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HAPTEN
1G1.E9'CL, ANTI-HORSE 44/47 CYTOCHROME C
MOR158'CL, ANTI-MORPHINE
GB4v1.0, ANTI-CD19
#21'CL, ANTI-LA RNP (RIBONUCLEOPROTEIN)
RF2-2'CL, ANTI-IGG2A
265-695'CL, ANTI-HEPATITUS B VIRUS SURFACE ANTIGEN ('A' DETERMINANT)
B8801'CL, ANTI-DENATURED DNA
2INH4'CL, ANTI-HUMAN INSULIN
AL3-5'CL, ANTI-POLYCATION
BKD23'CL, ANTI-DNA
81B1'CL, AUTOANTIBODY TO THYROGLOBULIN
7C53'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
F12.36E7'CL, ANTI-DSDNA
NM3E2 scFv, ANTI-CD16
28'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
402B-A7, ANTI-HIV GP120 V3-LOOP (K OFF = 4.2 X 10EXP-4 SEC-1)
17/9'CL, ANTI-INFLUENZA HEMAGGLUTININ PEPTIDE 98-110, YPYDVPDYASLRS
SiP018'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
mAb 123'CL, ANTI-INSULIN HYBRIDOMA
H1-59'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
9E10'CL, ANTI-C MYC
7F'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
PRECURSOR'CL, ANTI-PSICT3
3C5'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
bkv32'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
mAb5.G3'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE)
L05'CL, ANTI-RH(D)
AJ2'CL, ANTI-P-AZOPHENYLARSONATE
D83, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
mAb 127'CL, ANTI-INSULIN HYBRIDOMA
CP4 9-9'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
71-1A1'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
a'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
47SNQP39, ANTI-2-PHENYLOXAZOLONE
p7G1.5'CL, ANTI-HERPESVIRUS 1
AS7'CL, ANTI-DSDNA AUTOANTIBODY
PC284'CL, ANTI-PSICT3
NQ22.87.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
19.E7'CL, ANTI-DSDNA
10C9'CL, REACTS WITH HUMAN IGG.
Sulf-6'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
165.33'CL, ANTI-DNA
8C68'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
SR2E7'CL, ANTI-DIGOXIN
Py42, ANTI-PHOSPHOTYROSYLPROTEIN
131TP8H'CL, ANTI-THYROID PEROXIDASE (TPO)
1D7'CL, ANTI-HUMAN APOLIPOPROTEIN E (SPECIFIC FOR THE LOW DENSITY LIPOPROTEIN RECEPTOR-BINDING SITE)
10L-126-7'CL, ANTI-AMINOPHENYL-BETA-N-ACETYLGLUCOSAMINIDE, A/PR/8/34 INFLKUENZA VIRUS
CB 239'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
C8.5Vk'CL, ANTI-DSDNA
Day 4 15-164-10'CL, ANTI-2-PHENYL-5-OXAZOLONE
Tmu69'CL, ANTI-DNA
36-1'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
YTH 34.5HL'CL, ANTI-HUMAN LYMPHOCYTE HYBRIDOMA
402C-A11, ANTI-HIV GP120 V3-LOOP (K OFF = 3.9 X 10EXP-4 SEC-1)
F1_1252'CL, ANTI-FRACTION 1
Hb-2, ANTI-FOETAL HAEMOGLOBIN (HBF)
E73, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
2B12 (Dp2A)'CL, ANTI-DER P 2 (HOUSE DUST MITE ALLERGEN)
3F29-4-5'CL, ANTI-P-AZOPHENYLARSONATE
NQ2 17.4.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
F17.59.2'CL, ANTI-GLUTAMYLALANYLTYROSYL POLYPEPTIDE HYBRIDOMA
TB-2-H68'CL, RHEUMATOID FACTOR
Lb 89-H'CL, ANTI-DNP
TT125'CL, ANTI-TETANUS TOXIN, TOXOID AND A FRAGMENT (LIGHT CHAIN) OF TETANUS TOXIN
17p.73'CL, ANTI-DNA
3.1'CL, ANTI-FLUORESCEIN
402K-F10, ANTI-HIV GP120 V3-LOOP (K OFF = 2.0 X 10EXP-4 SEC-1)
PR-TS1'CL, POLYREACTIVE RHEUMATOID FACTOR
G2a'CL, ANTI-TRINITROPHENYL
NQ10.12.22'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
M5'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
ToPA246'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
IgG+ CLL'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
SP17-1'CL, ANTI-DNA
4H5'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
163.1'CL, ANTI-DNA
Jc_21-H'CL, ANTI-DINITROPHENYL
Nb 05-H'CL, ANTI-DNP
MMW.7.6'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
9d7d6'CL, ANTI-FLUORESCEIN
1A1'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
3a4D10'CL, ANTI-ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS
Meso 4, ANTI-MESOTHELIN-POSITIVE CELLS (BUT NOT RECOMBINANT MESOTHELIN)
N901H/KOL, ANTI-CD56
JU17'CL, ANTI-IDIOTYPIC ANTIBODY
HIV-LC26'CL, ANTI-HIV-1 GP120
mAb 127'CL, ANTI-INSULIN HYBRIDOMA
2C8'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
MRL1-26'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
CG-2'CL, ANTI-ERYTHROCYTE
N901L, ANTI-CD56
W108'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
E19, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
71-31'CL, ANTI-HIV TYPE 1 SPECIFIC FOR P24
S41'CL, ANTI-DNA
NPYI-46.1'CL, ANTI-NEUROPEPTIDE Y
MEMORY 6, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
Py2, ANTI-PHOSPHOTYROSYLPROTEIN
SM1.5'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
B12-10'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
F7.27G6'CL, ANTI-DSDNA
Reg-A'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
SiP055'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
k'CL, ANTI-2-PHENYLOXAZOL-5-ONE
1/17'CL, ANTI-DNA
SiP032'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
VH A121, ANTI-CD34
NQT15/17'CL, ANTI-2-PHENYLOXAZOLONE.
slkv9'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
H1-30'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
9F2H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GALGALNAC-BSA)
2INH7'CL, ANTI-HUMAN INSULIN
SiP056'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
SiP015'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
CB 20'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
La 18-H'CL, ANTI-DNP
p3'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
8.55'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
LS2'CL, ANTI-PR2 RBC AUTOANTIBODY
D23'CL, POLYREACTIVE AUTOANTIBODY HYBRIDOMA
16E4'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
H280-4'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
111.55'CL, ANTI-DNA
Ab2 A'CL, AUTO-ANTI-IDIOTYPIC DETERMINANT (ID/R) ON MAB 28/12
hsiglvl1189'CL, ANTI-RABBIT IGG
HIV-LC3'CL, ANTI-HIV-1 GP120
AN09'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=1.6X10EXP7)
MOR131'CL, ANTI-MORPHINE
40SNQP23, ANTI-2-PHENYLOXAZOLONE
PE24'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 175GSDNEEEVSKR185
93.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
s5D11'CL, ANTI-SSDNA AUTOANTIBODY
PJ14'CL, ANTI-PHOX
Day 4 15-164-3'CL, ANTI-2-PHENYL-5-OXAZOLONE
HA-8'CL, ANTI-ERYTHROCYTE
DNA11'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
WRI-176, ANTI-DNA
IC5-3A4'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
RF5-5'CL, ANTI-IGG2A
hsiglvl962'CL, ANTI-RABBIT IGG
THY-33'CL, ANTI-HUMAN THYROGLOBULIN
2097'CL, ANTI-BACTERIAL LEVAN
RF-IP12'CL, RHEUMATOID FACTOR
tat16'CL, ANTI-HIV-1 TAT
Jb_29-H'CL, ANTI-DINITROPHENYL
BB128'CL, ANTI HIV-1 P24 CORE PROTEIN
FF29-12-1'CL, ANTI-P-AZOPHENYLARSONATE
slkv1'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
ToPG427'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
36-7'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ
rev16/20'CL, ANTI-HIV I REV
F10.12-1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
17-1A'CL, ANTI-SW1083 COLORECTAL CARCINOMA CELL HYBRIDOMA
Na 73-H'CL, ANTI-DNP
Guo-1'CL, ANTI-QUANOSINE
ABA2'-7'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=8.8X10EXP6)
Mb_16-H'CL, ANTI-DINITROPHENYL
DaB2B3'CL, ANTI-HIV-1
Jb_10-H'CL, ANTI-DINITROPHENYL
scFv-KJ16 mut7'CL, ANTI-T-CELL RECEPTOR (V-BETA8 REGION)
PMN6'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
81.B1'CL, ANTI-FLUORESCEIN
Jb_19-H'CL, ANTI-DINITROPHENYL
17S29.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
A3.D7'CL, ANTI-FLUORESCEIN
MRL1-333'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
MOR35'CL, ANTI-MORPHINE
20-7D6'CL, ANTI-(T,G)-A--L HYBRIDOMA
RF-7'CL, ANTI-IGG1 RHEUMATOID FACTOR
E12, ANTI-MESOTHELIN
A06, ANTI-LYSOZYME HYBRIDOMA
1F5A9'CL, ANTI-FLUORESCEIN
BKD34'CL, ANTI-DSDNA
CB5'CL, ANTI-TRINITROPHENYL HYBRIDOMA
DPB'CL, ANTI-GLUTAMIC ACID DECARBOXYLASE 65
M182'CL, ANTI-B-TYPE CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
F16B3'CL, ANTI-DEXTRAN B512
Jb_41-H'CL, ANTI-DINITROPHENYL
3D8L'CL, ANTI-MURINE SERUM ALBUMIN
23'CL, ANTI-INSULIN
aPC-15-7'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
265 abs'CL, ANTI-PHOSPHORYLCHOLINE (P.MORGANII) HYBRIDOMA
17.2.25'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
K49-501, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
CAL-22'CL, ANTI-CARDIOLIPIN
5-5'CL, ANTI-IGG2A
A5'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
BKV29'CL, ANTI-DSDNA
T48.16-G8'CL, ANTI-HIV-1
A52'CL, ANTI-DNA AUTOANTIBODY, ANTI-POLY(DG) HYBRIDOMA
Gad-2'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
RF34, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
Jb_09-H'CL, ANTI-DINITROPHENYL
CM2'CL, ANTI-TOBACCO MOSAIC VIRUS PROTEIN HYBRIDOMA
1E102'CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
22F6'CL, ANTI-SM HYBRIDOMA
Hb-3, ANTI-FOETAL HAEMOGLOBIN (HBF)
3E5'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
II-481'CL, ANTI-GE, THE HERPES SIMPLEX VIRUS-1 FCG-BINDING PROTEIN
TB-1-M2'CL, RHEUMATOID FACTOR
NQ18.36.44'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
H6-3C4, ANTI-VH4-34
VH iv.'CL, ANTI-GLUTATHIONE S-TRANSFERASE
Ma_40-H'CL, ANTI-DINITROPHENYL
CAL-21'CL, ANTI-CARDIOLIPIN
64.3AII'CL, ANTI-DNA, ACTIN, MYOSIN, THYROGLOBULIN, IGG
ToP220'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
CH31'CL, ANTI-E. COLI
s5D4'CL, ANTI-SSDNA/CARDIOLIPIN AUTOANTIBODY
NQ22.61.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
NQ22.33.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
9-3'CL, ANTI-IGG2A
3B12-1'CL, ANTI-HELA NUCLEAR EXTRACT
145-2C11'CL, ANTI-MOUSE CD3 COMPLEX
BKD34'CL, ANTI-DSDNA
BW24-60'CL, ANTI-DNA
T7-4'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
cAbAMD10, ANTI-ALPHA-AMYLASE
MEMORY 16, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
24''CL, ANTI-P-AZOPHENYLARSONATE-KEYHOLE LIMPET HEMOCYANIN
B'20H, POLYREACTIVE (HIGH AFFINITY ANTI-HUMAN FC AND LOW AFFINITY ANTI-RABBIT IGG, ANTI-SSDNA, ANTI-TETANUS TOXOID) RHEUMATOID FACTOR (RF)
H230-7'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
CP5 A23-3'CL, ANTI-BROMELAIN-TREATED MOUSE RED BLOOD CELL HYBRIDOMA
40SNQP7, ANTI-2-PHENYLOXAZOLONE
F9A7'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
Na 75-H'CL, ANTI-DNP
RF-TT3'CL, RHEUMATOID FACTOR
Jb_43-H'CL, ANTI-DINITROPHENYL
3.2.3E5'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
O03'CL, ANTI-RH(D)
17s.139'CL, ANTI-DNA
CBBPC-3, ANTI-PHOSPHORYLCHOLINE
ToPA215'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
2INH8'CL, ANTI-HUMAN INSULIN
131TP2H'CL, ANTI-THYROID PEROXIDASE (TPO)
ToPA247'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
Jc_45-H'CL, ANTI-DINITROPHENYL
17s.93m'CL, ANTI-DNA
163.22, ANTI-P53
SP10-1'CL, ANTI-DNA
17p.101'CL, ANTI-DNA
C55-7F10'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
23-52D4, ANTI-ARS
14-13D1, ANTI-ARS
MMW.4.8'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
lambda2'CL, ANTI-HUMAN THYROGLOBULIN
M6'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBDIROMA
Bg53-27'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL (KA=1.8X10EXP7)
H120-2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
AB4'CL, ANTI-ACETYLCHOLINE RECEPTOR
'CL, ANTI-HEPATITIS B
i'CL, ANTI-2-PHENYLOXAZOL-5-ONE
Bg53-4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL (KA=1.3X10EXP7)
B8''CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
D01'CL, ANTI-RH(D)
VS2'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
HD11.4'CL, ANTI-2-PHENYLOXAZOLONE
mAb63'CL, POLYREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
752'CL, ANTI-P601E
47SNQP36, ANTI-2-PHENYLOXAZOLONE
133.23'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
126TP9H'CL, ANTI-THYROID PEROXIDASE (TPO)
MN215'CL, ANTI-V3 DOMAIN OF HIV-1 GP120.
402F-C4, ANTI-HIV GP120 V3-LOOP (K OFF = 4.0 X 10EXP-4 SEC-1)
RF6-6K'CL, ANTI-IGG1
RFB4'CL, ANTI-CD22
G4, ANTI-DIHYDROFLAVONOL 4-REDUCTASE FROM PETUNIA HYBRIDA
A28A'CL, ANTI-IGG2A
NQ7 1.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
PR1(FV)-PE38KDEL'CL, ANTI-PR1 ANTIGEN ON HUMAN PROSTATE CANCER CELLS AND NORMAL PROSTATE TISSUE
10F10'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
H1-39'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
AC21B'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
f'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
MMW.2.6.16'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
2A1-83'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
Fab clone 1, ANTI-RYE-GRASS POLLEN ALLERGEN (KD = 2.63 X 10EXP-9 M)
F2-6'CL, ANTI-DNA
FF29-36-14'CL, ANTI-P-AZOPHENYLARSONATE
5-1E4'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
KSd1C10'CL, ANTI-FLUORESCEIN
NZW4B9'CL, ANTI-DSDNA
BXW-14'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
PV6'CL, ANTI-DSDNA AUTOANTIBODY
MUTANT 12'CL, ANTI-PHOSPHORYLCHOLINE
12/231/93'CL, ANTI-HEPATITIS B VIRUS X PROTEIN
D'CL, ANTI-2-PHENYLOXAZOL-5-ONE
261.2F10'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
A34'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
73-22'CL, ANTI-DNA
73-21'CL, ANTI-DNA
ToP206'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
E42, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
8C35'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
F1_1260'CL, ANTI-FRACTION 1
Rh.E1'CL, ANTI-E
H230-2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
anti-(cyd-1)'CL, ANTI-(CYD-1)
HCV-3'CL, ANTI-PP65 VIRAL MATRIX PHOSPHOPROTEIN OF HUMAN CYTOMEGALOVIRUS
C108G clone 1'CL, ANTI-HIV-1 GP120
12A1'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
THY-29'CL, ANTI-HUMAN THYROGLOBULIN
O18 ALLELE'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCARIDE
+23-17'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
Agamma34-1'CL, ANTI-DNA
L2-5D2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
p2C7.5'CL, ANTI-HERPESVIRUS 1
NQT15/4'CL, ANTI-2-PHENYLOXAZOLONE
47SNQP32, ANTI-2-PHENYLOXAZOLONE
C8.5'CL, ANTI-DSDNA
L612'CL, ANTI-GANGLIOSIDE GM3
AN05'CL, ANTI-SPIN-LABELED DINITROPHENYL (STABILITY CONSTANT=9.5X10EXP6)
mAb D''CL, ANTI-CYCLOSPORINE
RF1-9'CL, ANTI-IGG2A
132'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
E7'CL, POLYREACTIVE AUTOANTIBODY HYBRIDOMA
40SNQP13, ANTI-2-PHENYLOXAZOLONE
MEMORY 9, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
SiP020'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
18-2-3'CL, ANTI-FLUORESCEIN HYBRIDOMA(BINDING CONSTANT=2.9X10EXP10)
417.F25'CL, POLYREACTIVE
Fc_04-H'CL, ANTI-DINITROPHENYL
402E-B4, ANTI-HIV GP120 V3-LOOP (K OFF = 4.2 X 10EXP-4 SEC-1)
heavy2'CL, ANTI-HUMAN THYROGLOBULIN
SON, CRYOGLOBULIN WITH ANTI-LOW-DENSITY LIPOPROTEIN ACTIVITY; B IDIOTYPE
HA-2'CL, ANTI-IGG (NO ANTI-ERYTHROCYTE ACTIVITY)
SA-4B'CL, ANTI-TITIN AUTOANTIBODY
A2b'CL, ANTI-HAEMOPHILUS INFLUENZA TYPE B (HIB)
S57'CL, ANTI-DNA
TEPC15, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=2.3 TO 4.3X10EXP5)
H130-5'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
anti-DigB'CL, ANTI-DIGOXIGENIN (BINDING CONSTANT = 1.15 X 10EXP7)
G5'CL, ANTI-GP41
B10'CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
Hb-4, ANTI-FOETAL HAEMOGLOBIN (HBF)
68.7, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
H37-60'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
COU-1'CL, ANTI-MODIFIED CYTOKERATIN
NPYII-14.1'CL, ANTI-NEUROPEPTIDE Y
HIV-B30'CL, ANTI-HIV-1 GP120
VK-25-39'CL, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
C94-10B9'CL, ANTI-(TYR,GLU)-ALA-LYS
45.21.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
NZB/NZW-13'CL, ANTI-DNA
T6-19'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
CLONE pMEK1HC'CL, ANTI-HLA-DR ANTIGENS
NQT15/17C'CL, ANTI-2-PHENYLOXAZOLONE
BKD10'CL, ANTI-DNA
HP22'CL, ANTI-PUBLIC IDIOTOPE HYBRIDOMA OF THE GAT SYSTEM
Day 2 15-164-2'CL, ANTI-2-PHENYL-5-OXAZOLONE
Bg46-5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
48SNQP32, ANTI-2-PHENYLOXAZOLONE
SiP023'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
47SNQP38, ANTI-2-PHENYLOXAZOLONE
131TP15H'CL, ANTI-THYROID PEROXIDASE (TPO)
260.2D5'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
1410E.10e'CL, ANTI-PHOSPHORYLCHOLINE, DSDNA
M25'CL, ANTI-HIV-1 GP41
Nb 49-H'CL, ANTI-DNP
D76, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
66.5A3'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
N1C12'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
32.B9'CL, ANTI-DSDNA
LG2-2'CL, ANTI-BOVINE THYMUS HISTONES (H2B RES. 1-13)
p5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
Ma_36-H'CL, ANTI-DINITROPHENYL
MMW.4.15'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
NQ5 61.1.2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
mAb67'CL, POLYREACTIVE ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
C95-5A1'CL, ANTI-(TYR,GLU)-ALA-LYS
D08, ANTI-LYSOZYME HYBRIDOMA
Da_04-H'CL, ANTI-DINITROPHENYL
27.4b.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
21H9'CL, ANTI-RH(D)
H26'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
NANUC-2'CL, ANTI-NEUTROPHIL
E66, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
MMW.8.1'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
TW4.20'CL, ANTI-HUMAN TRANSFERRIN (KA = 1.70 X 10EXP9)
13D2'CL, ANTI-RH(D)
AC15'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
Ma_72-H'CL, ANTI-DINITROPHENYL
EA7'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
174.2E11'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
p2'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
265.9F2'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
FF29-39-2'CL, ANTI-P-AZOPHENYLARSONATE
mAb C''CL, ANTI-CYCLOSPORINE
NQT15/9A'CL, ANTI-2-PHENYLOXAZOLONE
FF29-12-6'CL, ANTI-P-AZOPHENYLARSONATE
2A3'CL, ANTI-DNA
RF5-3'CL, ANTI-IGG2A
2-12'CL, ANTI-SM HYBRIDOMA
1-10'CL, ANTI-SM HYBRIDOMA
NC19F8'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
NQ10 15.3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
JSJ-1, ANTI-POLYAMINE, CROSS REACTS WITH PUTRESCINE AND SPERMINE
mAb1.H9'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
Z119VH5'CL, CD20
mAb A'CL, ANTI-CYCLOSPORINE
3C13'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
AKR-5'CL, ANTI-DNA
R6B8H'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
PE18'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
126TP15H'CL, ANTI-THYROID PEROXIDASE (TPO)
V-88'CL, ANTI-DNA
AHT107'CL, ANTI-HUMAN P55 IL-2 RECEPTOR
NEW-based resh. CAMPATH-9, ANTI-HUMAN CD4
LN2 121'CL, ANTI-MOUSE TYPE II COLLAGEN
HUMANIZED ABL364 VARIANT K, ANTI-LEWIS Y CARBOHYDRATE ANTIGEN (LE Y)
3B8G9'CL, ANTI-TG
PE2'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR
HB125'CL, ANTI-INSULIN
HY GAL12, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
126TP8H'CL, ANTI-THYROID PEROXIDASE (TPO)
3B12-3'CL, ANTI-88 KDA SPLICING FACTOR 53/4
MEMORY 4, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
CG-1'CL, ANTI-ERYTHROCYTE
CL-D'CL, ANTI-ERYTHROCYTE
BS-1, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
14-2D8, ANTI-ARS
2A10'CL, ANTI-(NANP) 3 DODECAPEPTIDE
2F7'CL, ANTI-FECAL BACTERIA
O02'CL, ANTI-RH(D)
7-F1, ANTI-ARS
MRL3-14'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
MEMORY 7, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
MEMORY 8, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
Lym-1'CL, ANTIBODY USED IN CANCER THERAPY
kappa7'CL, ANTI-HUMAN THYROGLOBULIN
S25'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 1 (KD = 7.3 X 10EXP-8)
2B1-48'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
64.18AI'CL, ANTI-DNA
SIE, ANTI-HUMAN GAMMA G GLOBULIN; WA IDIOTYPE
ToPA115'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
C10, ANTI-LYSOZYME HYBRIDOMA
4.1.3C4'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
1G4 (TE3)'CL, ANTI-TRICHOSANTHIN (AN ACTIVE COMPONENT OF A TRADITIONAL CHINESE MEDICINE USED FOR INDUCING ABORTION)
G5 BB 2.2, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
Fab17-IA'CL, ANTI-NEUTRALIZING IMMUNOGENIC SITE A OF HUMAN RHINOVIRUS 1
73-4'CL, ANTI-DNA
ToPA214'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
A6H4C5, ANTI-VH4-34
2H1, ANTI-CRYPTOCOCEUS NEOFORMANS, AN ENCAPSULATED FUNGUS THAT CAUSES MENINGOENCEPHALITIS
MD11'CL, ANTI-TETANUS TOXOID
T6-416'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
2D1'CL, ANTI-DNA
Z31VH4'CL, CD20
43SNQP7, ANTI-2-PHENYLOXAZOLONE
Da_06-H'CL, ANTI-DINITROPHENYL
MMW.8.3'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
CH4G5'CL, ANTI-FLUORESCEIN
624'CL, ANTI-MEP-1 17-31 PEPTIDE
83.22'CL, ANTI-DNA
La 11-H'CL, ANTI-DNP
ToP001'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
Mik-B1(Fv)-PE40'CL, ANTI-INTERLEUKIN-2 RECEPTOR BETA SUBUNIT (P75)
Bet 2/212'CL, ANTI-MOUSE IGM (KA = 5 X 10^7 M^-1)
BKD23'CL, ANTI-DSDNA
bfd89'CL, ANTI-SSDNA HYBRIDOMA
La 39-H'CL, ANTI-DNP
M02/02/01, ANTI-MUSK ODORANT TRASEOLIDE (6-ACETYL-1-ISOPROPYL-2,3,3,5-TETRAMETHYL-INDANE)
v'CL, ANTI-2-PHENYL0XAZOL-5-ONE
pab 101'CL, ANTI-CARBOXYL TERMINUS OF SV40 T ANTIGEN
Ia_29-H'CL, ANTI-DINITROPHENYL
aPC-61-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
TE33'CL, ANTI-CTP3
B17-6'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2-2G4'CL, ANTI-BROMELAIN-TREATED MOUSE RBC HYBRIDOMA
FLO, CRYOGLOBULIN WITH ANTI-IGG ACTIVITY; B IDIOTYPE
43SNQP4, ANTI-2-PHENYLOXAZOLONE
NQ2 45.10.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
HBp2'CL, ANTI-BORDETELLA PERTUSSIS LIPOOLIGOSACCHARIDE
rsv13H'CL, ANTI-RESPIRATORY SYNCYTIAL VIRUS F GLYCOPROTEIN
15E8'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
14-9F3, ANTI-ARS
ToPG415'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
WRD6'CL, RHEUMATOID FACTOR
2INL14'CL, ANTI-HUMAN INSULIN
301'CL, ANTI-INSULIN
11-9A12, ANTI-ARS
AZ-40'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
84-5'CL, ANTI-DNA
14B4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
CB1'CL, ANTI-TRINITROPHENYL HYBRIDOMA
kappa8'CL, ANTI-HUMAN THYROGLOBULIN
17s.145'CL, ANTI-DNA
PC41'CL, ANTI-PS1CT3
+10-16'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
2INL16'CL, ANTI-HUMAN INSULIN
P01'CL, ANTI-RH(D)
NZB/NZW-6'CL, ANTI-DNA
11'CL, ANTI-DNA AUTOANTIBODY
B423'CL, ANTI-4-HYDROXY-3-NITROPHENYLACETYL HYBRIDOMA
T8-3'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
PC42'CL, ANTI-PS1CT3
FS-7'CL, COLD AGGLUTININ
RF6-4'CL, ANTI-IGG2A
3H-3H'CL, ANTI-DIGOXIN
ToPG418'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
alpha-poxn5, ANTI-POXN
CB 379'CL, ANTI-HUMAN AND MOUSE TYPE II COLLAGEN C1 EPITOPE, RESIDUES 316 TO 333
T5-131'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
T9-1'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
126TO2H'CL, ANTI-THYROID PEROXIDASE (TPO)
hu2.10, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR
T10-649'CL, ANTI-ANTI-HLA-A2,28 MAB CR11-351 COUPLED TO KEYHOLE LIMPET HEMOCYANIN
MRL4-140, ANTI-DNA, ANTI-NUCLEAR
SiP009'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
2-2'CL, ANTI-IGG2A
F4, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
198.4D9'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
17s.5'CL, ANTI-DNA
Ab26'CL, POLYREACTIVE AUTOANTIBODY
206.5E11'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
F2-11'CL, ANTI-DNA
MMW.4.18'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
11-1G2, ANTI-ARS
Day 4 15-164-7'CL, ANTI-2-PHENYL-5-OXAZOLONE
44SNQP31, ANTI-2-PHENYLOXAZOLONE
14C7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
H1-16'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
RF49A, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
B2, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
BA145D-2'CL, ANTI-DSDNA
FS-5'CL, COLD AGGLUTININ
NQT17/29B'CL, ANTI-2-PHENYLOXAZOLONE
604'CL, ANTI-MEP-1 17-31 PEPTIDE
ML1'CL, ANTI-POLYDT, AND SSDNA
2E11'CL, CATALYTIC ANTIBODY
BW15D6F2'CL, ANTI-DSDNA
25G07, ANTI-LYSOZYME HYBRIDOMA
DP1'CL, ANTI-DNA
6E5'CL, EARLY ANTI-NUCLEOSOME AUTOANTIBODY (KD = 1X10EXP-8)
119-a20'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
HPCM1, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
C3H-10'CL, ANTI-DNA
FK-001'CL, ANTI-PSEUDOMONAS AERUGINOSA EXOTOXIN A HYBRIDOMA
B5'CL, ANTI-FLUORESCEIN
R18-9'CL, ANTI-IDIOTYPE OF ANTI-HLA-DQ3 ANTIBODY
22.94.4'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
1-5F6'CL, ANTI-SM HYBRIDOMA
257-D'CL, ANTI-HIV TYPE 1 SPECIFIC FOR THE PRINCIPLE NEUTRALIZING DOMAIN OF GP120 OF MN AND MAP TO RESIDUES KRIHI
rsv23L'CL, ANTI-RESPIRATORY SYNCYTIAL VIRUS F GLYCOPROTEIN
R16.7' 'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
2-2C8'CL, ANTI-BROMELAIN-TREATED MOUSE RBC HYBRIDOMA
Jb_47-H'CL, ANTI-DINITROPHENYL
Gar6E8'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE
5F8.B7'CL, ANTI-HORSE 60 CYTOCHROME C
LES-C'CL, RHEUMATOID FACTOR
FOG1-A4'CL, ANTI-HUMAN MAB FOG-1 (IGG1-KAPPA)
H142-3H5'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
3.4.1G6'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HA-2'CL, ANTI-IGG (NO ANTI-ERYTHROCYTE ACTIVITY)
CE10G11G2'CL, ANTI-P34
SiP044'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
WSc68'CL, ANTI-PHOSPHORYLCHOLINE
aPC-55-1'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP I)
CB0010, ANTI-RECOMBINANT HUMAN TUMOUR NECROSIS FACTOR-ALPHA
L81'CL, ANTI-HIV-1 GP120
N-HYB'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
ToPA155'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
WSc44'CL, ANTI-PHOSPHORYLCHOLINE
M02'CL, ANTI-RH(D)
12IIB6'CL, AUTOANTIBODY TO THYROGLOBULIN
221.3G5'CL, ANTI-PHOSPHORYLCHOLINE (P.MORGANII) HYBRIDOMA
95B6'CL, ANTI-FLUORESCEIN
La 40-H'CL, ANTI-DNP
Mb_18-H'CL, ANTI-DINITROPHENYL
NZW8f4'CL, ANTI-DSDNA
MMW.8.19'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
AD3/15'CL, ANTI-ERYTHROCYTE RH(D) 
L612'CL, ANTI-GANGLIOSIDE GM3, II3NEUAC-LACCER
137.5G6'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
M2 84'CL, ANTI-MOUSE TYPE II COLLAGEN
8.18-C5'CL, ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)
D04'CL, ANTI-RH(D)
Jc_13-H'CL, ANTI-DINITROPHENYL
MRL2-51 l'CL, ANTI-SSDNA, ANTI-HOMOGENEOUS NUCLEAR
TEL13'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
MH1'CL, ANTI-NICOTINIC ACETYLCHOLINE RECEPTOR
E4-14'CL, ANTI-CON A
L04'CL, ANTI-RH(D)
2E120'CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
T1'CL, ANTI-HEN BOVINE THYROGLOBULIN
417.F29'CL, MONOREACTIVE
SD6'CL, ANTI-FOOT-AND-MOUSE-DISEASE VIRUS C-S8C1
RF-3 PAN'CL, ANTI-IGG-PAN RHEUMATOID FACTOR
Lb 24-H'CL, ANTI-DNP
26C1'CL, ANTI-RH(D)
OVB3'CL, ANTI-OVARIAN CANCER CELLS
A15'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
103-34'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
NP11-2'CL, ANTI-DNA
F.12'CL, ANTI-ARS
D05'CL, ANTI-RH(D)
9F9'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
EL-9'CL, ANTI-FACTOR VIII
E37, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
PY102'CL, ANTI-HEMAGGLUTININ OF PR8 INFLUENZA VIRUS HYBRIDOMA
418.F63.35'CL, POLYREACTIVE
hsighvl295'CL, ANTI-RABBIT IGG
192VH25'CL, ANTI-MIR
20.11'CL, ANTI-POLY(GLU60,ALA30,TYR10) HYBRIDOMA
MRL-22'CL, ANTI-DNA AUTOANTIBODY HYBRIDOMA
D23M'CL, ANTI-SM AND ANTI-DNA
98QQ'CL, ANTI-3,5,3'-TRIIODO-L-THRYRONINE COUPLED KEYHOLE LIMPET HEMOCYANIN
250.3C3'CL, ANTI-PHOSPHORYLCHOLINE (P.MORGANII) HYBRIDOMA
239.2G6'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
103-A11'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
SiP052'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
FF61-2-E6'CL, ANTI-P-AZOPHENYLARSONATE
I08'CL, ANTI-RH(D)
2INH11'CL, ANTI-HUMAN INSULIN
D115, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA)
Amu1d4-3'CL, ANTI-DNA
B9601 (Vg-Jk2)'CL, RHEUMATOID FACTOR
35.21'CL, ANTI-DSDNA
5C9'CL, ANTI-MOUSE CYTOCHROME C AROUND RESIDUE 62
ToPA145'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
C97-2B6'CL, ANTI-(TYR,GLU)-ALA-LYS
MRL4-159, ANTI-DNA, ANTI-NUCLEAR
132.26'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
185.6'CL, ANTI-DNA
22.111.1'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID22 HYBRIDOMA
ANTI-LEU3a'CL, ANTI-HUMAN CD4
8C16'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
b'CL, ANTI-IDIOTYPE (EXPRESSED ON THE SURFACE OF NON-HODGKIN'S LYMPHOMA CELLS)
HIV-b11'CL, ANTI-HIV-1 GP120
HIV-s2'CL, ANTI-HIV-1 GP120
40SNQP30, ANTI-2-PHENYLOXAZOLONE
RF-IP20'CL, RHEUMATOID FACTOR
NQT17/45C'CL, ANTI-2-PHENYLOXAZOLONE
281.12'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
RAY4'CL, ANTI HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (RIBOSYLRIBITOLPHOSPHATE)
L17'CL, ANTI-HIV-1 GP120
TE-32'CL, ANTI-CHOLERA TOXIN PEPTIDE 3
Ia_04-H'CL, ANTI-DINITROPHENYL
H146-24B3'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
Ca_20-H'CL, ANTI-DINITROPHENYL
Mb_56-H'CL, ANTI-DINITROPHENYL
COL'CL, POLYREACTIVE
22G12'CL, ANTI-SM HYBRIDOMA
H37-82'CL, ANTI-INFLUENZA VIRUS HEMAGGLUTININ HYBRIDOMA
1G7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
C3'''CL, ANTI-HUMAN PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1 TO 34 (KA=2.4X10EXP9)
cAbAM04, ANTI-ALPHA-AMYLASE
37.1E5.2'CL, ANTI-ALPHA 1,6 DEXTRAN
TB-2-H70'CL, RHEUMATOID FACTOR
180.7C9'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
HUMLA1114'CL, KIM11.4
D14'CL, ANTI-RH(D)
3-7'CL, ANTI-SM, ANTI-SSDNA
60.1B5'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
DNA9'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
HCV-65'CL, ANTI-PP65 VIRAL MATRIX PHOSPHOPROTEIN OF HUMAN CYTOMEGALOVIRUS
C3'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
119-a45'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
T33-1'CL, ANTI-DNA
mAb112'CL, ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
H1-70'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
3E5'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
AL3-2'CL, ANTI-POLYCATION
Y2'CL, ANTI-SMALL NUCLEOPROTEIN SM
165.60'CL, ANTI-DNA
1AB1'CL, ANTI-FLUORESCEIN
T10-1'CL, ANTI-T3 EPITOPE (GLY 225) OF INFLUENZA VIRUS HEMAGGLUTININ
91A3, ANTI-ARSONATE
10.43'CL, ANTI-DNA
PR-SJ1'CL, POLYREACTIVE RHEUMATOID FACTOR
F7-7'CL, ANTI-DNA
vl6-19'CL, ANTI-IGG2A RHEUMATOID FACTOR
23-4B1, ANTI-ARS
10/12'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=1.0X10EXP8)
tat16/31'CL, ANTI-HIV I TAT
9-3A9'CL, ANIT-DOUBLE STRANDED DNA
H220-1'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
VH-OX1'CL, ANTI-PHOX
KS6'CL, ANTI-DSDNA AUTOANTIBODY
BW7F5'CL, ANTI-DSDNA
H152-42A3'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
HSCFV198, ANTI-ACHR
H8''CL, ANTI-PRE-S2 ANTIGEN OF HEPATITUS B VIRUS (ADR SUBTYPE)
MRA7H'CL, ANTI-HISTONE
AF5'CL, ANTI-HUMAN ALPHA-FETOPROTEIN
MOPC 460'CL, ANTI-DINITROPHENYL HYBRIDOMA
T15 mutated, ANTI-PHOSPHORYLCHOLINE
p7B7.2'CL, ANTI-HERPESVIRUS 1
44SNQP10, ANTI-2-PHENYLOXAZOLONE
VL G64'CL, ANTI-GLUTATHIONE S-TRANSFERASE
rsv13L'CL, ANTI-RESPIRATORY SYNCYTIAL VIRUS F GLYCOPROTEIN
RB4v1.2, ANTI-CD19
lambda5'CL, ANTI-HUMAN THYROGLOBULIN
S17'CL, ANTI-ARS
HIV-LC7'CL, ANTI-HIV-1 GP120
NZW2C8'CL, ANTI-DSDNA
CH32'CL, ANTI-DISTEAROYL PHOSPHATIDYL CHOLINE, BROMELAIN-TREATED MOUSE ERYTHROCYTES, SHEEP ERYTHROCYTES, CHICKEN ERYTHROCYTES
TE1'CL, ANTI-TRICHOSANTHIN (AN ACTIVE COMPONENT OF A TRADITIONAL CHINESE MEDICINE USED FOR INDUCING ABORTION)
RF-IP15'CL, RHEUMATOID FACTOR
NQT15/10B'CL, ANTI-2-PHENYLOXAZOLONE
45-20, ANTI-DIGOXIN
3-13''CL, ANTI-FLUORESCEIN (KA=5.0X10EXP4)
CH1D6'CL, ANTI-FLUORESCEIN
B27'CL, ANTI-B2-GLYCOPROTEIN-1 (KD = 1.5 X 10EXP-6)
3F10'CL, ANTI-HUMAN PROCOLLAGENASE
MEMORY 1, ANTI-4-HYDROXY-3-NITROPHENYLACETYL
68.2C4'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
La 15-H'CL, ANTI-DNP
E17'CL, ANTI-PHOSPHOCHOLINE PROTEIN, P-NITROPHENYL PHOSPHOCHOLINE
mAb E'CL, ANTI-HALOPERIDOL.
RF-TS1'CL, RHEUMATOID FACTOR AUTOANTIBODY
S32'CL, ANTI-ARS
HMST-1'CL, ANTI-LACTOTETRAOSYLCERAMIDE
8/7p17'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
R21.10'CL, ANTI-P-AZOBENZENEARSONATE HYBRIDOMA
MRL1-33.2'CL, ANTI-DNA
D07'CL, ANTI-RH(D)
E11, ANTI-MOUSE KAPPA LIGHT CHAIN, ANTI-P-AZOPHENYLARSONATE-BSA (ANTI-ARS-BSA), ANTI-IDIOTYPE
Jb_37-H'CL, ANTI-DINITROPHENYL
TEPC601, ANTI-BETA 1,6 D-GALACTAN
AZ-7'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
8E10'CL, ANTI-DNA, IGG HYBRIDOMA
DN5'CL, ANTI-MCPS
A23'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
280.17'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
BrM4'CL, ANTI-E. COLI, BROMELAIN-TREATED MOUSE RBC, TRIMETHYLAMMONIUM HYBRIDOMA
119.1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
DN1'CL, ANTI-MCPS
NQT15/2'CL, ANTI-2-PHENYLOXAZOLONE
NANUC-1'CL, ANTI-NEUTROPHIL
NQ11.7.12'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
4H8'CL, ANTI-SSDNA HYBRIDOMA
alpha-poxn4, ANTI-POXN
T33-14'CL, ANTI-DNA AUTOANTIBODY
1E127'CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
39D10, HUMAN IL-5
SiP036'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
248.8D2'CL, ANTI-PHOSPHOCHOLINE-SPECIFIC DETERMINANT IN PROTEUS MORGANII
180.6D10'CL, ANTI-PHOSPHORYLCHOLINE (P. MORGANII) HYBRIDOMA
2A4'CL, ANTI-DNA
73-3'CL, ANTI-DNA
ToPA137'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
167.1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
4.18'CL, KIM11.4
cAbCA06, ANTI-CARBONIC ANHYDRASE
16'CL, ANTI-DSDNA
BSb20'CL, ANTI-PHOSPHORYLCHOLINE
E18'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
HuMc3, ANTI-BA46 (A 46-KDA GLYCOPROTEIN OF THE HUMAN MILK FAT GLOBULE MEMBRANE EXPRESSED IN BREAST CARCINOMA CELLS)
3C10'CL, ANTI-FECAL BACTERIA
3374, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
4C8 (TE4)'CL, ANTI-TRICHOSANTHIN (AN ACTIVE COMPONENT OF A TRADITIONAL CHINESE MEDICINE USED FOR INDUCING ABORTION)
SiP001'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
417.F9.5'CL, MONOREACTIVE TO SSDNA
mAb A41'CL, ANTI-HUMAN INTERLEUKIN-2 RECEPTOR BETA SUBUNIT (P75)
D3F3'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE
1.6'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
3A3.C2'CL, ANTI-HORSE 60 CYTOCHROME C
B17-5'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
LS4'CL, ANTI-PR2 RBC AUTOANTIBODY
CAL-13'CL, ANTI-CARDIOLIPIN
ALN/16/53'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
126.33'CL, ANTI-B1335 DEX
Mb_17-H'CL, ANTI-DINITROPHENYL
TEL14'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
FS-8'CL, COLD AGGLUTININ
E3'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
40SNQP9, ANTI-2-PHENYLOXAZOLONE
126TP1H'CL, ANTI-THYROID PEROXIDASE (TPO)
FF29-36-2'CL, ANTI-P-AZOPHENYLARSONATE
PL2-1'CL, ANTI-SUBNUCLEOSOMES (H2A-H2B-DNA)
H17-L7'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
C3H-5'CL, ANTI-DNA
NC6.8'CL, ANTI-(N-(P-CYANOPHENYL)-N'-(DIPHENYLMETHYL)GUANIDINE ACETIC ACID COUPLED TO BSA
MMW.7.14'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
s4D5'CL, ANTI-SSDNA/CARDIOLIPIN AUTOANTIBODY
3-31'CL, ANTI-SM HYBRIDOMA
HIV-LC22'CL, ANTI-HIV-1 GP120
RR.VH1.2'CL, ANTI-CARDIOLIPIN/SSDNA AUTOANTIBODY
8C40'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
E3, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
E03'CL, ANTI-RH(D)
SiP021'CL, ANTI-CAPSULAR POLYSACCHARIDE OF HAEMOPHILUS INFLUENZAE TYPE B
PC281'CL, ANTI-PSICT3
219.23'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-FICOLL HYBRIDOMA
L1'CL, ANTI-HEN EGG WHITE LYSOZYME
113FU'CL, ANTI-FLUORESCEIN
Day 4 15-164-17'CL, ANTI-2-PHENYL-5-OXAZOLONE
WG1'CL, ANTI-PROTEINASE 3
1E9'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
3F29-5-34'CL, ANTI-P-AZOPHENYLARSONATE
C80-4E12'CL, ANTI-POLY-D,L-ALA-POLY-L-LYS HYBRIDOMA
103-A13'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
3B9'CL, ANTI-MORPHINE
402K-D1, ANTI-HIV GP120 V3-LOOP (K OFF = 3.9 X 10EXP-4 SEC-1)
A'CL, ANTI-2-PHENYLOXAZOL-5-ONE
H10''CL, ANTI-LAMININ
FF61-2-E2'CL, ANTI-P-AZOPHENYLARSONATE
kappa4'CL, ANTI-HUMAN THYROGLOBULIN
B'CL, ANTI-2-PHENYLOXAZOL-5-ONE
ITC63B'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
DSC, ANTI-IDIOTYPIC
BW24-P23'CL, ANTI-DNA
L17'CL, AUTOANTIBODY
Z116VH4'CL, CD20
MH6'CL, ANTI-ACETYLCHOLINE RECEPTOR
NQT15/17B'CL, ANTI-2-PHENYLOXAZOLONE
PA4'CL, ANTI-CHROMATIN
MRL-DNA4'CL, ANTI-DNA AUTOANTIBODY
CNJ206'CL, ANTI-P-NITROPHENYL PHOSPHONATE
Mab2'CL, ANTI-PHOSPHORYLCHOLINE SPECIFIC FOR TRICHINELLA SPIRALIS
3-C4F5, ANTI-TESTOSTERONE
AL3-3'CL, ANTI-POLYCATION
73-12'CL, ANTI-DNA
kappa2'CL, ANTI-HUMAN THYROGLOBULIN
HG2B10K'CL, ANTI-GANGLIOSIDE AUTOANTIBODY (GA1)
N01'CL, ANTI-RH(D)
18B7'CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
L93'CL, ANTI-HUMAN CD4
CAL-11'CL, ANTI-CARDIOLIPIN
LV1L1'CL, RHEUMATOID FACTOR
626'CL, ANTI-MEP-1 17-31 PEPTIDE
NN3'CL, ANTI-HUMAN N BLOOD GROUP ANTIGEN
402P4-B5, ANTI-HIV GP120 V3-LOOP (K OFF = 0.88 X 10EXP-4 SEC-1)
VK2.R149'CL, ANTI-CARDIOLIPIN/SSDNA AUTOANTIBODY
hsiggll150'CL, ANTI-RABBIT IGG
C39'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC) EPITOPE 2 (KD = 2.3 X 10EXP-9)
mAb59'CL, ANTI-RABIES VIRUS
19A5'CL, ANTI-RH(D)
CLONE 1F7'CL, ANTI-HUMAN RED BLOOD CELL
AKR-7'CL, ANTI-DNA
TEPC191, ANTI-BETA 1,6 D-GALACTAN
L2-10CL'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
C15'CL, ANTI-BOTULINUM NEUROTOXIN TYPE A BINDING DOMAIN (BONT/A HC)
Sulf-2'CL, ANTI-P-AZOPHENYLSULFONATE-KEYHOLE LYMPET HEMOCYANIN
9/24'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=7X10EXP7)
8.3.6'CL, ANTI-DNA, ACTIN, MYOSIN
BSb10'CL, ANTI-PHOSPHORYLCHOLINE
NQT15/4B'CL, ANTI-2-PHENYLOXAZOLONE
mAb B''CL, ANTI-CYCLOSPORINE
Ma_12-H'CL, ANTI-DINITROPHENYL
NQ2 45.1'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
L2E5'CL, ANTI-SSDNA/CARDIOLIPIN AUTOANTIBODY
E4'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
48SNQP104, ANTI-2-PHENYLOXAZOLONE
Da_12-H'CL, ANTI-DINITROPHENYL
F5-2'CL, ANTI-ACTIN, MYOSIN, TUBULIN, DSDNA, SSDNA AUTOANTIBODY (BINDING CONTANTS RANGE BETWEEN 10EXP6 TO 10EXP8)
PE19'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
HA3D1'CL, RHEUMATOID FACTOR
1-9'CL, ANTI-IGG2A
9C6E10'CL, ANTI-FLUORESCEIN
aPC-126-6'CL, ANTI-PHOSPHORYLCHOLINE COUPLED TO KLH AND BSA HYBRIDOMA (GROUP II)
Amu6-3'CL, ANTI-DNA
Fc_03-H'CL, ANTI-DINITROPHENYL
Mb_02-H'CL, ANTI-DINITROPHENYL
BW24-G13'CL, ANTI-DNA
128'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
XRPC25, ANTI-DINITROPHENYL
Lb 23-H'CL, ANTI-DNP
F5-1126'CL, ANTI-IDIOTYPIC ANTIBODY AGAINST ANTI-HLA-DR1,4,W14,W8,9 MAB AC1.59 COUPLED WITH KEYHOLE LIMPET HEMOCYANIN
1/11'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
DPA'CL, ANTI-GLUTAMIC ACID DECARBOXYLASE 65
Q'CL, ANTI-2-PHENYLOXAZOL-5-ONE
26/9'CL, ANTI-INFLUENZA HEMAGGLUTININ PEPTIDE 98-110, YPYDVPDYASLRS
GP13'CL, ANTI-CD4-BINDING SITE OF HIV-1 GP120.
6O'CL, ANTI-DNA
FS-6'CL, COLD AGGLUTININ
NQ19.2.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
43SNQP15, ANTI-2-PHENYLOXAZOLONE
2F8.C10'CL, ANTI-RAT 44 CYTOCHROME C
cyd-1'CL, ANTI-CYTIDINE
A/J-ANTI-ARS, ANTI-P-AZOPHENYLARSONATE
9500'CL, ANTI-DENATURED DNA, ANTI-PLATELET
5G5'CL, ANTI-HUMAN PROCOLLAGENASE
D17'CL, ANTI-RH(D)
Ga_17-H'CL, ANTI-DINITROPHENYL
S/SB5-41'CL, ANTI-H4
KL.SJA83.12'CL, ANTI-DEXTRAN B1355 HYBRIDOMA
NC9B4'CL, ANTI-PHOSPHATIDYL CHOLINE HYBRIDOMA
VH A47, ANTI-CD34
MMW.2.6.15'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
hsiggll295'CL, ANTI-RABBIT IGG
25-5E10'CL, ANTI-(T,G)-A--L HYBRIDOMA
mAb 125'CL, ANTI-INSULIN HYBRIDOMA
1E13'CL, ANTI-RABBIT-ANTI-MOUSE-C-LAMBDA-2 ANTIBODY COUPLED TO LIPOPOLYSACCHARIDE HYBRIDOMA
NQ5 78.2.6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
110'CL, ANTI-KEY HOLE LIMPET HEMOCYANIN-COUPLED ANGIOTENSIN II
SS, ANTI-RECOMBINANT MESOTHELIN
NC5-A11'CL, ANTI-PHOSPHATIDYL CHOLINE
71-4H12'CL, ANTI-PHOSPHORYLCHOLINE HYBRIDOMA
mAb111'CL, ANTI-IGG FC FRAGMENT RHEUMATOID FACTOR
NQ10.2.12.4'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
slkv11'CL, ANTI-IGG POLYCLONAL RHEUMATOID FACTOR
MMW.8.16'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
WRD1'CL, RHEUMATOID FACTOR
7C5'CL, ANTI-SM HYBRIDOMA
103-2'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
L59'CL, ANTI-HIV-1 GP120
NQT17/53A'CL, ANTI-2-PHENYLOXAZOLONE
DB1-453.2'CL, ANTI-5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL HYBRIDOMA
ANTI-DNP, ANTI-DINITROPHENYL
IgG2a-2'CL, ANTI-DINITROPHENYL
24F3'CL, ANTI-P-AZOPHENYLARSONATE
Day 4 15-164-11'CL, ANTI-2-PHENYL-5-OXAZOLONE
RF-MR20'CL, RHEUMATOID FACTOR
L22'CL, AUTOANTIBODY
Pab 405'CL, ANTI-CARBOXYL TERMINUS OF SV40 T ANTIGEN
YFC51.1'CL, ANTI-HUMAN CD18
43SNQP17, ANTI-2-PHENYLOXAZOLONE
scFv195'CL, ANTI-MIR
Ga_11-H'CL, ANTI-DINITROPHENYL
RF-IP14'CL, RHEUMATOID FACTOR
19.1.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
JV6, ANTI-IGG MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
BKV29'CL, ANTI-DSDNA
G5 BB 2.2 (AB1), ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
H36-8'CL, ANTI-INFLUENZA VIRUS (A/PR/8/34) HEMAGGLUTININ SECONDARY ANTIBODIES (SB) HYBRIDOMA
26-10, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=3.1X10EXP9)
402L-E12, ANTI-HIV GP120 V3-LOOP (K OFF = 2.2 X 10EXP-4 SEC-1)
scFv6, ANTI-LOW DENSITY LIPROPROTAIN RECEPTOR THUS INHIBITING RHINOVIRUS INFECTION
LD-3'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
M2 76'CL, ANTI-MOUSE TYPE II COLLAGEN
scFv40'CL, ANTI-COAT PROTEIN OF POTATO VIRUS V
PC45'CL, ANTI-PS1CT3
MICA 2'CL, ANTI-GLUTAMATE DECARBOXYLASE (MAJOR ISLET CELL AUTOANTIGEN)
40-90, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=5.4X10EXP9)
DNA5'CL, ANTI-CALF THYMUS DNA HYBRIDOMA
ALN/12/88'CL, ANTI-CHONDROITIN SULPHATE PROTEOGLYCAN NG2, A TUMOR-SPECIFIC ANTIGEN ON THE 3-4 BENZPYRENE-INDUCED RAT CHONDROSARCOMA HSN
MMW.8.9'CL, ANTI-(4-HYDROXY-3-NITROPHENY)ACETYL
MRL3-41'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
MRL2-18'CL, ANTI-SSDNA, ANTI-HOMOGENOUS NUCLEAR
K87-529, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
PD1'CL, ANTI-CHROMATIN
KS13'CL, ANTI-HLA-DQ3
RF-2, ANTI-RSV
PA2'CL, ANTI-CHROMATIN
ToPG410'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
10G9'CL, ANTI-IDIOTYPIC ANTIBODY TO THE MONOCLONAL ANTI-HALOPERIDOL ANTIBODY WITH SPECIFIC BINDING AFFINITY TO SIGMA RECEPTOR
7A9, ANTI-E-SELECTIN (AN ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1)
tat104/107'CL, ANTI-HIV I TAT
N1F10'CL, ANTI-PSEUDOMONAS AERUGINOSA A-BAND LIPOPOLYSACCHARIDE
DN2'CL, ANTI-MCPS
Y238 scFv'CL, ANTI-P21 RAS
CLONE 1B4'CL, ANTI-HUMAN RED BLOOD CELL
NC19-E10'CL, ANTI-PHOSPHATIDYL CHOLINE
VH BEN'CL, ANTI-LAMIN B AUTOANTIBODY
Ma_65-H'CL, ANTI-DINITROPHENYL
D8'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
20.119.25'CL, ANTI-BALB/C ANTI-IDIOTYPIC MONOCLONAL ANTIBODY HP-ID20 HYBRIDOMA
402P4-D11, ANTI-HIV GP120 V3-LOOP (K OFF = 1.3 X 10EXP-4 SEC-1)
36.1.2D'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
SB1/D8'CL, ANTI HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (RIBOSYLRIBITOLPHOSPHATE)
1261P5K'CL, ANTI-THYROID PEROXIDASE (TPO)
NQT15/24A'CL, ANTI-2-PHENYLOXAZOLONE
ITC63B'CL, ANTI-MAJOR NEUTRALIZATION DETERMINANT (AD-1) OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B (GP58/116)
HUM1V1LI'CL, KIM11.4
1G10'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA
NQT15/3A'CL, ANTI-2-PHENYLOXAZOLONE
61.1E9.9'CL, ANTI-IDIOTYPIC ANTIBODY
627'CL, ANTI-MEP-1 17-31 PEPTIDE
14-43E4, ANTI-ARS
N4-2'CL, ANTI-DS DNA HYBRIDOMA
A25.9.7'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
L6' 'CL, ANTIBODY TO A CARBOHYDRATE ANTIGEN ON SURFACE OF HUMAN CARCINOMAS OF LUNG, BREAST AND OVARY
E11-14'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL-CONJUGATED CHICKEN GAMMA GLOBULIN
NQT15/26A'CL, ANTI-2-PHENYLOXAZOLONE
L47'CL, THE AUTHORS ESTIMATED THAT THERE ARE ABOUT 0.2-0.5% OF PERIPHERAL BLOOD B LYMPHOCYTES WHICH ARE KAPPA + AND LAMBDA +.
HIV-LC5'CL, ANTI-HIV-1 GP120
N02'CL, ANTI-RH(D)
H'CL, ANTI-2-PHENYLOXAZOL-5-ONE
62'CL, ANTI-THYROGLOBULIN AUTOANTIBODY HYBRIDOMA
1F4'CL, ANTI-IDIOTOPE OF 4-4-20
CBLC270.1'CL, ANTI-BACTERIAL LEVAN
Mb_44-H'CL, ANTI-DINITROPHENYL
6-2, ANTI-DINITROPHENYL HYBRIDOMA,EPSILON-DNP-AMINOCAPROATE(BINDING CONSTANT=3.5X10EXP6)
43SNQP25, ANTI-2-PHENYLOXAZOLONE
3-19'CL, ANTI-SM HYBRIDOMA
6.29'CL, ANTI-PNEUMOCOCCAL/ANTI-DSDNA
Y19-10'CL, ANTI-IGG HYBRIDOMA
H1-90'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
Nb 56-H'CL, ANTI-DNP
clone 2'CL, ANTI-F(AB')2 AUTOANTIBODY
Fc_17-H'CL, ANTI-DINITROPHENYL
A8/4'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
TB-3-D6'CL, RHEUMATOID FACTOR
48SNQP119, ANTI-2-PHENYLOXAZOLONE
OX-34, ANTI-RAT CD2
F12'CL, ANTI-DESMOSOME AUTOANTIBODY
La 02-H'CL, ANTI-DNP
2A1-62'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
mAb E''CL, ANTI-HALOPERIDOL.
126TP6H'CL, ANTI-THYROID PEROXIDASE (TPO)
Na 20-H'CL, ANTI-DNP
SW2-2'CL, ANTI-DNA
BW19G10'CL, ANTI-DSDNA
202p.38'CL, ANTI-DNA
126TP7K'CL, ANTI-THYROID PEROXIDASE (TPO)
NQ16.113.8'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
168'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
g'CL, ANTI-2-PHENYLOXAZOL-5-ONE
C488-21G'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
IgG2a-1'CL, ANTI-DINITROPHENYL
G8 AD 3.8, ANTI-POLY(GLU60,ALA30,TYR10) BALB/C HYBRIDOMA
HUC'CL, ANTI-SM
Lb 30-H'CL, ANTI-DNP
H2-4C2'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
A.22'CL, ANTI-ARS
4D2.5'CL, ANTI-HISTONE 2A-HISTONE 2B-DNA SUBNUCLEOSOME
C6B2'CL, ANTI-DNA HYBRIDOMA
heavy3'CL, ANTI-HUMAN THYROGLOBULIN
H1-24'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
I09'CL, ANTI-RH(D)
C488-15E'CL, ANTI-(4-HYDROXY-3-NITRO-PHENYL) ACETYL COUPLED TO CHICKEN GAMMA GLOBULIN
HA-4'CL, ANTI-ERYTHROCYTE
2F7'CL, ANTI-HUMAN PROCOLLAGENASE
SD15'CL, ANTI-POLYSACCHARIDE OF HEMOPHILUS INFLUENZAE TYPE B
HY GAL1, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
PE15'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
BWR5.H'CL, ANTI-RNA,POLY(A)-POLY(U),POLY(I)-POLY(C)
48SNQP27, ANTI-2-PHENYLOXAZOLONE
Fa_07-H'CL, ANTI-DINITROPHENYL
Jb_40-H'CL, ANTI-DINITROPHENYL
224.4B11'CL, ANTI-PHOSPHORYLCHOLINE (S.PNEUMONIAE STR. R36A) HYBRIDOMA
TEL9'CL, ANTI-TURKEY EGG-WHITE LYSOZYME
Ab21'CL, POLYREACTIVE AUTOANTIBODY
AC41'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
3C6'CL, ANTI-FECAL BACTERIA
48SNQP22, ANTI-2-PHENYLOXAZOLONE
163.7, ANTI-P53
EL-16'CL, ANTI-FACTOR VIII
111.109'CL, ANTI-DNA
TR1.8'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
2B2'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
57R-1'CL, ANTI-3M-1/ANTI-TUBULAR BASEMENT MEMBRANE
44SNQP9, ANTI-2-PHENYLOXAZOLONE
1B5'CL, ANTI-FECAL BACTERIA
48SNQP132, ANTI-2-PHENYLOXAZOLONE
17s.83'CL, ANTI-DNA
H140-1E6'CL, ANTI-CA/CB SITE OF INFLUENZA VIRUS A/PR/8/34 HEMAGGLUTININ (PR8 HA)
Ca_22-H'CL, ANTI-DINITROPHENYL
UCVK'CL, ANTI-DNA, ANTI-MYELIN
179'CL, ANTI-(4-HYDROXY-3-NITROPHENYL) ACETYL
Da_07-H'CL, ANTI-DINITROPHENYL
hVH65-212'CL, ANTI-P-AZOPHENYLARSONATE HYBRIDOMA(BINDING CONSTANT=3.6X10EXP6)
T15-H11-CDR, ANTI-PHOSPHORYLCHOLINE
tat31'CL, ANTI-HIV-1 TAT
pB8S1'CL, ANTI-HERPESVIRUS 1
103-A1'CL, ANTI-HAPTEN 2-PHENYL-5-OXAZOLONE
VH4-34, ANTI-VH4-34
AC37'CL, ANTI-HUMAN CYTOMEGALOVIRUS (CMV) MEMBRANE GLYCOPROTEIN GP58/116 (GB) AD2 EPITOPE, RESIDUES 67 TO 86 OF GP116
JV2'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
BS-5, ANTI-TYPE III PNEUMOCOCCAL POLYSACCHARIDE
AZ-30'CL, CATALYTIC OXY-COPE ANTIBODY SPECIFIC FOR A COMMON TRANSITION STATE ANALOG HAPTEN
Lb 22-H'CL, ANTI-DNP
L16'CL, ANTI-POLYDT, CARDIOLIPIN, AND SSDNA
13G7'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
NQT17/53C'CL, ANTI-2-PHENYLOXAZOLONE
Clone F'CL, RHEUMATOID FACTOR WHICH BOUND SPECIFICALLY TO MRL IGG2A ALLOTYPE (IGH-1J) BUT NOT B6 IGG2A ALLOTYPE (IGH-1B)
ToPA203'CL, ANTI-HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE
Fom-1'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
AKR-9'CL, ANTI-DNA
H1-12'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL HYBRIDOMA
BW24-11'CL, ANTI-DNA
3E3'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
T15, ANTI-PHOSPHORYLCHOLINE
37A4'CL, ANTI-ALPRENOLOL HYBRIDOMA
MRL3-38'CL, ANTI-DNA
SC13'CL, ANTI-MCPS
C9'CL, ANTI-THYROID PEROXIDASE AUTOANTIBODY
10.2.8a'CL, ANTI-ALPHA 1,6 DEXTRAN
C'CL, ANTI-2-PHENYLOXAZOL-5-ONE
HOPC8, ANTI-PHOSPHORYLCHOLINE(BINDING CONSTANT=2.4X10EXP5)
aly54-31'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL
AT13/5'CL, ANTI-CD38, A SURFACE ANTIGEN ON MYELOMA CELLS
2H1''CL, ANTI-CRYPTOCOCCUS NEOFORMANS (SEROPTYPE A) GLUCURONOXYLOMANNAN-TETANUS TOXOID CONJUGATE
Jac-10'CL, ANTI-ERYTHROCYTE RH(D) ALLOANTIGEN
NQ10.1.12'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
1F6'CL, ANTI-PRE-S2 REGION OF HEPATITIS B VIRUS
CH1H12'CL, ANTI-FLUORESCEIN
HIV-LC28'CL, ANTI-HIV-1 GP120
La 52-H'CL, ANTI-DNP
PE14'CL, ANTI-HUMAN PROENKEPHALIN, A NEUROPEPTIDE PRECURSOR, PEPTIDE 155DLLKELL161
E2''CL, ANTI-HUMAN PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1 TO 34 (KA=6.8X10EXP8)
B10H2'CL, ANTI-THYROGLOBULIN AUTOANTIBODY HYBRIDOMA
t'CL, ANTI-2-PHENYLOXAZOL-5-ONE
NQ10 12.4.6'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
402J-G3, ANTI-HIV GP120 V3-LOOP (K OFF = 2.1 X 10EXP-4 SEC-1)
44SNQP17, ANTI-2-PHENYLOXAZOLONE
kappa1'CL, ANTI-HUMAN THYROGLOBULIN
AIG'CL, ANTI-FC IGG
A26'CL, ANTI-IGG1 MONOCLONAL AUTOANTIBODY (RHEUMATOID FACTOR)
Bg46-1'CL, ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL (KA=1.3X10EXP7)
RF-IP4'CL, RHEUMATOID FACTOR
RF3-5A'CL, ANTI-IGG1
12S84-3'CL, ANTI-ANTI-ARSONATE ANTIBODY HYBRIDOMA
Y5236, ANTI-PHOSPHORYLCHOLINE
XRPC24, ANTI-BETA 1,6 D-GALACTAN
BP.2.5'CL, ANTI-HIV-1 GP120 V3 LOOP
3-13'CL, ANTI-FLUORESCYL HAPTEN
SAPC10, ANTI-BETA 1,6 D-GALACTAN
H61-15'CL, ANTI-A/PR/8/34 INFLUENZA VIRUS HEMAGGLUTININ DIRECTED TO THE CB SITE
NQ22.15.18'CL, ANTI-2-PHENYL OXAZOLONE HYBRIDOMA
MVAR1'CL, ANTI-2-PHENYLOXAZOL-5-ONE
Fab-7, ANTI-HUMAN PROTEIN C
11A10'CL, ANTI-SM HYBRIDOMA
CEM231.6.7'CL, ANTI-HUMAN CARCINOEMBRYONIC ANTIGEN HYBRIDOMA
1-18'CL, ANTI-SM HYBRIDOMA
12-40'CL, ANTI-FLUORESCEIN (KA=3.4X10EXP6)
B43'CL, ANTI-CD19
417.F32.36'CL, MONOREACTIVE
6-2F11, ANTI-ARS
KOL-based resh. CAMPATH-9, ANTI-HUMAN CD4
